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 Neural circuit assembly requires that the axons and dendrites of the same neuron do not 
overlap each other while interacting freely with those from different neurons. This requires that 
each neuron have a unique cell surface identity to that of its neighbors and that neural self-
recognition leads to repulsion, a process known as self-avoidance. Self-avoidance is perhaps 
best understood in Drosophilia, where homophilic recognition between individual Dscam1 
isoforms on the cell surface of neurons leads to repulsion between sister dendrites and axons. 
However, in contrast to Drosophila, where alternative splicing of the Dscam1 gene can generate 
thousands of isoforms, vertebrate Dscam genes do not generate significant diversity. The most 
promising candidate to fill this role in vertebrates is the clustered protocadherins (Pcdhs). 
Despite this hypothesis, little is known about clustered Pcdh proteins and how they interact. 
The clustered Pcdh genes are encoded in three contiguous gene loci, Pcdha, Pcdhb, 
and Pcdhg, which encode three related families of proteins, Pcdhα, -β, and -γ isoforms. Pcdh 
isoforms are comprised of six extracellular cadherin (EC) domains, a single-pass 
transmembrane domain, a short cytoplasmic extension, and, in the case of Pcdhα and Pcdhγ 
isoforms, a cluster-specific intracellular domain. Recent work showed that the Pcdhg gene 
cluster is required for self-avoidance starburst amacrine and Purkinje cells in mouse. Another 
recent study characterized the homophilic binding properties of a subset of Pcdhγ isoforms and 
suggested that Pcdhγ isoforms form promiscuous cis tetramers with distinct trans binding 
specificities. However, these conclusions were based on bulk binding assays and molecular 





determine molecular weights of elongated molecules such as Pcdhs. The binding properties of 
Pcdhα and Pcdhβ isoforms also remain unknown. 
The primary goal of this thesis is to characterize the binding properties of Pcdh 
complexes. In this work, we perform extensive cell aggregation studies showing that Pcdh 
isoforms from each gene cluster can mediate specific homophilic interaction, that cell surface 
delivery of Pcdhα isoforms requires cis interactions with other Pcdh isoforms, and that the EC6 
domain plays a critical role in this process. Further, we show that combinatorial expression of up 
to five distinct Pcdh isoforms generates new cell recognition specificities depending on the 
identity of all isoforms expressed. Remarkable, even a single mismatched Pcdh isoform 
between two cells interferes with their ability to interact. Theoretical considerations based on 
these findings suggesting that while the formation of Pcdh cis multimers increases Pcdh 
diversity, the current prevailing model of promiscuous cis tetramers encounters problems in self-
recognition. We present possible alternative mechanisms but the nature of the Pcdh recognition 
complex remains to be determined. 
We have also performed extensive bioinformatics analysis, structural, mutational, and 
biophysical studies to better understand Pcdh structure and the mechanism through which 
Pcdhs may mediate recognition. Sequence comparisons with related “classical” cadherins show 
that Pcdh molecular architecture and adhesive mechanism differs from that of classical 
cadherins. The classical cadherins contain five extracellular (EC) domains while the Pcdhs 
contain six. Classical cadherins bind in trans through an adhesive interface mediated by their 
EC1 domains. Following cell-cell contact, classical cadherins form cis interactions and form 
ordered assemblies known as adherens junctions. In contrast to cells expressing classical 
cadherins, whose binding specificity is determined primarily through by the membrane-distal 
EC1 domain, neurons expressing Pcdhs are likely to achieve their identity through the formation 





previous studies of Pcdhγ isoforms suggested that EC1 is necessary for binding and that that 
EC2 and EC3 domains are the specificity determining regions. This study also suggested that 
Pcdh binding is much less calcium dependent than classical cadherins. 
Another goal of this work was to determine the structural basis for Pcdh specificity. Here 
we present x-ray structures of the amino-terminal EC1-EC3 domains of PcdhγC5, which contain 
the specificity determining region. Both biophysical characterization and the crystal structures 
indicate that this protein behaves as a monomer. Nevertheless, we have built homology models 
for the EC1-EC3 domains of Pcdhs from each cluster and performed domain shuffling and 
mutagenesis experiments that localize the binding interface to a specific region near the EC2-
EC3 junction. Our domain shuffling experiments also show that, in addition to the EC2 and EC3 
domains, EC1 is important to Pcdh trans binding specificity. Indeed, in all cases tested, shuffling 
the EC1-EC3 domains between Pcdh isoforms alters the binding specificity to that of the EC1-
EC3 domains. Given these results, why is it that the soluble PcdhγC5 EC1-EC3 behaves as a 
monomer? 
A likely possibility is that cis interactions in the membrane proximal EC4-EC6 domains 
are required in order to form a functional trans binding interface. In cell aggregation assays, only 
Pcdh constructs containing EC1-EC3 and at least one of the membrane-proximal (EC4, EC5, or 
EC6) domains can mediate cell aggregation. In addition, we produced soluble Pcdh proteins 
containing EC1-EC4, EC1-EC5, and EC1-EC6 and characterized them biophysically. In each 
case tested, soluble Pcdhs containing at least the first four N-terminal EC domains form 
multimeric complexes. Whether the interactions we observe occur in trans or in cis remains to 
be determined. Although these efforts have not yet revealed the nature of Pcdh complexes or 
the binding interface, the experiments and methods described here lay the ground work for 






Table of Contents 
List of Tables .............................................................................................................................................. iv 
List of Figures ............................................................................................................................................ iv 
Acknowledgements .................................................................................................................................... v 
Dedication .................................................................................................................................................. vii 
Chapter 1. Introduction ............................................................................................................................... 1 
Neuronal diversity and self-avoidance ...................................................................................................... 1 
Invertebrate Dscams ................................................................................................................................. 1 
Clustered protocadherins .......................................................................................................................... 5 
Cadherin superfamily .............................................................................................................................. 12 
Classical cadherins ................................................................................................................................. 15 
Non-classical cadherins - Protocadherin-15, cadherin-23, and DN-cadherin ......................................... 20 
Significance of the work presented in this dissertation ........................................................................... 21 
Chapter 2. Generation of single cell identity by specific homophilic interactions between ............. 23 
combinations of α, β, and γ protocadherins (Manuscript in review) .................................................... 23 
Chapter Introduction ................................................................................................................................ 23 
Summary ................................................................................................................................................. 25 
Introduction.............................................................................................................................................. 25 
Results .................................................................................................................................................... 29 
Discussion ............................................................................................................................................... 36 
Experimental procedures ........................................................................................................................ 43 
Figure Legends ....................................................................................................................................... 44 
Supplemental Figures ............................................................................................................................. 57 
Supplemental information ........................................................................................................................ 64 
Chapter 3. Protocadherin construct design, protein production and purification............................. 79 
Introduction.............................................................................................................................................. 79 
Methods................................................................................................................................................... 81 
Vectors and constructs ........................................................................................................................ 81 
Protein production – adherent system ................................................................................................ 84 
Protein production – suspension system ............................................................................................ 85 
Protein purification .............................................................................................................................. 86 





Results .................................................................................................................................................... 87 
Prediction of N-terminus ...................................................................................................................... 87 
Design of the C-terminus for Pcdh expression constructs .................................................................. 88 
Pcdh expression optimization and purification in adherent cells ........................................................ 89 
Pcdh expression optimization and purification in suspension cells .................................................... 90 
PcdhγC5 characterization by deglycosylases and native gel electrophoresis .................................... 94 
Discussion ............................................................................................................................................... 95 
Chapter 4. Biophysical characterization of purified Pcdhs .................................................................. 97 
Introduction ........................................................................................................................................... 97 
Methods.................................................................................................................................................. 98 
Size Exclusion Chromatography - Multi-angle light scattering (SEC-MALS) ...................................... 98 
Analytical Ultracentrifugation (AUC)- Sedimentation Equilibrium Experiments .................................. 99 
Results .................................................................................................................................................. 100 
Sedimentation equilibrium experiments with PcdhγC5 EC1-EC3 and PcdhαC2 EC1-EC6 produced in 
adherent cells .................................................................................................................................... 100 
SEC-MALS and sedimentation equilibrium experiments of PcdhγC5 EC1-EC3 Strep-his produced in 
suspension cells ................................................................................................................................ 100 
Biophysical data summary for other Pcdh constructs ....................................................................... 101 
Discussion ........................................................................................................................................... 103 
Chapter 5. Crystallization, data collection, phasing, and structure determination of PcdhγC5 EC1-
EC3 ........................................................................................................................................................... 106 
Introduction ......................................................................................................................................... 106 
Methods................................................................................................................................................ 108 
Crystallization Screens (96-well) and optimization ........................................................................... 108 
Heavy atom soaks and re-screening with YbCl3 ............................................................................... 109 
Data Collection at APS ID-24E ......................................................................................................... 110 
Data processing, phasing and solving the structures of each crystal form ....................................... 110 
K562 cell aggregation assay ............................................................................................................. 111 
Results ................................................................................................................................................. 111 
Crystallization screens, optimization, data collection, and analysis (native data sets) ..................... 111 
Crystallization screens, optimization, data collection, and phasing .................................................. 115 
Model building, and refinement for P43212 crystal form .................................................................... 118 
Molecular replacement and refinement of C2 and P21 crystal forms ................................................ 119 
Comparison of all three crystal forms ............................................................................................... 121 
Analysis of the N-terminus ................................................................................................................ 124 
Discussion ........................................................................................................................................... 125 
Chapter 6. Crystallization trials of additional Pcdhs: PcdhγB6 EC1-EC6, PcdhγB6 EC1-EC5, Pcdhα7 
EC1-EC5, PcdhγA8 EC1-EC4, and Pcdhβ1 EC1-EC3 ........................................................................... 127 
Introduction............................................................................................................................................ 127 
Methods................................................................................................................................................. 128 





PcdhγB6 EC1-EC6 crystal optimization and freezing ....................................................................... 128 
Pcdhα7 EC1-EC5 crystal optimization and freezing ......................................................................... 129 
PcdhγA8 EC1-EC4 crystal optimization and freezing ....................................................................... 130 
PcdhγC5 EC1-EC3 ExtN crystal optimization and freezing .............................................................. 130 
Data Collection at APS ID-24E ......................................................................................................... 131 
Results .................................................................................................................................................. 131 
Discussion ............................................................................................................................................. 134 
Chapter 7. Identification of Pcdh trans binding specificity determining regions (Manuscript in 
preparation) ............................................................................................................................................. 136 
Introduction............................................................................................................................................ 136 
Identification of Pcdh trans binding specificity determining regions...................................................... 138 
Summary ............................................................................................................................................... 138 
Introduction............................................................................................................................................ 138 
Results .................................................................................................................................................. 141 
Rod-like structure of PcdhγC5 ........................................................................................................... 141 
Pcdh binding is calcium dependent .................................................................................................. 143 
Identification of candidate specificity determining regions in EC1, EC2, and EC3 ........................... 143 
EC Domain shuffling between closely-related Pcdh isoform pairs ................................................... 144 
Identification of specificity-determining residues in EC1, EC2, and EC3 ......................................... 146 
Charge scanning mutations of PcdhγC5 can abrogate binding ........................................................ 147 
Discussion ........................................................................................................................................... 148 
Methods................................................................................................................................................. 150 
Figures .................................................................................................................................................. 153 
Tables ................................................................................................................................................... 158 
Figure Legends ................................................................................................................................... 159 
Supplemental Figures ......................................................................................................................... 162 
Future Directions ................................................................................................................................... 164 
Characterization and crystallization of additional Pcdh constructs ................................................... 164 
Additional possibilities for uses of purified Pcdh proteins ................................................................. 165 
Future Directions ................................................................................................................................... 168 
Characterization and crystallization of additional Pcdh constructs ................................................... 168 
Additional possibilities for uses of purified Pcdh proteins ................................................................. 169 








List of Tables 
Table 1. Vectors used for Pcdh expression ...............................................................................82 
Table 2. Pcdh Expression Constructs .......................................................................................84 
Table 3. Summary of successfully purified Pcdhs .....................................................................94 
Table 4. Pcdh SEC-MALS data summary ............................................................................... 102 
Table 5. Pcdh AUC data summary .......................................................................................... 103 
Table 6. Summary of Diffraction Data for C2 and P21 crystal forms ........................................ 114 
Table 7. Unit cell size for native and heavy atom data sets ..................................................... 117 
Table 8. Anomolous signal in EMP data set ............................................................................ 117 
Table 9. Final Refinement Statistics ........................................................................................ 121 
Table 10. Summary of Pcdh crystals currently undergoing optimization .................................. 133 
Table 11. Predicted unit cell and space group of PcdhgB6 EC1-EC6 and Pcdha7 EC1-EC5 
crystals.................................................................................................................................... 133 
 
List of Figures 
Figure 1:  Schematic of Drosophila Dscam1 gene and gene products ....................................... 2 
Figure 2: Schematic of gene-clustered Pcdhs ............................................................................ 7 
Figure 3:  Schematic representations of selected cadherin superfamily members .....................14 
Figure 4: Classical cadherin trans binding .................................................................................17 
Figure 5: Classical type I cadherin cis interface and formation of an organized cadherin network
 .................................................................................................................................................19 
Figure 6: Crystal structures of atypical cadherins ......................................................................21 
Figure 7. Prediction of N-terminus with SignalP. .......................................................................88 
Figure 8. Membrane-Proximal EC domains ...............................................................................89 
Figure 9. Purification of His-tagged PcdhγC5 EC1-EC3 compared to TAP-tagged ....................90 
Figure 10. PcdhαC2 EC1-EC6 purification and SEC .................................................................91 
Figure 11. GFP expression in FreeStyle™ 293 cells transfected with the PEI transfection 
method ......................................................................................................................................92 
Figure 12. Pcdh expression in suspension 293 cells. ................................................................93 
Figure 13. PcdhγC5 EC1-EC3 digestion by EndoH and PNGase F. ..........................................95 
Figure 14. PcdhγC5 EC1-EC3 SEC-MALS .............................................................................. 101 
Figure 15. Crystal hits from PcdhγC5 EC1-EC3 produced in FreeStyle 293 cells .................... 112 
Figure 16. Crystal hits from PcdhγC5 EC1-EC3 produced GNTi suspension cells................... 113 
Figure 17. Diffraction images from native PcdhγC5 crystals .................................................... 114 
Figure 18. Heavy atom native gels .......................................................................................... 116 
Figure 19. YbCl3 crystal hits from JCSG screens with PcdhγC5 EC1-EC3 produced in FreeStyle 
293 cells. ................................................................................................................................. 117 
Figure 20. Initial electron density map used for model building. .............................................. 118 
Figure 21. Refinement statistics .............................................................................................. 120 
Figure 22. Crystal Interface and Mutations .............................................................................. 123 
Figure 23. PcdhγC5 EC1-EC3 N-terminus .............................................................................. 124 






There are many people who I would like to thank for their help throughout my years at 
Columbia. 
Larry Shapiro has been an advisor to me since I made the decision to come to Columbia for 
graduate school. Over the years, Larry has spent hours listening to my ideas/concerns and 
talking me through the best solutions. Perhaps most importantly, Larry encouraged me to keep 
going at a time where I had lost much of my self-confidence and always treated me as an equal.  
Larry’s lab was the first that I rotated through at Columbia and Barry Honig’s was the second. 
Today, we are the Honig-Shapiro lab and I could not ask for a better group of colleagues. I 
would like to thank Barry Honig for useful feedback and hours of discussion about the Pcdh 
project and for encouraging regular lab meetings. Despite a busy schedule, Barry has always 
made himself available for discussions and guidance. His feedback helped hone my 
presentation and writing skills.  
It is fortuitous that I met with Tom Maniatis around the time that I decided to join the Honig-
Shapiro lab. My meeting with Tom inspired me to work on the Protocadherin (Pcdh) project 
despite warnings from others that many had spent years on this project with little to no success. 
I would also like to thank the remaining members of my committee, Filippo Mancia and Wes 
Gruber. 
The Pcdh project involved collaboration between a large group of scientists including members 
of the Honig-Shapiro lab, Rotem Rubenstein, Klara Felsovalyi, Fabiana Bahna, Seetha 
Mannepalli, Goran Ahlsen, and Kerry Goodman, and members of the Maniatis lab including 
Chan Aye Thu and Maxime Chevee. The work presented here would not have been possible 





In addition to those mentioned above, Julia Brasch and Oliver Harrison spent hours answering 
questions and providing guidance with everything from cloning to processing diffraction data. 
Nithya Baburajendran also provided suggestions for protein purification and model refinement. 
Phini Katsamba provided valuable insight when investigating alternative tags for labeling and 
purification of Pcdhs. I would also like to thank Filip Cosmanescu for brightening the lab with his 
stories and positive attitude over the years. Hang Song has also provided encouragement and 
support as the Pcdh project progressed. Donald Petry and Jeremie Vendome also helped with 
the calculation of electrostatic surface maps for the PcdhC5 structure and Jeremie taught me 
about the conserved sequence features of cadherin domains and how to predict their 
beginning/end according to sequence. More generally, I would like to thank the entire Honig-
Shapiro lab for their support and feedback. 
I would like to thank Katie Rosa, Rachel Hernadez, Ed Johnson, and Anna Kaczynska for all of 
their administrative work including (but not limited to!) ordering lab supplies, ensuring the lab 
equipment is repaired, scheduling of lab meetings, talks, and of course, my defense, and for 
facilitating the submission of grants. 
Lastly, I would like to thank my friends and family for their emotional support throughout the 
























Chapter 1. Introduction 
Neuronal diversity and self-avoidance 
An essential feature of neural circuit assembly is that the axons and dendrites of the 
same neuron do not overlap each other while interacting freely with those from different 
neurons. This characteristic of neural circuits requires that dendritic arborations from the same 
neuron repel each other (Montague and Friedlander 1989, Hughes, Bortnick et al. 2007, 
Matthews, Kim et al. 2007, Grueber and Sagasti 2010, Zipursky and Sanes 2010, Lefebvre, 
Kostadinov et al. 2012, Gibson, Tymanskyj et al. 2014), a process known as self-avoidance. 
This phenomenon was first described in leech (Kramer and Stent 1985) and is highly conserved 
in evolution. Self-avoidance requires the each neuron have a unique cell surface identity to that 
of neighboring neurons. Surprisingly, neurons of the same subtype interact with neighboring 
cells without triggering repulsion, suggesting that neurons are able to discriminate self from non-
self.  
Recent studies have highlighted the importance of self-avoidance in neural patterning in 
both invertebrates and vertebrates (Wang, Su et al. 2002, Hattori, Demir et al. 2007, Hughes, 
Bortnick et al. 2007, Matthews, Kim et al. 2007, Soba, Zhu et al. 2007, Lefebvre, Kostadinov et 
al. 2012). Self-avoidance is best understood in Drosophila, where a large family of 
immunoglobulin (Ig)-containing proteins, encoded by the down syndrome cell adhesion 
molecule (Dscam1) gene locus, mediate this process (Wang, Su et al. 2002, Zhan, Clemens et 
al. 2004, Hughes, Bortnick et al. 2007, Matthews, Kim et al. 2007, Soba, Zhu et al. 2007). In the 
case of vertebrates however, Dscam genes do not generate significant cell surface diversity 
(Schmucker and Chen 2009), suggesting that other genes may serve this function in the 
vertebrates. The most promising candidate is the clustered protocadherins (Pcdhs) (Zipursky 






The Drosophila Dscam1 gene encodes a large family of Ig-containing cell adhesion 
molecules. Alternative splicing of Dscam1 generates thousands of Dscam1 isoforms 
(Schmucker, Clemens et al. 2000). A schematic of the Drosophila Dscam1 gene structure is 
shown in Figure 1A. Variable exons 4, 6, and 9 correspond to three variable extracellular Ig-
domains, Ig2, Ig3, and Ig7, which determine the specificity of each isoform. Variable exons 4, 6, 
and 9 encode 12, 48, and 33 variants respectively. Alternative splicing of the Drosophilia 
 
Figure 1:  Schematic of Drosophila Dscam1 gene and gene products  
A) Schematic of Dscam1 gene. Variable exons are colored in red, green, and blue for exons 4, 6, and 9. 
Another alternative exon is present in the transmembrane region and is colored in yellow.  Alternative 
splicing generates an mRNA containing three variable regions in the Dscam1 ectodomain. A schematic of 
the protein immunoglobulin domains (ovals), fibronectin type III domains (rectangles) and a 
transmembrane domain (yellow rectangle). Each Dscam1 isoform contains one variable exon from each 
colored region. The Dscam1 gene encodes 19,008 isoforms with distinct ectodomains. B) S-shaped 
homodimer. Dscam1 has been shown to form an S-shaped homodimer. Variable extracellular regions are 





Dscam1 gene has the potential to generate 19,008 isoforms with distinct extracellular domains. 
Each of these isoforms can engage in specific homophilic binding (Wojtowicz, Flanagan et al. 
2004, Wojtowicz, Wu et al. 2007). Genetic studies have shown that the cell surface diversity 
generated by Dscam1 expression is required for neurite self-avoidance and self and non-self 
discrimination. Reducing the cell surface diversity generated by Dscam1 expression with 
genetic manipulation impairs neurite self-avoidance (Hattori, Chen et al. 2009).   
Homophilic binding occurs through modular binding of three interfaces between variable 
domains, Ig2-Ig2, Ig3-Ig3, and Ig7-Ig7 (Fig. 1B) (Wojtowicz, Wu et al. 2007). Heterophilic 
binding was only observed in cases where two out of the three variable domains matched and 
the third variable domain was closely-related. X-ray crystal structures of Dscam1 extracellular 
regions reveal a symmetric homodimer between Dscam1 molecules (Meijers, Puettmann-
Holgado et al. 2007, Wojtowicz, Wu et al. 2007). The Dscam Ig1-Ig4 structures and electron 
micrographs of Dscam Ig1-Ig8 suggest that the N-terminal four Ig domains form a horseshoe 
(Meijers, Puettmann-Holgado et al. 2007). Dscam Ig1-Ig8 forms an S-shaped homodimer, with a 
sharp bend observed between Ig5-Ig6 (Wojtowicz, Wu et al. 2007). Both structures show an 
anti-parallel binding interaction between the Ig2 and Ig3 variable domains, and a similar anti-
parallel binding interaction is observed for the variable Ig7 domain in DscamIg1-Ig8. It was 
suggested that matching between the three variable Ig domains and intramolecular interactions 
between Ig5-Ig6 facilitate the formation of an S-shaped dimer between apposed cells upon 
homophilic binding and that this conformational change may play a role in signal transduction 
leading to repulsion (Wojtowicz, Wu et al. 2007). Thus, it appears that Dscam1 acts as a 
monomeric recognition unit.  
A model for self-recognition of posits that individual neurons, which stochastically 
express unique combinations of distinct Dscam1 protein isoforms (Neves, Zucker et al. 2004, 
Zhan, Clemens et al. 2004), are capable of engaging in highly specific homophilic interactions. 





depending on the species (Graveley, Kaur et al. 2004, Brites, McTaggart et al. 2008) and each 
neuron expresses 10-50 randomly chosen isoforms (Neves, Zucker et al. 2004, Zhan, Clemens 
et al. 2004). The probability that neighboring cells expressing the same combination of Dscam1 
isoforms will encounter each other is very low due to the high level of Dscam1 single cell 
diversity. However, expression of multiple isoforms per cell increases the probability that two 
neurons will express isoforms in common. As an example, two neurons, each expressing 30 
isoforms randomly chosen from 5,000 will have a 16% chance of having at least one isoform in 
common, raising the possibility that such neurons might incorrectly recognize each other 
(Hattori, Chen et al. 2009, Forbes, Hunt et al. 2011). For this reason it was suggested that two 
contacting neurons could tolerate some fraction of common isoforms without repelling one 
another (Hattori, Chen et al. 2009).  
For Dscams, the probability of incorrectly recognizing a neighboring neuron as self 
depends on three factors: the size of the isoform pool, the number of distinct isoforms 
expressed per cell, and a tolerance for shared isoforms. Hattori et al. (2009) computed 
probabilities as a function of these variables and concluded that, for a common-isoform 
tolerance up to 20%, it was possible to provide neurons with a sufficiently distinct identity to 
account for the highly specific sister-neurite repulsion. Importantly, thousands of isoforms were 
found to be required to achieve this discrimination between neurons. This model for self-
recognition and non-self discrimination is strongly supported by genetic, cellular and 
biochemical studies in Drosophila (Schmucker, Clemens et al. 2000, Wojtowicz, Flanagan et al. 
2004, Hattori, Demir et al. 2007, Matthews, Kim et al. 2007, Wojtowicz, Wu et al. 2007, Sawaya, 






The clustered Pcdh genes are encoded in three contiguous gene loci, Pcdha, Pcdhb, 
and Pcdhg, which encode three subfamilies of proteins, the α−, β−, and γ-Pcdhs (Wu and 
Maniatis 1999, Wu, Zhang et al. 2001). The mouse Pcdha and Pcdhg loci include 14 and 22 
large “variable” exons respectively. Each variable exon encodes an entire Pcdh extracellular 
region, comprising six extracellular cadherin domains (EC), a transmembrane region (TM), and 
a short cytoplasmic extension. Each of the variable exons is spliced to three “constant” exons 
that encode a cytoplasmic domain specific to the Pcdhα or Pcdhγ subfamily (Fig. 2A). Another 
feature of the Pcdh gene clusters is that the last two ectodomain-encoding variable exons in the 
Pcdha cluster (c1 and c2) and the last three variable exons in the Pcdhg cluster (c3, c4, and c5) 
are more similar to each other than to other isoforms within their respective cluster (Wu, Zhang 
et al. 2001, Aricescu and Jones 2007), indicating that these “C-type” Pcdhs may serve a special 
common purpose. The Pcdhb locus encodes 22 variable exons, but lacks the constant 
cytoplasmic region and C-type isoforms (Fig. 2A). A schematic of all clustered Pcdh subtypes is 
shown in Figure 2B. Each of the variable exons is preceded by a promoter (Tasic, Nabholz et 
al. 2002, Wang, Su et al. 2002, Ribich, Tasic et al. 2006), and single cell Pcdh expression was 
shown to occur thorough stochastic promoter choice and alternative pre-mRNA splicing (Esumi, 
Kakazu et al. 2005, Kaneko, Kato et al. 2006, Hirano, Kaneko et al. 2012).  
Pcdhs are highly expressed in the brain and have been observed in synapses and 
growth cones as well as axons and dendrites (Kohmura, Senzaki et al. 1998, Wang, Weiner et 
al. 2002, Kallenbach, Khantane et al. 2003, Phillips, Tanaka et al. 2003, Junghans, Heidenreich 
et al. 2008).  These observations led to speculation that Pcdhs play a role in neuronal 
connections and self-avoidance (Shapiro and Colman 1999, Takeichi 2007). Consistent with the 
idea that Pcdhs play a role in neuronal connectivity, it was shown that PcdhγC5 interactions with 





receptor, and plays a role in the stabilization and maintenance of some GABAergic synapses 
(Li, Xiao et al. 2012). However, PcdhγC5 is not essential for GABAergic synapse formation and 
direct evidence for a role for Pcdhs in neuronal connectivity remains to be demonstrated. By 
contrast, loss of one of the mouse Pcdh gene clusters (Pcdhg) in retinal starburst amacrine cells 
or in Purkinje cells results in the loss of dendritic self-avoidance (Lefebvre, Kostadinov et al. 
2012), clearly demonstrating a role for Pcdhs in self-avoidance. However, it is important to note 
that a role for Pcdhs in self-avoidance has only been observed in two cell types so far.  
Single-cell RT-PCR studies of mouse Purkinje cells have shown that one to three non-C-
type variable exons in Pcdha, Pcdhb, and Pcdhg are expressed stochastically from a single 
allele (Esumi, Kakazu et al. 2005, Kaneko, Kato et al. 2006, Hirano, Kaneko et al. 2012). In 
contrast, the expression of the C-type variable exons in the Pcdha and Pcdhg clusters is biallelic 
and uniform (Esumi, Kakazu et al. 2005, Kaneko, Kato et al. 2006). However, these studies 
were based on a single cell type, Purkinje neurons, at one developmental stage, and whether 
Pcdh transcription remains the same throughout development or in other cell types remains 
unknown. Subsequent studies showed that promoter choice occurs through stochastic DNA 
looping between transcriptional enhancers located downstream from the Pcdha and Pcdhg 
gene clusters and the alternate isoform promoters and this looping requires the DNA binding 
proteins CTCF and cohesion (Ribich, Tasic et al. 2006, Guo, Monahan et al. 2012, Hirayama, 
Tarusawa et al. 2012). It also appears that promoter choice is stable (Guo, Monahan et al. 
2012). Stochastic promoter choice and alternative splicing generates extraordinary Pcdh 






Figure 2: Schematic of gene-clustered Pcdhs 
A) Schematic of the clustered Pcdh gene locus from mouse. Variable exons are colored in red, green, 
blue, and yellow. The Pcdha and Pcdhg gene clusters include “C-type” variable exons shown in yellow. 
Each variable exon encodes the entire ectodomain, comprising six extracellular cadherin (EC) domains, a 
transmembrane domain (TM) and an intracellular domain (ICD). Each variable exon has its own 
promoter. Alternative splicing of the Pcdha and Pcdhg genes generates an mRNA containing one 
variable region and a common ICD specific to the gene cluster. The Pcdhb gene cluster lacks an ICD. 
The C-type Pcdhs are constitutively and biallecally expressed (ref), while the alternate Pcdhs (red, green, 
and blue) are stochastically and monollelically expressed (refs). B) Schematic of five subtypes of 
clustered Pcdhs. Stochastic promoter choice and alternative splicing have the potential to generate up to 
58 Pcdhs with distinct extracellular regions. A cartoon of each possible subtype is shown where Pcdhα, 
PcdhαC, Pcdhβ, Pcdhγ, and PcdhγC isoforms are arranged from top to bottom. 
Despite breakthroughs in understanding Pcdh gene expression and function, very little is 
known about the molecular mechanisms by which this diversity leads to self-avoidance. There 
are only 58 distinct Pcdh isoforms in mouse compared to 19,008 Dscam1 isoforms in 
Drosophila, raising the question of whether Pcdh diversity is sufficient to function in the nervous 
system-wide discrimination between self and non-self. One possibility is that higher levels of 
Pcdh diversity are generated by the formation of promiscuous cis-mulitmers with distinct 
recognition properties,  thus increasing their functional diversity.  
Previous studies have demonstrated that at least seven Pcdhγ isoforms engage in 
specific homophilic trans interactions and bulk binding assays support the idea that Pcdhγ cis-





Detergent-solubilized Pcdhγ complexes isolated from overexpression in mammalian cell culture 
correspond to the molecular weight of tetramers as estimated by size-exclusion chromatography 
(Schreiner and Weiner 2010). Theoretical considerations for the tetramer model were discussed 
by Yagi (2012). Combination of 58 Pcdh isoforms into promiscuous cis-tetramers can generate 
12,209 distinct tetramers. The probability of matching cis-tetramers between a pair of neurons 
expressing 15 isoforms, where five are in common, was calculated to be 0.013 (Yagi 2012). 
This number suggests that Pcdh tetramers can generate sufficient single-cell diversity for non-
self discrimination. The implications for a tetramer on self-recognition were not discussed. 
 Although the role of the Pcdhα and Pcdhβ isoforms in cell-cell interactions has not been 
established, both were shown to participate in a large super-molecular complex with the Pcdhγ 
proteins (Schalm, Ballif et al. 2010). In addition, Pcdhγ isoforms were shown to facilitate 
membrane delivery of Pcdhα isoforms (Murata, Hamada et al. 2004). These studies suggest 
that Pcdh multimers can contain members of all subfamilies. However, the size the Pcdh 
recognition unit and molecular determinants of Pcdh specificity remain unclear.  
 Sequence comparisons with related “classical” cadherins show that Pcdh molecular 
architecture and adhesive mechanism differs from that of classical cadherins (Posy, Shapiro et 
al. 2008). While the structure of the trans interaction for “classical” cadherins is well established 
(Tamura, Shan et al. 1998, Boggon, Murray et al. 2002, Chen, Posy et al. 2005, Patel, Ciatto et 
al. 2006, Shapiro 2007, Katsamba, Carroll et al. 2009, Ciatto, Bahna et al. 2010, Harrison, 
Bahna et al. 2010, Brasch, Harrison et al. 2011), little is known of the structure of Pcdhs, or of 
their homophilic complexes. The classical cadherins contain five extracellular (EC) domains 
while the Pcdhs contain six. In addition, classical cadherins bind in trans through their EC1 
domains (Brasch, Harrison et al. 2012) whereas for Pcdhs, domain shuffling experiments in 





Pcdhα4-EC1 domain is insufficient for trans binding (Morishita, Umitsu et al. 2006). Additional 
deletion and domain shuffling experiments suggest that at least the N-terminal EC1-EC3 
domains are required for trans binding (Schreiner and Weiner, 2010).  
Initial structural characterization by NMR of the N-terminal EC1 domain from Pcdhα4 
revealed a disulfide bonded Cys-X5-Cys loop, conserved among all clustered Pcdhs, and an 
RGD containing loop that is conserved in all Pcdhαs (Morishita, Umitsu et al. 2006). There did 
not appear to be a hydrophobic pocket large enough to bury a tryptophan residue as occurs in 
the strand-swapped classical cadherin dimer discussed in detail below. In contrast to cells 
expressing classical cadherins, whose adhesive identity is determined primarily through the 
specificity of trans binding mediated by the membrane-distal EC1 domain, neurons expressing 
Pcdhs may achieve their identity through the formation of multi-protein cis complexes with 
distinct homophilic trans-binding properties. A question of particular interest is the interplay 
between trans and cis interactions, a common theme in many cell adhesion receptors (Aricescu 
and Jones 2007).  
Clustered Pcdhs also mediate intracellular signaling. Pcdhs from each gene cluster have 
distinct cytoplasmic extensions and the isoforms from the Pcdha and Pcdhg gene clusters have 
cluster-specific intracellular domains (Figure 2). These domains are highly conserved in 
vertebrate evolution, suggesting a conserved function. Pcdhα and Pcdhγ isoforms also bind the 
receptor tyrosine kinase Ret which is required for the stabilization and phosphorylation of Pcdh 
intracellular domains (Schalm, Ballif et al. 2010). Pcdhs are also required for the stabilization 
and phosphorylation of Ret, suggesting that Pcdhs and Ret are part of a phosphorylation-
dependent signaling complex (Schalm, Ballif et al. 2010). The intracellular domains of Pcdhα 
and Pcdhγ isoforms also interact with and inhibit proline-rich tyrosin kinase 2 (Pyk2) and focal 





survival and dendritic patterning in Pcdha- or Pcdhg-deficient neurons (Chen, Lu et al. 2009, 
Garrett, Schreiner et al. 2012, Suo, Lu et al. 2012). It has been suggested that a large number 
of additional proteins including phosphatases, kinases, synaptic proteins, and cell adhesion 
molecules also interact with Pcdh proteins (Han, Lin et al. 2010, Schalm, Ballif et al. 2010), 
suggesting that clustered Pcdhs may form large multi-component complexes. However, the 
function of these complexes remains unknown. 
Protocadherins also undergo proteolytic processing by the γ-secretase complex. 
Proteolytic fragments are endocytosed and released into the cytoplasm (Haas, Frank et al. 
2005, Hambsch, Grinevich et al. 2005, Reiss, Maretzky et al. 2006, Bonn, Seeburg et al. 2007, 
Buchanan, Schalm et al. 2010). During neuronal differentiation, a decrease in cleavage 
products from this process is observed (Buchanan, Schalm et al. 2010), but the role of these 
cleavage products remains unclear. It is possible that they may enter the nucleus and regulate 
gene expression similar to other cell-surface proteins such as N-cadherin (Rajagopal, Mains et 
al. 2012).  
In Pcdhg-deficient mice, massive apoptosis and loss of spinal interneurons and retinal 
cells are observed, indicating a role for Pcdhg family members in neuronal survival (Wang, 
Weiner et al. 2002, Weiner, Wang et al. 2005, Lefebvre, Zhang et al. 2008, Prasad, Wang et al. 
2008). In addition, in BCL2-associated X protein-null mutants where neuronal apoptosis is 
genetically blocked, synaptic density in Pcdhg-mutant spinal cords are also reduced (Weiner, 
Wang et al. 2005). These results are consistent with the possibility that the loss of 
Pcdhγ proteins may lead to synaptic loss and compromise neuronal survival (Chen and Maniatis 
2013). However, in the absence of neuronal apoptosis, there is a rescue of synaptic loss in the 
retina (Lefebvre, Zhang et al. 2008). Thus, the mechanism of neuronal cell death in Pcdhg-
deficient mice remains unclear. Interestingly, mice where the three C-type genes (Pcdhgc3, 





mouse Pcdhg cluster knockout mice (Chen, Alvarez et al. 2012). However, genetically blocking 
apoptosis in the C-type gene knockout mice rescues neonatal lethality, which is not the case for 
mice where the entire Pcdhg cluster is knocked out. These results suggested that the role of the 
Pcdhg cluster in neuronal survival is primarily regulated by one or more of the Pcdhγ C-type 
isoforms. Since the Pcdhg knockout mice die as neonates, even in the absence of apoptosis, 
Pcdhγ isoforms must play a role in postnatal development (Chen and Maniatis 2013). Pcdhg 
knockout mice also display defects in dendritic branching and arborization in cortical neurons 
(Garrett, Schreiner et al. 2012). This study also proposed that these defects are a result of the 
association between Pcdhγ isoforms and Fak, which down regulates the protein kinase 
C/phospholipase C/myristoylated alanine-rich C-kinase substrate (PKC/PLC/MARCKS) pathway 
(Garrett, Schreiner et al. 2012). 
In contrast to the Pcdhg-deficient mice, Pcdha knockout and severe hypomorph mice 
are viable and have no obvious defects (Hasegawa, Hamada et al. 2008, Katori, Hamada et al. 
2009, Suo, Lu et al. 2012). However, the deletion of the Pcdha constant region caused 
abnormal axonal projections in olfactory sensory neurons and serotonergic neurons (Hasegawa, 
Hamada et al. 2008, Katori, Hamada et al. 2009). Constitutive expression of a single Pcdhα 
isoform, Pcdhα1, was shown to be sufficient to rescue the axonal coalescence defects in 
olfactory sensory neurons in mice lacking all other Pcdhα isoforms (Hasegawa, Hirabayashi et 
al. 2012). Similar to Pcdhg-deficient mice, Pcdha knockouts have defects in dendritic branching 
and spine morphogenesis. It has been suggested that Pcdhα isoforms regulate these processes 
by inhibition of kinase activities of Fak and Pyk2, which activate GTPases and lead to 
cytoskeleton reorganization (Suo, Lu et al. 2012). Studies of Pcdhb cluster knockouts have not 





 Many questions remain regarding Pcdh structure and function. These questions include 
whether the stochastic, monoallelic expression of alternate Pcdh isoforms and constitutive 
expression of C-type Pcdh isoforms is true throughout development and/or in cell types other 
than Purkinje neurons. At this time, the mechanism by which Pcdh cleavage occurs and the role 
of Pcdh cleavage products play in intracellular signaling remain unknown. The role of C-type 
Pcdh isoforms in neuronal apoptosis also requires further investigation. By comparison to 
related classical cadherins, it is clear the Pcdhs bind in trans through a distinct binding interface, 
but the nature of the binding interface and molecular determinants of specificity remain unclear. 
In addition, the nature and specificity of Pcdh cis multimers remains unknown. Further 
understanding the binding properties and specificities of Pcdhs will provide valuable insight into 
Pcdh function. 
Cadherin superfamily 
Pcdhs are a large family of proteins within the cadherin superfamily. Cadherins are cell-
surface glycoproteins whose ectodomains are comprised of multiple β-sandwich domain 
repeats. These domains adopt an immunoglobulin-like fold and are referred to as extracellular 
cadherin (EC) domains. An EC domain is comprised of a seven strand β-barrel containing ~110 
residues with N- and C-termini positioned on opposite sides of the domain (Brasch, Harrison et 
al. 2012). EC domains are arranged in tandem and contain linker regions between each 
domain. In most cases, the linker regions are stabilized by the binding of three Ca2+ ions. 
Calcium binding protects the linker from proteolysis and rigidifies the ectodomain structure 
(Nagar, Overduin et al. 1996). In some cases, EC domains may lack Ca2+ binding residues, 
resulting in a Ca2+-free linker, suggesting flexibility between domains that may alter the protein 





 Members of the cadherin superfamily are classified based on protein domain 
composition, genomic structure, and phylogenetic analysis of protein sequences (Nollet, Kools 
et al. 2000, Hulpiau and van Roy 2009). Based on these considerations, Hulpiau and van Roy 
(2009) proposed the separation of the cadherin superfamily into two major branches, the 
cadherin branch and the cadherin-related branch. Schematic representations of selected 
cadherin superfamily members are shown in Figure 3. Members from the cadherin branch are 
shown on the left and members of the cadherin-related branch are shown on the right. Each of 
these family members has been at least partially characterized structurally. In considering Pcdh 
molecular binding mechanisms, it is useful to first examine cadherin superfamily members with 







Figure 3:  Schematic representations of selected cadherin superfamily members 
Both classical cadherins and DN-cadherin from Drosophila melanogaster have a prodomain which is 
removed by a furin protease on the cell surface. DN-cadherin also contains non-EC domains, laminin A G 
domains and epidermal growth factor (EGF)-domains. The first EC domain of DN-cadherin is predicted by 







The vertebrate classical cadherins are the best characterized member of the cadherin 
superfamily. Classical cadherins can be divided into two groups, the “type I” and “type II” 
cadherins. In classical cadherins, each ectodomain contains five tandem EC domains, a single-
pass transmembrane domain, and an intracellular domain that binds to β-catenin (Harris and 
Tepass 2010). Linkers between successive EC domains bind to three Ca2+ ions and binding 
between classical cadherins is calcium dependent (Nagar, Overduin et al. 1996, Boggon, 
Murray et al. 2002, Harrison, Jin et al. 2011). Classical cadherins localize to adherins junctions, 
which form between apposed cells. The cytosolic face of adherins junctions are linked to the 
actin cytoskeleton. The process of junction formation is mediated by cooperation between two 
types of interactions between cadherin molecules, trans interactions (between molecules on 
apposed cells) and cis interactions (between molecules on the same cell).  
Cadherins form trans dimers through their membrane-distal, N-terminal EC1 domains. 
Atomic resolution structures reveal that all classical cadherins share a common binding 
mechanism in which the N-terminal β-A-strand, A*, is swapped between EC1 domains of the 
partner molecule. The N-terminus of classical cadherins is dictated by the removal of a 
prodomain that includes a furin protease site and the N-terminal residues are critical to the 
formation of mature “strand-swapped” dimers (Fig. 3). A key to formation of the strand-swapped 
dimer is the successful docking of hydrophobic residues located on the A* strand, tryptophan 2 
(Trp2) for type I cadherins and Trp2 and Trp4 for type II cadherins, into a conserved 
hydrophobic pocket in the EC1 domain on the partner molecule (Fig. 4A). The physiological 
relevance of this dimer has been confirmed by mutagenesis and characterization of mutants by 
electron microscopy, and structural and cellular studies (Patel, Chen et al. 2003, Troyanovsky, 






In both type I and type II cadherins, the strand-swapped interface involves the Trp2 
residue, but the interfaces in each differ. In type I cadherins, the interface includes only the 
pocket region of EC1 where Trp2 docks into the partner molecule. However, in type II 
cadherins, the interface involves the docking of Trp2 and Trp4 into EC1 of the partner molecule 
and an additional hydrophobic interface at the base of EC1 (Fig. 4A). In both cases, domain 
shuffling experiments confirm that homophilic binding specificity is governed by the EC1 domain 
(Nose, Tsuji et al. 1990, Klingelhofer, Troyanovsky et al. 2000, Shan, Tanaka et al. 2000, Patel, 
Ciatto et al. 2006), suggesting that differences in these interfaces regulate specificity. 
Heterophilic interactions are not observed between the type I and type II cadherin subfamilies 
(Shimoyama, Tsujimoto et al. 2000, Patel, Ciatto et al. 2006, Katsamba, Carroll et al. 2009, 
Shapiro and Weis 2009), but within subfamilies both homophilic and heterophilic interactions are 
observed (Shimoyama, Takeda et al. 1999, Shimoyama, Tsujimoto et al. 2000, Patel, Ciatto et 
al. 2006, Miloushev, Bahna et al. 2008, Katsamba, Carroll et al. 2009). 
FRET studies of cadherin mutants incapable of forming strand swapped dimers found 
that dimers still formed, but with different FRET differences than those of strand-swapped 
dimers. These results suggested the presence of a non-swapped dimer. AFM experiments 
found that this non-swapped dimer was weaker than the strand-swapped dimer, which 
energetically consistent with the role of the non-swapped dimer as an intermediate. 
Crystallographic studies of strand-swap impaired mutants found numerous examples of a new 
dimer interface between the EC1-EC2 domains. This dimer is now referred to as an “X-dimer”. 
Since the formation of this dimer interface does not require domain swapping, the energetic 
costs of forming this interaction are low. Formation of X-dimer also positions the A*-strands of 





  The role of the X-dimer as a binding intermediate is supported by numerous mutational 
studies. For example, when the X-dimer interface is mutated in cadherins with slow binding 
kinetics such as E-cadherin and cadherin-6, no binding is observed in short-term SPR assays 
but there is no loss of affinity in long-term analytical ultracentrifugation experiments (Miloushev, 
Bahna et al. 2008, Sivasankar, Zhang et al. 2009). In addition, X-dimer mutant proteins could be 
resolved as monomers and dimers in size exclusion chromatography and velocity 
ultracentrifugation experiments, indicating slow exchange rates between monomers and dimers. 
 
Figure 4: Classical cadherin trans binding 
A) Strand swapped dimer. The left panel shows EC1 of the strand swapped, E-cadherin dimer (pdb-ID: 
2QVF), a type I classical cadherin. The Trp2 residue (side chain depicted as sticks) is docked into the 
partner molecule. The right panel shows EC1 of the strand swapped, cadherin-11 dimer (pdb-ID: 2A4E), 
a type II classical cadherin. The Trp2 and Trp4 residues (side chains depicted as sticks) are docked into 
the partner molecule. Additional hydophobic interactions are observed at the base of EC1 and side chains 
are shown as sticks. B) Formation of a mature strand swapped dimer. E-cadherin monomers are shown 
as green and maroon ribbon diagrams (left panel). Mature strand swapped dimers form through a kinetic 
intermediate referred to as the “X-dimer”. In the X-dimer, the N-terminal β-strands are not swapped but 
are positioned close to one another (middle panel). Swapping of the N-terminal β-strands leads to 





Structural and functional observations for type I E-cadherin and type II cadherin-6, which are 
only 34% identical in their EC1-EC2 domains, suggest that the X-dimer mechanism may be 
general among members of both classical cadherin subfamilies. 
 Cell-cell adhesion is mediated in part by adherins junctions containing classical 
cadherins. Classical cadherin trans dimers assemble in adherins junctions via cis clustering 
(Yap, Brieher et al. 1997, Hong, Ran et al. 2010). Crystal structures of complete ectodomains 
from N- and E-cadherin revealed molecular layers containing a similar array of cis and trans 
interactions. These interactions are also observed in the crystal lattice of the full ectodomain of 
C-cadherin and are the only interactions observed in all three crystal lattices. The cis interface 
of N-, E-, and C-cadherin a non-symmetrical interaction between the EC1 domain of one 
molecule and the EC2/3 region of a partner molecule (Fig. 5). The cis interface orients 
molecules in parallel, as if from the same cell surface, and each molecule can engage in two 
identical cis interactions: one via its EC1 domain and the other via its EC2/3 region. Formation 
of these cis interactions arranges cadherins into linear arrays. Mutations in the cis interface 
slightly diminish liposome aggregation, destabilize cadherin junctions in A-431 cells, which were 
previously shown to efficiently incorporate Dendra2-tagged E-cadherin into junctions along with 
endogenously-expressed E-cadherin (Hong, Ran et al. 2010), and effect the sub-cellular 
distribution of E-cadherin, suggesting that cis interactions play a role in assembly of junctions 
(Harrison, Jin et al. 2011). Differences in sequence and function suggestion that the cis 
interface is specific to type I cadherins. 
 Extensive crystallographic and biophysical studies have elucidated the molecular 
mechanisms that underlie the function of the ectodomain of classical cadherins. These proteins 
bind in trans through an adhesive interface mediated by their EC1 domains (Boggon, Murray et 
al. 2002, Patel, Ciatto et al. 2006) Biophysical studies have shown that classical cadherins differ 





can be correlated with the identity of the EC1 domain and with its homophilic and heterophilic 
binding affinities (Katsamba, Carroll et al. 2009). Following cell-cell contact, classical cadherins 
assemble into ordered assemblies known as adherens junctions, where both cis and trans 
interactions in classical cadherins cooperate to form a two-dimensional molecular layer 
observed in crystal structures of numerous classical cadherins, and that this molecular layer 
corresponds to the extracellular structure of adherens junctions (Boggon, Murray et al. 2002, 
Harrison, Jin et al. 2011). 
 
Figure 5: Classical type I cadherin cis interface and formation of an organized cadherin network 
A) N-cadherin cis interface. The cis interface occurs between EC1 of one molecule (purple) and EC2 and 
the apex of EC3 of the partner molecule (maroon) (pdb-ID: 3Q2W). The cis interface occurs on the 
opposite side of the molecule from the trans interface, allowing both interfaces to be engaged at once. B) 
Combination of cis and trans interfaces forms an organized network. 
An important distinction between classical cadherins and clustered Pcdhs is that the 
former mediate cell-cell adhesion while the latter mediate neuronal self-avoidance through 
activation of intracellular signaling. In the case of type I classical cadherins, it appears the 
stronger trans interactions drive the formation of weaker cis interactions. However, in Pcdhs, 
where it has been shown that expression of Pcdhγs facilitate the membrane delivery of Pcdhαs 
(Murata, Hamada et al. 2004), it is possible the formation of cis interactions occurs prior to trans 





units (Schreiner and Weiner 2010, Yagi 2012). The nature of these interactions may only be 
understood when structures for the molecules are solved.  
Non-classical cadherins - Protocadherin-15, cadherin-23, and DN-cadherin 
Some members of the cadherin superfamily contain many EC domains. Some, such as 
Pcdh-15 and cadherin-23 adopt extended structures (Vollrath, Kwan et al. 2007). Pcdh-15 and 
cadherin-23 form a structure known as the tip-link which links the stereocilia of hair cells via 
trans heterophilic interactions between cis homodimers (Kazmierczak, Sakaguchi et al. 2007). 
Structure determination of a complex between the N-terminal EC1-EC2 domains of Pcdh-15 
and cadherin-23 revealed an overlapped, antiparallel heterodimer (Sotomayor, Weihofen et al. 
2012). Interestingly, cadherin-23 contains an additional calcium binding site at the apex of EC1 
(Fig. 6) (Elledge, Kazmierczak et al. 2010, Sotomayor, Weihofen et al. 2010, Sotomayor, 
Weihofen et al. 2012).  
  DN-cadherin in Drosophila melanogaster is considered an invertebrate classical 
cadherin in that it mediates Ca2+-dependent cell-cell adhesion and forms adherens junctions 
(Tepass and Hartenstein 1994, Meng and Takeichi 2009, Oda and Takeichi 2011). Though the 
function of DN-cadherin is similar to vertebrate classical cadherins, the extracellular domain 
organization is different. DN-cadherin has 16 EC domains followed by epidermal growth factor 
(EGF)-like and laminin G domains (Fig. 3). Structure determination revealed the presence of a 
Ca2+-free linker between the EC2-EC3 domains that results in a ‘kink’ in the structure (Jin, 
Walker et al. 2012). Sequence analysis of long cadherins found that other long cadherins lack 
some or all of the residues required for Ca2+ binding. Interestingly, one of the C-type Pcdhs, 
PcdhaC1, lacks some of the Ca2+ binding residues between the EC3-EC4 domains. Whether 
the absence of these residues results in a difference in the structure or function of this molecule 






Figure 6: Crystal structures of atypical cadherins  
A) Structure of Pcdh-15 and cadherin-23 complex. Ca2+ coordination was observed between the EC1-
EC2 domains of cadherin-23 and Pcdh-15. Interestingly, cadherin-23 contains a Ca2+ binding site at the 
apex of EC1 referred to as site 0. The Pcdh-15 and cadherin-23 heterocomplex revealed an anti-parallel 
dimer (pdb-ID: 4AQ8). B) Structure of DN-cadherin. Structure determination of DN-cadherin EC1-EC4 
revealed four tandem EC domains (pdb-ID: 3UHB). Interestingly, Ca2+ coordination was only found 
between the EC1-EC2 and EC3-EC4 domains and not between the EC2-EC3 domains. The presence of 
this Ca2+-free linker results in a ‘kink’ in the structure. 
 
Significance of the work presented in this dissertation 
 Here we develop an improved mammalian protein expression system which we use to 
produce Pcdh extracellular regions. We report crystal structures of the amino-terminal three EC 
domains of PcdhγC5 which are expected to encode Pcdh binding specificity. All three structures 
presented are monomeric in crystals and solution. Since our crystallographic construct included 
a non-native signal peptide and we observed a hydrophobic pocket near the N-terminal residue, 
we tested the N-terminus used in our crystallographic construct in a cell aggregation assay and 
produced a soluble PcdhγC5 EC1-EC3 construct with an extended N-terminus. We find that the 





that the construct with the extended of the N-terminus is also monomeric in solution. In order to 
further investigate Pcdh binding specificity, we perform an extensive sequence analysis to 
identify the most closely-related pairs of Pcdh isoforms within each gene cluster with distinct 
binding specificities. Guided by the PcdhgC5 structure, we built structural models of each of the 
closely-related Pcdh pairs and mapped the residues that differ between them onto the models. 
Combined with domain shuffling and mutagenesis experiments, we suggest that the FG loop in 
the EC3 domain and the AB loop in the EC2 domain are important to Pcdh binding specificity. 
We also show that a S116R mutation in the AB loop of EC2 of PcdhγC5 is sufficient to abrogate 
binding. While the trans binding interface for Pcdhs remains unknown, our work localize regions 
in EC2 and EC3 involved in trans binding. We also find that all Pcdh EC1-EC3 constructs that 
we produce behave as monomers in solution but constructs containing the first four or more EC 
domains behave as dimers or larger multimers and we suggest that the EC4 domain may be 
required to form cis interactions prior to the formation of trans interactions. Consistent with this 
hypothesis, we report dissociation constants for three Pcdh homodimers: 30 ± 1.5µM for 
PcdhγA8 EC1-EC4, ~20µM for PcdhγA8 EC2-EC6, and ~5µM for Pcdhα7 EC1-EC5. We cannot 
yet be sure whether the dissociation constants we have measured correspond to trans or cis 
dimers. However, since the EC1 domain is required for Pcdh trans binding, our results suggests 





Chapter 2. Generation of single cell identity by specific homophilic interactions between 
combinations of α, β, and γ protocadherins (Manuscript in review) 
Chapter Introduction 
Prior to the work presented in the manuscript below, Schreiner and Weiner (2010) used 
a K562 cell aggregation assay to show that a subset of mouse Pcdhγ isoforms could mediate 
cell aggregation and that Pcdhγ specificities were strictly homophilic. Schreiner and Weiner 
(2010) also proposed that Pcdhγ isoforms form promiscuous cis tetramers with distinct 
homophilic specificities. However, this tetramer model was based largely upon molecular weight 
estimates from size exclusion chromatography of detergent-solubilized Pcdhγ complexes. 
However, the molecular weight of elongated proteins such as Pcdhs cannot be rigorously 
determined by this method, nor can the method distinguish between cis and trans multimers. 
Nevertheless, Yagi (2012) carried out a theoretical analysis based on the tetramer model. His 
analysis assumed that all 58 clustered Pcdh isoforms (including α and β) bind homophilically 
and contribute equally to tetramer formation. Based on this model, combination of 58 Pcdh 
isoforms into promiscuous cis-tetramers can generate 12,209 distinct tetramers (Yagi 2012). 
The probability of matching cis-tetramers between a pair of neurons expressing 15 isoforms, 
where five are in common, was calculated to be 0.013 (Yagi 2012). From this, Yagi (2012) 
concluded that Pcdh cis tetramers allow Pcdhs to achieve functional diversity similar to that of 
invertebrate Dscams, which play a functional role similar to that of clustered Pcdhs. A functional 
connection between clustered Pcdhs and invertebrate Dscam1 was made by the observation 
that a conditional deletion of the mouse Pcdhγ gene cluster in retinal starburst amacrine cells or 
in Purkinje cells results in defective dendritic self-avoidance (Lefebvre, Kostadinov et al. 2012).  
 Despite the advances described above, many questions remain. The focus of the work 
described below was to investigate the binding specificity of all mouse Pcdh isoforms (including 





expression of multiple Pcdhs per cell, and to consider the implications of alternate Pcdh 
multimers on diversity. Chan Aye Thu designed and performed experiments. Weisheng Chen 
co-initiated the study, and contributed to the design and establishment of experimental 
approaches. Rotem Rubenstein led the computational and statistical analysis. Klara Felsovalyi 
predicted the EC domain alignment. Maxime Cheeve provided technical support. Juan Carlos 
Tapia contributed to image analysis. Chan Aye Thu, Weisheng Chen, Rotem Rubenstein, Larry 
Shapiro, Barry Honig, Tom Maniatis, and I analyzed the data and wrote the paper. Larry 
Shapiro, Klara Felsovalyi, a former graduate student in the Honig-Shapiro lab, and I  co-
authored a co-investigator NIH R01 grant with Chan Aye Thu, a post-doc in the Maniatis lab, 
and Tom Maniatis to help fund the experiments presented here and to outline experimental 
goals. Barry Honig aided in the writing and proof-reading of the grant. In addition, we met with 
the Maniatis lab regularly to discuss experimental results, required controls, possible future 
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Individual mammalian neurons express distinct repertoires of protocadherin (Pcdh) -α, -β and -γ 
proteins that function in neural circuit assembly. Here we show that all three types of Pcdhs can 
engage in specific homophilic interactions, that cell surface delivery of alternate Pcdhα isoforms 
requires cis interactions with other Pcdh isoforms, and that the extracellular cadherin domain 
EC6 plays a critical role in this process.  Analysis of specific combinations of up to five Pcdh 
isoforms showed that Pcdh homophilic recognition specificities strictly depend on the identity of 
all of the expressed isoforms, such that mismatched isoforms interfere with cell-cell interactions. 
We present a theoretical analysis showing that the assembly of Pcdh-α, −β and −γ isoforms into 
multimeric recognition units, and the observed tolerance for mismatched isoforms can generate 
the cell surface diversity necessary for single-cell identity.  However, competing demands of 
non-self discrimination and self-recognition place limitations on the mechanisms by which 
recognition units can function. 
Introduction 
 An essential feature of neural circuit assembly is that the cellular processes (axons and 
dendrites) of the same neuron do not contact one another, but do interact with processes of 
other neurons. This feature requires “self-avoidance” between sister neurites of the same cell, a 
phenomenon that is highly conserved in evolution. Self-avoidance, in turn, requires a 






 A model for self-recognition, based on studies of the Drosophila Dscam1 gene 
(Schmucker, Clemens et al. 2000), posits that individual neurons stochastically express unique 
combinations of distinct Dscam1 protein isoforms that are capable of engaging in highly specific 
homophilic trans interactions between proteins on apposing cell surfaces  (Hattori, Millard et al. 
2008).  If neurites of the same neuron contact each other, the identical Dscam1 protein 
repertoire on their cell surfaces will result in homophilic interactions, which in turn leads to 
contact-dependent repulsion and neurite self-avoidance. In contrast, neurites from different 
neurons display distinct combinations of Dscam1 isoforms that do not engage in homophilic 
interactions, and thus not repel one another (Hattori, Millard et al. 2008).  
 The generation of extraordinary Dscam1 isoform diversity is a consequence of the 
unique structure of the Drosophila Dscam1 gene, and stochastic alternative splicing of Dscam1 
pre-mRNAs (Neves, Zucker et al. 2004, Zhan, Clemens et al. 2004, Miura, Martins et al. 2013, 
Sun, You et al. 2013). In Drosophila this leads to the generation of 19,008 Dscam1 protein 
isoforms with distinct ectodomains, the vast majority of which can engage in highly specific 
homophilic interactions, apparently as monomers (Wojtowicz, Flanagan et al. 2004, Wojtowicz, 
Wu et al. 2007, Wu, Ahlsen et al. 2012)  Genetic studies have shown that thousands of Dscam1 
isoforms are required for neurite self-avoidance and non-self discrimination (Hattori, Chen et al. 
2009). By contrast to Drosophila Dscam1, vertebrate Dscam genes do not generate significant 
cell surface diversity (Schmucker and Chen 2009), suggesting that other genes may serve this 
function in vertebrates. The most promising candidates are the clustered protocadherin (Pcdh) 
genes (for recent reviews see (Zipursky and Sanes 2010, Yagi 2012, Chen and Maniatis 2013, 
Zipursky and Grueber 2013)).  
In the mouse 58 Pcdh proteins are encoded by the Pcdha, Pcdhb, and Pcdhg gene 
clusters, which are arranged in tandem (Figure 1A) (Wu and Maniatis 1999, Wu, Zhang et al. 
2001). Each of the Pcdh gene clusters contains multiple variable exons that encode the entire 





(TM), and a short cytoplasmic extension.  The Pcdhα and Pcdhγ gene clusters also contain 
three cluster-specific “constant” exons that encode a common intracellular domain (ICD). The 
last two variable exons in the Pcdha gene cluster, and the last three variable exons of the 
Pcdhg gene cluster  are divergent from other Pcdh “alternate” isoforms and are referred to as 
“C-type” Pcdhs (Wu and Maniatis 1999, Wu, Zhang et al. 2001). Each of the variable exons is 
preceded by a promoter, and Pcdh expression occurs through promoter choice (Tasic, Nabholz 
et al. 2002, Wang, Su et al. 2002, Ribich, Tasic et al. 2006). Single cell RT-PCR studies in 
cerebellar Purkinje cells indicate that promoter choice of alternate isoforms is stochastic and 
independent on the two allelic chromosomes, whereas C-type Pcdhs are constitutively and 
biallelically expressed (Esumi, Kakazu et al. 2005, Kaneko, Kato et al. 2006,, Hirano, Kaneko et 
al. 2012). As a result, each neuron expresses approximately 15 Pcdh isoforms, including a 
random repertoire of 10 alternate α, β and γ isoforms and all 5 C-type isoforms (Yagi 2012).  
  
A critical functional connection between Drosophila Dscam1 isoforms and vertebrate 
clustered Pcdhs was made by the observation that conditional deletion of the mouse Pcdhg 
gene cluster in retinal starburst amacrine cells or in Purkinje cells results in defective dendritic 
self-avoidance (Lefebvre, Kostadinov et al. 2012). This observation, in conjunction with the 
stochastic promoter choice mechanism, suggests that clustered Pcdhs may also mediate 
neurite self-avoidance by specifying single cell identity. Consistent with this suggestion, 
previous studies showed that a subset of Pcdh-γ isoforms can engage in specific homophilic 
interactions (Reiss, Maretzky et al. 2006, Schreiner and Weiner 2010), suggesting that Pcdhs 
mediate contact-dependent repulsion in a manner similar to that of invertebrate Dscam1 
proteins. However, the question of whether all Pcdh-α, –β, -γ and C-type isoforms engage in 
homophilic interactions, which would be required to generate sufficient diversity, has yet to be 





compared to 19,008 Dscam1 isoforms with distinct ectodomains in Drosophila, raising the 
question of whether the molecular diversity provided by clustered Pcdhs is sufficient for 
discrimination between self and non-self. A possible answer to this question was proposed in a 
previous study that suggested that Pcdhγs can associate promiscuously as cis (same cell) 
tetramers that bind with homophilic specificity in trans (different cells) (Schreiner and Weiner 
2010). The large number of possible Pcdh tetramers would then dramatically increase cell 
surface diversity (Schreiner and Weiner 2010, Yagi 2012). However, In order to reach the level 
of diversity predicted by this model, and to determine whether alternate models are possible or 
likely, it is necessary to establish the binding behavior of all the clustered Pcdhs, including that 
of the Pcdh α and β isoforms, which were not previously tested.  
 Here we provide direct evidence that all but one of the 58 clustered Pcdh isoforms 
mediate highly specific homophilic trans interactions. We show that the EC6 domains of 
alternate Pcdhαs and PcdhγC4 inhibit cell surface delivery and that cis interactions involving the 
membrane proximal EC domains (EC5-EC6) of other Pcdh isoforms can relieve this inhibition. 
Furthermore, when multiple clustered Pcdh isoforms representing all three clusters are co-
expressed, strict homophilic cell-cell recognition is observed. Remarkably, cells expressing as 
many as 5 different Pcdh isoforms display specific homophilic interactions in cell aggregation 
assays. However, aggregation is prevented by the expression of a single mismatched Pcdh 
isoform. In contrast, when the mismatch is generated by co-expression of classical N-cadherin 
(N-cad), there is no effect on homophilic recognition mediated by the Pcdhs, revealing a 
fundamental difference between the behaviors of classical cadherins and Pcdhs. Based on 
these findings we present a theoretical analysis of the dependence of Pcdh diversity on the 
number of subunits in putative cis-multimeric recognition units, and on the number of common 
isoforms that can be tolerated between two contacting cells without resulting in incorrect self-





discrimination, and argue that these requirements raise questions concerning the validity of a 
current model in which the basic Pcdh recognition unit is a random assembly of Pcdh tetramers.   
 
Results 
Cluster-wide analysis of Pcdh-mediated homophilic interactions  
The mouse Pcdh gene cluster encodes diverse subfamilies of cell surface proteins: 12 
alternate Pcdhα, 22 Pcdhβ, 19 Pcdhγ isoforms and 5 C-type Pcdh-α  or -γ isoforms (Figures 1A 
and 1B). We examined the ability of each Pcdh isoform to mediate homophilic recognition using 
a K562 cell aggregation assay. K562 cells are non-adherent in culture with no endogenous 
Pcdh expression, and thus provide an assay for homophilic interactions mediated by transfected 
clustered Pcdh cDNAs (Reiss, Maretzky et al. 2006, Schreiner and Weiner 2010). It is important 
to note that while this aggregation assay provides an excellent system for studying homophilic 
interactions between Pcdh proteins on the cell surface, it cannot provide information regarding 
the self-avoidance (neurite repulsion) function of Pcdhs in the nervous system.  
We carried out a systematic analysis of the homophilic interactions of all 58 Pcdh 
proteins (α, β, γ and C type Pcdhs) by transfecting cDNA plasmids encoding individual Pcdh C-
terminal mCherry fusion proteins into K562 cells and visualizing cell aggregation.  We found that 
all 22 Pcdhβs, 19 alternate Pcdhγs, and the C-type Pcdhs -αC2, -γC3 and -γC5 form aggregates 
when assayed individually (Figure 1D), We note that the size of the aggregates observed varies 
significantly (Figure S1B), which is likely the consequence of differences in expression, cell 
surface delivery, or intrinsic trans-binding affinities of individual Pcdh isoforms.  By contrast, 
none of the alternate Pcdhα isoforms nor Pcdh-αC1 or -γC4 form aggregates (Figure 1D), 
presumably due to the lack of membrane localization (Murata, Hamada et al. 2004, Bonn, 






Pcdhβs, Pcdhγs, and a subset of C-type Pcdhs display highly specific homophilic 
interactions 
  The EC2 and EC3 domains, which display the highest level of amino acid 
sequence diversity among the EC domains (Figure S2A) (Wu 2005) were previously shown to 
comprise the specificity-determining region for a subset of Pcdhγ isoforms (Schreiner and 
Weiner 2010). In order to determine the stringency of recognition specificity, we generated 
pairwise sequence identity heat maps of the EC2-EC3 domains (Figures 2B and S2B). Using 
these heat maps, we identified Pcdh pairs with greater than 80% pairwise sequence identity in 
their EC2 and EC3 domains. If the most closely related Pcdhs within the same cluster fail to 
recognize each other thru heterophillic interactions, it is unlikely that the more distantly related 
Pcdhs would interact. Notably, among the closely related Pcdh pairs, Pcdhβ6-Pcdhβ8 and 
PcdhγA8-PcdhγA9 both share more than 90% sequence identity within their EC2-EC3 domains. 
Eight of the closely related Pcdhs were tested along with twelve more distantly related Pcdhs. In 
total, we tested 89 unique pairs of Pcdhs with sequence identity for non-self pairs ranging from 
50-95% in their EC2-EC3 domains.  
 Each protein was expressed with mCherry or mVenus fused to the C-terminus and 
tested for binding specificity (Figure 2A). Pairwise Pcdh isoform combinations were tested within 
each Pcdh subtype (Figures 2C-2E and S2C) and between different subtypes (Figure S2D). 
Only self-pairs on the matrix diagonals displayed intermixing of mCherry- and mVenus-
expressing cells, while all non-self pairs exclusively segregate into red and green cell 
homophilic aggregates. Despite their high level of sequence identity, even the Pcdhβ6-Pcdhβ8 
and PcdhγA8-PcdhγA9 pairs form separate, non-interacting homophilic cell aggregates. Thus, 
all of the Pcdh-γ and -β proteins tested display strict trans homophilic specificity. 
 





As mentioned above, Pcdhα isoforms are not delivered to the plasma membrane when 
expressed alone (Murata, Hamada et al. 2004, Bonn, Seeburg et al. 2007), so this likely 
explains why all of the Pcdhα isoforms fail to engage in homophilic interactions in the K562 
assay (Figure 1D). We therefore used Pcdh constructs bearing an extracellular c-Myc tag to 
visualize cell surface localization by immunofluorescence in K562 cells. We first showed that 
Pcdh-β17, -γB6, and the C-type -αC2 and -γC3 isoforms, all of which engage in homophilic 
interactions (Figure 1D), can be detected on the cell surface (Figure 3A (ii-v)). By contrast, 
neither the wild type nor intracellular domain (ICD) deleted Pcdhα4 can be detected on the cell 
surface (Figure 3A (i and vi)). This observation is consistent with the idea that failure to detect 
homophilic interactions of Pcdhαs in the cell aggregation assay is due to failure of Pcdhαs to 
localize to the plasma membrane. 
Previous studies have shown that Pcdhγs can facilitate membrane delivery of Pcdhαs 
(Murata, Hamada et al. 2004). We confirmed this finding with PcdhγB6 (Figure 3A (ix)) and in 
addition, found that Pcdhβ17 (Figure 3A (viii)) and the C-type Pcdh-αC2 and -γC3 isoforms 
(Figure 3A (vii and x)) could also facilitate membrane delivery of Pcdhα4. Deletion of Pcdh EC1 
domains was previously shown to abrogate Pcdh homophilic interactions (Figure 3C (i-iv)) 
(Schreiner and Weiner 2010) but not their cell surface delivery (Figure S3A (ii)). In order to 
determine whether Pcdhαs can directly mediate homophilic interactions, we co-expressed 
Pcdhα isoforms with ∆EC1-Pcdh isoforms, reasoning that cis interactions with these ∆EC1-Pcdh 
constructs would assist in cell surface delivery but would not participate in trans binding. Thus, 
the EC1-deleted “carrier” proteins should not affect the recognition specificity (see e.g. Figure 
3C (ix – xii). We confirmed that all of the ∆EC1-Pcdh proteins tested can deliver Pcdhα4 to the 
cell surface (Figure 3A (xi-xiv)) and facilitate cell aggregation (Figure 3C (v-viii)).  Consistent 
with these observations, Flag-tagged Pcdhα4 co-immunoprecipitates with mCherry fusions of 





Pcdhs for membrane delivery, we found that all 12 alternate Pcdhαs mediate strict homophilic 
interactions (Figures 3B, S3D and S3E). Similar to the Pcdh -βs and −γs, EC1 deletion in Pcdhα4 
abolished its homophilic binding activity when co-expressed with a carrier protein (Figure 3B 
(vii) and (xiv)).   
 In addition to the Pcdhα isoforms, PcdhγC4 and PcdhαC1 did not mediate homophilic 
interactions when transfected alone (Figure 1D). PcdhγC4 exhibits behavior similar to that of the 
Pcdhαs: its membrane delivery and homophilic interactions are promoted by co-transfection 
with carrier Pcdhs (Figure S3F, second row). By contrast, we found that PcdhαC1 homophilic 
interactions could not be rescued by co-expression with any of the carrier Pcdhs (Figure S3F, 
third row). To determine whether the co-transfected Pcdhα  isoform defines binding specificity, 
we selected the closely related Pcdhα pairs, Pcdh-α8 and -α7 (97% identity in the EC2-EC3 
domains) and Pcdh-α8 and -α4 (74% identity) for testing in cell aggregation assay (Figure 3D). 
Cells expressing the same Pcdhα isoform showed homophilic interactions (Figure 3E (ii)), 
whereas those expressing different Pcdhα isoforms did not interact (Figure 3E (i and iii)). 
Conversely, when the Pcdhα isoform is the same for all transfectants, but the carrier Pcdhs are 
varied (Figure 3F), intermixing of the red and green cells is observed between all transfectants, 
irrespective of the identity of the carrier Pcdh. These results demonstrate that the recognition 
specificity between cells co-transfected with an alternate Pcdhα and a carrier Pcdh depends 
only on the identity of the Pcdhα isoform.  
 
Role of the membrane-proximal EC6 domain in cell surface localization  
To identify the regions of Pcdhβ/γ proteins responsible for the carrier function, we 
produced an EC-domain deletion series of PcdhγB6 in which EC domains were successively 





(Figures 4A (i-vi) and S4G). We then co-transfected Pcdhα4 with each of the PcdhγB6 ∆EC 
constructs and assayed for cell aggregation. When co-transfected with Pcdhα4, aggregation 
was observed when up to four EC domains were deleted from PcdhγB6 (Figures 4A (vii-x) and 
S4G). Cell aggregation was not observed in co-transfectants in which the first five or all six EC 
domains were deleted from PcdhγB6 (Figures 4A (xi and xii) and S4G). When co-transfected 
with Pcdhα4, the PcdhγB6∆EC1-4 mediates efficient membrane delivery of Pcdhα4 (Figure 4A 
(xv)). PcdhγB6∆EC1-5 localizes to the cell surface when transfected alone (Figure 4A (xiv)), yet 
does not deliver Pcdhα4 to the cell surface (Figure 4A (xvi)). Similarly, Pcdhβ17∆EC1-4 also 
mediates efficient membrane delivery of Pcdhα4 (Figure S4A). We conclude that the EC5 and 
EC6 domains of Pcdhβ or γ are necessary to deliver the Pcdhα isoform to the cell membrane.   
To determine which Pcdh domains regulate membrane delivery we performed 
experiments in which domains were shuffled between Pcdhα4, which does not localize to the 
membrane (Figure 3A (i)), and PcdhγC3, which does (Figure 3A (x)). Constructs in which EC 
domains or the ICD of Pcdhα4 were replaced with the corresponding domains of PcdhγC3, or 
vice versa, were produced and tested for cell aggregation activity (Figure 4B and S4H), a proxy 
for membrane delivery. Chimeric constructs bearing the EC6 domain of PcdhγC3 mediate 
homophilic interactions (Figures 4B (i-iv, vii, xiv) and S4B (ii))) and are delivered to the cell 
surface (Figure S4B (iv)). By contrast, chimeric constructs that include the EC6 domain from 
Pcdhα4 showed no cell aggregation activity (Figures 4B (vi, ix-xiii, xv) and S4B (i)) due to the 
failure to localize to the plasma membrane (Figure S4B (iiii)). To address the possibility that the 
domain substitutions affect properties other than cell surface delivery, we co-transfected all 
Pcdhγ-Pcdhα chimera constructs containing the EC6 domain of Pcdhα4 (Figure S4C (i-vi)) with 
the carrier PcdhγB6∆EC1. We found that these co-transfectants mediate homophilic interactions 





shuffling experiments were performed for other alternate Pcdhα isoforms (Figure S4D) and C 
type isoforms (Figures S4E and S4F).  We conclude that the EC6 domain of alternate Pcdhα 
isoforms and of the PcdhγC4 isoform inhibit membrane delivery.  
We next determined whether deletion of the EC6 domain in Pcdhα isoforms can rescue 
membrane delivery and homophilic binding. We found that Pcdhα4∆EC6 is, in fact, efficiently 
delivered to the cell surface (Figure 4C (iii)) and mediates cell aggregation (Figures 4C (i) and 
S4I). These results, together with the domain swapping experiments (Figures 4B and S4D-S4F), 
show that the EC6 domain regulates Pcdh cell surface delivery but is not required for homophilic 
trans interactions.   
 
Co-expression of multiple Pcdh isoforms generates new homophilic specificities 
Previous studies suggested that multiple Pcdhγ isoforms form cis tetramers capable of 
mediating homophilic interactions (Schreiner and Weiner 2010). Since all Pcdh-α, β and γ 
isoforms except PcdhαC1, mediate homophilic interactions (Figures 1D, 3B and S3D), and 
appear to associate with each other in cis (Figure S3B)(Han, Lin et al. 2010, Schalm, Ballif et al. 
2010), we tested the possibility that recognition specificity is diversified by co-expression of 
multiple Pcdh isoforms from all three subfamilies. Cells co-expressing Pcdhα4 and Pcdhβ4 were 
mixed with cells expressing both of these isoforms, or only one (Figure 5A (i-iii)). Cells 
expressing two distinct isoforms failed to co-aggregate with cells expressing either isoform 
alone. However, robust aggregation was observed with cells that co-express both isoforms. 
Similar results were observed for each of the Pcdh pairs shown in Figures 5A, S5A and S5C. 
These results suggest that the presence of one non-matching isoform can interfere with co-
aggregation.  
To test whether this type of interference is unique to Pcdhs, we carried out experiments 





Pcdhs.  Figure 5B shows the results of aggregation assays with cells expressing various 
combinations of N-cad and Pcdhβ18 or PcdhγB6. Three types of aggregation behavior are 
observed. These three behaviors can be described as (1) formation of completely separate red 
and green aggregates, (2) complete intermixing between cell populations, and (3) formation of 
separate red and green aggregates that adhere to one another. Two of these aggregation 
phenotypes are seen in the top panels of Figure 5B, where red cells expressing N-cad form 
separate aggregates from green cells expressing any of the two Pcdhs (i and ii), but form a 
completely mixed aggregate with green cells expressing N-cad (iii).  For these two cases, the 
different aggregation behaviors reflect the fact that N-cad does not bind to these Pcdhs, but 
binds strongly to itself. Figures 5B (iv-ix), S5D, S5F and S5G depicts the behavior of cells co-
expressing N-cad and one Pcdh when they are allowed to mix with either N-cad or Pcdh 
expressors.  In each case, these green cells form completely intermixed aggregates with red 
cells expressing N-cad alone, or with red cells expressing N-cad and the identical Pcdh or non-
matching Pcdh, reflecting strong homophilic N-cad interactions with which Pcdhs do not 
interfere.  The third type of aggregation behavior is observed when the red cells express both N-
cad and a Pcdh isoform, and the green cells express only the identical Pcdh isoform (Figure 5B 
vi and ix).  In this case, separate green and red homophilic aggregates are formed, but 
importantly they now adhere to one another. Similarly, all three types of behavior are observed 
for cells co-expressing N-cad and two Pcdhs (Figures S6D-E and S6G). The behavior of N-
cad/Pcdh co-transfectants is strikingly different from that observed for Pcdh co-transfectants 
with mismatches, in which all homophilic aggregates remain completely separate.  
These results strongly suggest that Pcdhs interact in cis so as to create new homophilic 
specificities that differ from the specificities of the individual Pcdh isoforms. In contrast, N-
cad/Pcdh co-transfectants behave in a way that can be explained by a summation of the 
properties of the individual proteins, showing no evidence of cis interaction between them 





co-IP experiments are consistent with cis interactions between Pcdhs, and with their absence 
between Pcdhs and N-cad (Figures S5E-S5G, and S6F). 
 To further characterize the Pcdh interference phenomenon, we assessed the ability of 
cells co-transfected with up to five Pcdh isoforms to co-aggregate with cells containing various 
numbers of mismatches (Figures 5C-G, 6A-C, S5B, S5G, S6A-C and S6F). In all cases, mixed 
aggregates were observed only for cells expressing identical isoforms whereas cells expressing 
mismatched isoforms formed separate non-adhering aggregates (Figure 5 and 6). Remarkably, 
even cells co-expressing distinct sets of four or five isoforms with even a single non-matching 
isoform resulted in the formation of large non-contacting homophilic aggregates with no contacts 
between them (Figure 6C).  
Discussion 
 The stochastic single-cell expression of clustered Pcdhs, the diversity of Pcdh 
extracellular domains, and the demonstration that the Pcdhg gene cluster is required for 
dendritic self-avoidance in starburst amacrine and Purkinjie cells support the hypothesis that the 
clustered Pcdhs provide single cell identity necessary for self-recognition in vertebrate nervous 
systems (Zipursky and Sanes 2010, Yagi 2012, Chen and Maniatis 2013, Zipursky and Grueber 
2013). Here we provide evidence that different combinations of Pcdh α, β and γ isoforms 
interact in cis to generate combinatorial trans recognition specificities. The importance of Pcdh 
cis interactions is demonstrated by their role in delivering Pcdhα isoforms to the membrane. 
Below, we summarize evidence supporting these conclusions, we provide a theoretical analysis 
of Pcdh single cell diversity and we discuss the implications of this analysis on a prevailing 
model based on tetrameric cis recognition units (Schreiner and Weiner 2010, Yagi 2012).  We 
conclude that, although recognition involving coupled cis and trans interactions (Wu, Jin et al. 





establish single-cell identity, the nature of Pcdh recognition units and the mechanism of their 
interactions remains uncertain.  
 
α, β, γ and C-type Pcdhs mediate specific homophilic recognition  
 We showed that Pcdh isoforms from all three gene clusters (α, β and γ) can mediate 
highly specific homophilic interactions (Figures 1D, 3B, S3D and S3F). Striking examples of this 
trans homophilic specificity are provided by the observation that Pcdh isoform pairs with as 
great as 91-97% identity in their EC2-EC3 recognition domains (α7-α8, β6-β8 and γA8-γA9) do 
not engage in heterophilic interactions (Figures 2C, 2D, and 3E). While PcdhαC1 does not 
interact homophilically in the aggregation assay (Figures 1D and S3F), a chimeric construct 
containing the PcdhαC1 EC1-EC3 domains can mediate homophilic interactions (Figure S4E 
(i)). Thus, it seems likely that the function of PcdhαC1 involves self-recognition, although the 
biological context is not yet understood. We note that, unlike the other Pcdhs, the calcium-
binding motif DRE is not present in the EC3 domain of PcdhαC1 (Figure S1A).  Rather, this 
motif is replaced by the sequence GPP, which is conserved in the PcdhαC1s in other species. 
We therefore speculate that the unique behavior of PcdhαC1 in the cell aggregation assay may 
result from differences in protein structure due to the absence of the calcium-binding motif, as, 
for example, in DN-cadherin (Jin, Walker et al. 2012). 
Evidence for Pcdh cis interactions 
Definitive evidence for cis interactions between distinct Pcdh isoforms is lacking. 
However, a number of experimental observations provide strong support for this possibility.  
First, we observe an altered recognition specificity when multiple Pcdh isoforms are expressed, 
a property thus far unique to Pcdhs. It is difficult to imagine how this could occur without cis 





surface in a process that requires membrane proximal domains (EC5 and EC6) of the carrier 
proteins, which are likely to be involved in cis interactions (Figure 4A). Third, distinct Pcdh-α, β  
and  γ isoforms can be co-immunoprecipitated (Murata, Hamada et al. 2004, Han, Lin et al. 
2010, Schalm, Ballif et al. 2010, Schreiner and Weiner 2010)  (Figures S3B and S6F). Fourth, 
multiple Pcdh isoforms are found in high molecular weight detergent-solubilized Pcdh 
complexes from the brain (Han, Lin et al. 2010).  
Analysis of domain deletion and substitution experiments revealed a critical role of 
Pcdhα EC6 domains in the inhibition of cell surface delivery. Differential cell surface localization 
functions of EC6 domains may be reflected in amino acid sequence differences between them. 
The EC6 domains are the most highly conserved within the Pcdh -β and -γ subfamilies (Figures 
S2A and 4D), but differ from the EC6 domains of the Pcdhα isoforms (Figures 4D and 4E). The 
correspondence between membrane-delivery phenotypes and distinct EC6 sequence 
signatures suggests that the carrier function is a conserved property of clustered Pcdhs. The 
question of whether Pcdh cis complexes are stable on the cell surface, or can exchange cis 
partners in the plasma membrane remains to be determined.  Reassortment of multimeric 
complexes on the cell surface would have obvious implications for Pcdh cell surface diversity 
and combinatorial specificity.  
 
Combinatorial homophilic interactions between Pcdh α, β & γ isoforms 
The key findings of cell aggregation assays can be interpreted in terms of the  
differential adhesion hypothesis (Foty and Steinberg 2005) and the relationship between 
molecular binding affinities and the strength of cell-cell adhesion (Katsamba, Carroll et al. 2009). 
Specifically, the aggregates we observe are likely the consequence of maximizing the number 
of favorable protein-protein interactions between cells. For example, cells expressing five Pcdh 





than to intermix with cells expressing only four of the five isoforms (Figure 6C). The cells 
expressing four Pcdh isoforms would similarly be expected to form homophilic aggregates with 
each other, in order to maximize the number of protein-protein interactions. However, one would 
also expect the two types of homophilic aggregates to adhere to one another, again to maximize 
favorable protein-protein contacts, as was observed in the experiments with N-cad and Pcdh(s) 
(Figures 5B, 5H, S6D and S6E).  Remarkably, contact between aggregates expressing distinct 
Pcdh isoforms does not occur, suggesting a mechanism in which mismatched isoforms interfere 
with intercellular interactions.  Indeed in all cases tested here, even a single Pcdh mismatch is 
sufficient to prevent the two types of homophilic aggregates from adhering to each another. 
What is the maximum fraction of expressed isoforms that two cells can have in common 
before incorrectly recognizing each other as self? Our results suggest that at least in the cases 
examined, up to 80% (4/5) of the Pcdh common-isoforms can be shared between two cell 
populations without triggering co-aggregation (Figure 6C).  In contrast, Schreiner and Weiner 
(2010) reported a graded recognition in which expression of 50% (1/2) and 75% (3/4) common-
isoforms resulted in corresponding percentage of binding (~30-50% and ~70% respectively). 
These differences are likely to be due, at least in part, to different experimental approaches. 
Specifically, we used direct visualization to assess the specificity of cell-cell interactions and to 
determine which types of aggregates are formed (Figure S5G and S6G). In contrast, the 
previous report utilized an indirect colorimetric assay in which different types of aggregates 
could not be distinguished.  
 
Theoretical analysis of Pcdh-mediated neuronal diversity 
The prevailing model for generating neuronal diversity by Pcdhs involves the existence 
of discrete tetrameric recognition units formed by random combinations of Pcdh proteins that 





evaluate the implications of the high level of common-isoform tolerance identified in our study, 
we carried out an independent analysis of the factors that may contribute to Pcdh-mediated 
neuronal identity. Our analysis is based in part on earlier studies on Dscam1 by (Hattori, Chen 
et al. 2009) and by (Forbes, Hunt et al. 2011), but focuses on the issue of isoform tolerance and 
introduces a factor not addressed previously; specifically how do neurites of the same neuron 
recognize that they are “the same”? We believe that the cis-tetramer model fails to answer this 
question.  We begin with an analysis of isoform tolerance, which is key to understanding 
neuronal non-self discrimination. 
For both Pcdhs and invertebrate Dscam1, the probability of errors in non-self 
discrimination depends on three parameters: the total number of potential isoforms, the number 
of distinct isoforms expressed per cell, and the tolerance for common isoforms between cells in 
contact (Hattori, Chen et al. 2009).  Common-isoform tolerance is defined as the maximum 
percentage of common isoforms that can be present in two cells in contact without incorrect 
recognition as self. Based on this model (Hattori, Chen et al. 2009), if two cells have a higher 
fraction of common isoforms than the tolerance, they will inappropriately recognize each other 
as self. Hattori et al., (2009) assumed low tolerance for Dscam1 (10-20%), which is intuitively 
reasonable, since two cells expressing larger fractions of common isoforms would be expected 
to bind to one another. However to our knowledge, no experimental measure of tolerance has 
been reported for Dscam1. The results of the work presented here reveal much higher common-
isoform tolerance levels for Pcdhs than assumed for Dscam1. This difference is likely the 
consequence of homophilic interactions between Pcdh cis multimers, in contrast to the Dscam1 
isoforms which appear to interact as monomers. In the following section, we present an analysis 
of the inter-related effects of isoform diversity and isoform tolerance on non-self recognition. 
This in turn makes it possible to discuss Pcdhs and Dscam1 within a common framework.  
Figure 7A shows the probabilities that two cells stochastically expressing different 





of possible isoforms, the number of isoforms expressed per cell (the x-axis in the figure), and a 
common-isoform tolerance, analytical expressions (Forbes, 2011) or Monte-Carlo simulations 
(Hattori, Chen et al. 2009) can be used to calculate these probabilities (See Supplemental 
Information). Results for Dscam1 were reported for a 5000-member isoform pool with a 15% 
tolerance (Hattori, Chen et al. 2009). In the case of Pcdhs, we made the conservative 
assumption of 67% tolerance (2/3 as observed in Figure 6A), and a 58-member isoform pool. 
Remarkably, even with a 67% common-isoform tolerance for clustered Pcdhs, the probabilities 
of incorrect recognition are as low as those for Dscam1 isoforms over much of the region that 
includes the expected number of isoforms (estimated at about 15 for Pcdhs and 10–50 for 
Dscam1) (Hattori, Chen et al. 2009, Yagi 2012). These results suggest that a mechanism for 
achieving extremely high common-isoform tolerance is a key factor explaining how only 58 
Pcdhs may be sufficient to mediate non-self discrimination in vertebrates. 
 Combinatorial specificity of Pcdh interactions based on the assembly of multimeric cis 
Pcdh recognition units containing isoforms from all three gene clusters provides a possible 
mechanism to achieve the observed high level of tolerance. To illustrate this, we consider a 
model similar to that proposed for cis-tetramers (Schreiner and Weiner 2010, Yagi 2012, 
Weiner, Jontes et al. 2013). We noted that the cis-tetramer model was based on a molecular 
weight estimate from size-exclusion chromatography (Schreiner and Weiner 2010). However, 
the molecular weight of elongated proteins such as Pcdhs cannot be rigorously determined by 
this method, nor can it distinguish between cis and trans multimers. We therefore did not 
assume a specific multimeric state in our analysis.  
A specific case where two cells each express one common and one different isoform 
and engage in cell-cell interactions through monomer, dimer, trimer or tetramer recognition units 
is illustrated in Figure 7B. As the multimer size increases, the fraction of common-recognition 
units decreases. This behavior is generalized in Figure 7C, which shows that at the same 





tolerance, thus increasing cell surface diversity. For example, assuming tetrameric recognition 
units with 67% common isoforms (2/3) between two cells, only 20% of the recognition units will 
be shared, well within the range assumed for Dscam1 monomers (Hattori, Chen et al. 2009). 
This result highlights the essential feature of the tetramer model (Yagi 2012). A tetrameric 
recognition unit implies that different neurons will have only a small fraction of recognition units 
in common even if they have a high fraction of common isoforms. In this way, mismatched 
isoforms will interfere with cell-cell adhesion by diluting the number of common recognition units 
(Hirayama and Yagi 2013).  
In contrast, randomly assembled tetrameric recognition units, in which all Pcdh isoforms 
form multimers with equal probability, fails to explain how two neurites from the same cell body 
are able to recognize each other as self. The point can be easily seen by calculating the 
average number of copies of each multimeric recognition unit per cell as a function of the 
number of copies of each Pcdh isoform in a cell. Figure 7D reports these numbers for the case 
of 15 different isoforms expressed per cell. A striking conclusion is that, for tetramers, there 
would be an unacceptably small number of copies of each recognition unit per neuron. For 
example, assuming that there are 5,000 copies each of 15 distinct Pcdh isoforms in an 
individual cell (75,000 Pcdhs total - in the range estimated for cells overexpressing classical 
cadherins (Duguay, Foty et al. 2003)), 12,720 unique tetramers could form and there would thus 
be fewer than two copies (approximately 75,000/(12,720*4)=1.4) of each unique recognition unit 
per neuron (Yagi, 2012). This number is clearly insufficient for self-recognition by neurons with 
many neurites. This self-recognition problem is reduced but not eliminated for trimeric and 
dimeric recognition units (Figure 7D). 
 These considerations bring into question the validity of the tetramer model in which all 
isoforms have equal probability of participation. This would be less of a problem if only certain 
combinations of Pcdh isoforms could assemble into multimers. For example, our data indicates 





constitutively expressed C-type isoforms to function on the cell surface. The obligate assembly 
could also determine the nature of the multimeric complexes. Another possibility is that like 
classical cadherins (Harrison, Jin et al. 2011), Pcdhs could form junction-like structures 
involving cis and trans interactions, which require a minimal percentage of matched isoforms to 
mediate stable adhesion.  With such a mechanism, an excess of mismatched isoforms in 
contacting cells would reduce the number of favorable interactions so as to prevent junction 
formation.  
Experimental procedures 
Plasmid construction. Coding sequence of each clustered Pcdh isoform was PCR amplified 
from C57BL/6 genomic DNA or brain cDNA, cloned into modified Gateway vectors to generate 
C-terminal mCherry- or mVenus-tagged Pcdh proteins.  Domain deletions, substitutions, or 
insertion of an extracellular c-Myc tag were created by overlapping PCR. See Extended 
Experimental Procedures for details. 
Cell aggregation assay. Expression constructs were transfected into K562 cells (human 
leukemia cell line, ATCC CCL243) by electroporation using Amaxa 4D-Nucleofactor (Lonza). 
After 24 hours in culture, the transfected cells were allowed to aggregate for one to three hours 
on a rocker kept inside the incubator. The cells were then fixed in 4% PFA for 10 minutes, 
washed in PBS, and cleared with 50% glycerol for imaging. Quantification of the sizes of cell 
aggregates was described in Extended Experimental Procedures.  
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Figure Legends 
Figure 1. The Pcdh gene cluster encodes a large repertoire of cell surface recognition 
proteins. 
(A) Schematic representation of the mouse Pcdh-a, -b and -g gene clusters. Variable exons of 
each subtype are differentially color-coded. Pcdha and Pcdhg variable exons are joined via cis-
splicing to three constant exons. An example is shown for Pcdha9. Each variable exon encodes 
six EC domains, a TM, and a short cytoplasmic extension. The constant exons encode the 
common ICD domain.  
(B) Schematic diagrams representing the four major subtypes of Pcdhs are shown.  
(C) Schematic diagram of the cell aggregation assay. mCherry-tagged Pcdh proteins are 





examples, cells expressing mCherry alone do not aggregate, while robust cell aggregation is 
observed with cells expressing PcdhγC3-mCherry.  
(D) Survey of homophilic binding properties of all 58 Pcdh isoforms in the cell aggregation 
assay. Scale bar, 50 µm. (See also Figure S1B). 
  
Figure 2. Pcdh-β, −γ,  and C-type  isoforms engage in specific homophilic interactions.  
(A) Schematic diagram of the binding specificity assay. Cells expressing differentially tagged 
Pcdh isoforms are then mixed and assayed for homophilic or heterophilic interactions. A strict 
homophilic interaction is indicated by mixed red-and-green co-aggregates between cells 
expressing only the identical isoforms and segregation of separate red and green aggregates 
between cells expressing different isoforms.  
(B) Heat map of pair-wise protein sequence identities of the EC2-EC3 domains of Pcdh 
isoforms and their evolutionary relationship is presented.  Subsets of the isoforms within the 
boxed region were assayed. (See also Figure S2B).  
(C-E) Pairwise combinations within each subtype Pcdhβ (C), Pcdhγ (D), and C-type (E) isoforms 
were assayed for their binding specificity. Scale bar, 50 µm. (See also Figure S3C).  
 
Figure 3. Pcdhα isoforms engage in specific homophilic interactions when delivered to 
the cell surface by co-expressed Pcdh-β or -γ isoforms.  
(A) Surface expression of mCherry-tagged Pcdh constructs bearing an extracellular c-Myc tag 





(B) Cells transfected with single Pcdhα isoforms (upper panels) and cells co-transfected with 
Pcdhα isoforms and PcdhγB6ΔEC1 (lower panels) were assayed for aggregation. Scale bar, 50 
µm. 
(C) Cells expressing ΔEC1-Pcdhs alone (upper panels), Pcdhα4/ΔEC1-Pcdhs (middle panels) 
were assayed for aggregation. Cells co-expressing Pcdhα4 and a carrier ΔEC1-Pcdhs do not 
interact with cells expressing only the wild-type carrier Pcdhs (lower panels). Scale bar, 50 µm. 
(See also Figure S3C). 
(D) Heat map of pairwise sequence identities of the EC2-EC3 domains of Pcdhα isoforms. The 
boxed region shows Pcdh-α4, -α7 and -α8, which share a high level of sequence conservation.  
(E-F) Cells co-expressing differentially tagged Pcdhαs and ∆EC1-Pcdhs were assayed for co-
aggregation. 
 
Figure 4. The role of EC6 domains in membrane delivery.  
(A) Mapping the minimum binding region of carrier Pcdhs. Cells expressing PcdhγB6 mutants 
alone (Upper panels) and with Pcdhα4 (Lower panels) were assayed for aggregation. Cell 
surface expression of Myc-tagged Pcdhα were shown (xv-xvi). (See also Figure S4G)  
(B) Schematic representation of chimeric proteins and the results of homophilic binding assays 
are presented. All of the chimeras bearing the EC6 domain from PcdhγC3 (yellow) mediate cell 
aggregation. All of the chimeras bearing the EC6 domain of Pcdhα4 (red) fail to mediate cell 





(C) Cells expressing Pcdhα4 EC6/ICD domain deletion mutants are tested for aggregation (i-ii). 
Surface expression of Pcdhα constructs were shown on the right (iii-iv). (See also Figure S4I) 
(D) Heat map of pairwise sequence identities for EC6 domains. The EC6 domain is highly 
conserved in alternate Pcdhβ and Pcdhγ isoforms, but the EC6 domains of alternate Pcdhα 
isoforms are less conserved. 
(E) Multiple sequence alignment of EC6 domains of membrane-delivered Pcdhs (light gray) and 
non-membrane delivered Pcdhs (dark grey). Residues conserved within only one group are 
highlighted in blue and invariant residues in red.  
White arrows indicate the c-Myc staining at cell-cell contacts in A and C.  Scale bar, 50 µm. 
 
Figure 5. Co-expression of two distinct Pcdh isoforms generates a unique cell surface 
identity. 
(A) Cells co-expressing two distinct mCherry-tagged Pcdh isoforms were assayed for interaction 
with cells expressing an mVenus-tagged Pcdh isoform or identical pairs. Pcdhα4+ is efficiently 
membrane-delivered and it possess the EC6 domain from PcdhγC3. (See also Figures S5A, 
S5C, S5G) 
(B) Cells expressing mCherry-tagged N-cad were assayed for interaction with cells expressing 
single Pcdh isoform (Upper panels). Cells co-expressing pair of mCherry-tagged N-cad and 
Pcdh isoform were assayed for interaction with cells expressing an mVenus-tagged N-cad or 
Pcdh isoform (Middle and last panels). (See also Figures S5D, S5G, S6D, S6E and S6G) 
(C-G) Cells co-expressing different combinations of differentially tagged Pcdh/Pcdh pairs were 





(H) Illustration of the outcome of cell-cell interaction dictated by combinatorial homophilic 
specificity of two distinct Pcdh isoforms (e.g a-c). Illustration of the outcome of cell-cell 
interaction dictated by cells co-expression N-cad and single Pcdh isoform (e.g d-g). This 
schematic diagram presented here does not reflect t the cis-dimer and asterisk represents the 
non-matching Pcdhγ.  
 
Figure 6. Combinatorial co-expression of multiple Pcdh isoforms generates unique cell 
surface identities.  
(A-C) Cells co-expressing an identical or a distinct set Pcdh-α, −β, and −γ isoforms (A) and with 
C-type isoforms (B-C) were assayed for co-aggregation. Pcdhα4+ is efficiently membrane-
delivered and it possess the EC6 domain from PcdhγC3. The non-matching isoforms between 
two cell populations were underlined. (See also Figure S6A-C and G) 
(D) Illustration of the different behaviors of cell-cell interaction generated by combinatorial 
homophilic specificity of distinct sets of multiple Pcdh isoforms.  
Figure 7. Probabilistic analysis of Pcdh and Dscam1 recognition 
(A) Probabilities of incorrect non-self recognition between two cells as a function of the number 
of isoforms expressed per cell.  Lines in the plot appear jagged due to the integer number of 
tolerated isoforms. 
 (B) Schematic representation of recognition units for different cis-multimeric states.  Two cells 
share one common Pcdh isoform (blue) and one distinct isoform (red and yellow). Unique 





(C) The relationships between common-isoforms and common-recognition units for different 
multimeric states. Vertical dotted lines mark the cases of 50% and 67% common Pcdh isoforms 
and show the corresponding percentage of common recognition units for monomers, dimers, 
trimers and tetramers. For the same percentage of common isoforms, larger multimers have a 
smaller percentage of common recognition unit. 
(D) Monte-Carlo simulations were used to estimate the average number of copies of each 
multimer in a single cell. For the case of 15 Pcdh isoforms expressed per cell, the average 
number of copies of each multimeric recognition unit generated by the stochastic assembly of 



















































































Legends for supplementary Figures 
Figure S1. Protein sequence alignments of the clustered Pcdhs  
(A) Amino acid sequence alignment of representative clustered Pcdh isoforms. Sequences were 
aligned with Muscle (Edgar 2004) and divided into individual EC domains based on the DXNDN-
XPXF motif (Posy, Shapiro et al. 2008). The location of β-strands is indicated above the 
alignment, with the conserved residues that form the hydrophobic core of the EC domain 
highlighted in blue. Red boxes indicate the canonical Ca2+ binding motifs and are labeled 
according to which inter-domain Ca2+ binding site they belong to. The N-terminus based on 
signal peptide prediction is shown with a grey arrow. The XPXF motifs at the start of the ECs 
are highlighted in green. The end of EC6 domain is predicted using a cadherin database 
created in the lab of Dr.Barry Honig (http://cadherindb.c2b2.columbia.edu/) The “DRE” mortif of 
EC3 domain is absent in PcdhαC1. 
(B) Quantification of cell aggregate size – A graph showing the size distribution of cell 
aggregates generated by cells expressing a single Pcdh isoform. All 12 alternate Pcdhαs fails to 
mediate cell adhesion. Among 22 members of Pcdhβ cluster, Pcdhβ7 and Pcdhβ19 expressing 
cells make very small aggregates. Any of 19 members of PcdhγAs or PcdhγBs expressing cells 
make relatively medium and large aggregaes. Among 5 C type isoforms, PcdhαC2 and 
PcdhγC4 expressing cells fail to mediate cell aggregation. The cell aggregates were classified 
according to the number of cells they contain - small size (<10 cells), medium size (10-30 cells), 
and large size (>30 cells). The representative bar graph shown here quantified the types of cell 
aggregates from one experiment. The cell aggregation experiments for each of the Pcdh 





Figure S2. Sequence identity of EC domains and Pcdh binding specificities.  
(A) Average pair-wise sequence identity of individual EC domains of Pcdh subtypes. The left 
panel shows the average pairwise sequence identity of individual EC domains of all four Pcdh 
subtypes.  Among the six EC domains, EC2 and EC3 are the most divergent, and EC6 is highly 
conserved (except in the case of the C-types).  
(B) Heat map of the pair-wise protein sequence identity of the EC2 and EC3 domains. A subset 
of Pcdh -α, -β or -γ isoforms (shaded in red) shares a high level of sequence identity in their 
EC2 and EC3 domains. 
(C) PcdhγA8 and PcdhγA9 do not engage in homophilic interactions. Low magnification views 
for differentially-tagged Pcdhs tested for binding specificity are shown. Cells expressing 
PcdhγA8 fail to co-aggregate with cells expressing PcdhγA9 (top panel). Cells expressing 
PcdhγA9 fused to mCherry co-aggregate with cells expressing PcdhγA9 fused to mVenus (lower 
panel). These results demonstrate the high level of homophilic specificity of interactions of 
closely related Pcdh isoforms.  Scale bar, 50 µm. 
(D) Binding specificity of different Pcdh subtypes.  Representative members of each Pcdh 
subtype - Pcdhβ17, -γA8, -γB6, and C-type γC3 were tested for binding specificity. Co-
aggregation was only observed for cells expressing the same Pcdh isoform (i and xiii), but not 
for cells expressing different Pcdh isoforms (ii-vii). Scale bar, 50 µm. 
Figure S3. Pcdhα and a subset of C-type isoforms engage in specific homophilic 
interactions when delivered to the cell surface by a carrier Pcdh. 
(A) The EC1 domain is required for homophilic interaction, but not for the membrane delivery. 





tagged PcdhγB6∆EC1 is delivered to the cell surface (ii) but fail to mediate cell aggregation (i). 
White arrows indicate the c-Myc staining at cell-cell contacts.  Scale bar, 50 µm (i), 10 µm (ii). 
(B) Cis-interaction between Pcdhα and wild-type or ∆EC1 carrier Pcdhs. Wild-type or ∆EC1 
carrier Pcdh-αC2, -β17, -γB6 or -γC3 (fused to mCherry) are co-expressed with Pcdhα4-TAP 
(one HA epitope tag, followed by two TEV protease cleavage sites and two FLAG epitope tags) 
in HEK293 cells. The cells were lysed, and Pcdhα4 was immunoprecipitated using anti-FLAG 
beads. Western blotting with anti-mCherry antibodies shows the interaction between Pcdhα4 
and the carrier Pcdh isoforms. Western blotting with anti-Flag antibodies shows that Pcdhα4 is 
present in all co-IP experiments.  IP,immunoprecipitation; IB, immunoblotting. 
(C) Quantification of cell aggregate size. Data presented in graph show the size distribution of 
the number of cell aggregates generated by singly transfected cells expressing carrier Pcdhs 
(∆EC1-Pcdh-αC2, -β17, -γB6 or -γC3), or cells co-expressing ∆EC1-Pcdhs with Pcdhα4 from 
Figure 3C (i-viii). According to the number of cells they contain, cell aggregates are classified 
into small size (<10 cells), medium size (10-30 cells), and large size (>30 cells). Scale bar, 50 
µm. 
(D) Alternate Pcdhα isoforms mediate homophilic interactions when co-transfected with different 
carrier Pcdhs. Cells transfected with single Pcdhα isoforms are shown (first row). Aggregation is 
observed for cells co-transfected with Pcdhβ17ΔEC1 (second row), PcdhγC3ΔEC1 (third row), 
or PcdhαC2ΔEC1 (fourth row) and an alternate Pcdhα isoform.  
(E) Quantification of cell aggregate size. Data presented in graph show the size distribution of 
the quantified number of cell aggregates generated by the third row in Figure S3D. According to 
the number of cells they contain, cell aggregates are classified into small size (<10 cells), 





(F) Pcdhγs mediate homophilic interactions when co-transfected with carrier Pcdhs, while 
PcdhαC1 does not. Cells transfected with single ∆EC1-carrier Pcdhs fail to mediate cell 
aggregation (first row). PcdhγC4 and PcdhαC1 fail to mediate homophilic interactions when 
transfected alone (v and x). Cells co-expressing PcdhγC4 and ∆EC1-carrier Pcdhs mediate cell 
aggregation (second row). The aggregates are relatively small and it may be due to the low 
surface expression of PcdhγC4 isoforms and/or the proteins display a weak trans-binding 
affinity. Cells co-expressing PcdhαC1 and ∆EC1-carrier Pcdhs failed to mediate cell 
aggregation (third row). Scale bar, 50 µm. 
Figure S4. The universal role of EC6 domains in cell surface delivery for all Pcdh 
subtypes. 
 (A) EC5-EC6 domains of Pcdhβ are the minimum region required for Pcdhα cell surface 
delivery. Schematic representations of Pcdh constructs are shown above the image. 
Immunostaining of c-Myc-tagged Pcdhs was used to visualize cell surface localization. While 
Pcdhα4 does not localize to cell surface (iii) and fails to engage in homophilic interaction (i), co-
expression of Pcdhβ17(∆EC1-4) facilitates the membrane delivery of Pcdhα4 (iv) and 
subsequent cell aggregation (ii). White arrows indicate the c-Myc staining at cell-cell contacts.  
(B) EC6 domains of Pcdhα or PcdhγC3 isoforms inhibit or promote membrane delivery 
respectively. Schematic representations of Pcdh constructs are shown above the experiment. 
Cell surface localization of c-Myc-tagged Pcdhs was used to visualize cell surface localization. 
Chimeras of Pcdhα4 bearing the EC6 domain from PcdhγC3 localize to cell membrane (iv) and 
mediate robust cell aggregation (ii). Chimeras of PcdhγC3 bearing the EC6 domain of Pcdhα4 
fail to localize to the cell membrane (iii) and fail to mediate cell aggregation (i). White arrows 





(C) ∆EC1-carrier Pcdhs promote the aggregation activity of chimeras bearing the EC6 domain 
from Pcdhαs. Schematic representations of Pcdh constructs are shown above the experiment. 
Chimeras of Pcdhγs bearing the EC6 domain of Pcdhα4 fail to mediate cell aggregation (upper 
panels, i-vi) but they mediate robust cell aggregation with co-transfected carrier PcdhγB6∆EC1 
(lower panels, vii-xii).  
(D) The EC6 domains of Pcdhβ17, PcdhγB6, or PcdhγC3 can rescue the inability of Pcdhα 
isoforms to localize to the membrane. Schematic representations of Pcdh constructs are shown 
above the experiment. Chimeras of Pcdhα isoforms bearing the EC6 domains of Pcdhβ17, 
PcdhγB6, or PcdhγC3 mediate robust cell aggregation (upper panels, i-iii). Chimeras of Pcdh 
isoforms bearing the EC6 domain of Pcdh-α4 or -α8 fail to mediate cell aggregation (lower 
panels, iv-vi).  
(E) Domain substitution experiments with C-type Pcdh isoforms. Schematic representations of 
chimeras are shown above the cell aggregation results. Chimeric PcdhαC1(EC1-3)-γC3 
mediates cell aggregation (i). However, chimeric PcdhαC1(EC1-5)-γC3 fail to mediate cell 
aggregation (ii). Similarly, cell aggregation was observed for chimeric PcdhγC4(EC1-3)- γC3 and 
PcdhγC4(EC1-5)- γC3 (iii-iv) but not for the PcdhγC4 chimera bearing the ICD domain of 
PcdhγC3 (v). Conversely, all the chimeras of PcdhγC3 proteins bearing the EC6 domain of 
PcdhαC1 or PcdhγC4 fail to mediate cell aggregation (vi-ix). PcdhγC3 chimera bearing the ICD 
domain of PcdhγC4 mediates homophilic interaction (x).  
(F) The EC6 domain of PcdhγC4 inhibits membrane delivery, whereas the EC6 domain of 
PcdhγC3 promotes cell surface localizations. Schematic representations of Pcdh constructs are 
shown above the experiment. Chimeras of PcdhγC4 bearing the EC6 domain from PcdhγC3 





Chimeras of PcdhγC3 bearing the EC6 domain of PcdhγC4  failed to localize to the cell surface, 
as observed for wild-type PcdhγC4 (ii and iii). White arrows indicate the c-Myc staining at cell-
cell contacts.  
(G-I) Quantification of cell aggregate size. Data presented in graph show the size distribution of 
the quantified number of cell aggregates generated by experiments shown in Figure 4A (G), 
Figure 4B (H), and Figure 4C (I). According to the number of cells they contain, cell aggregates 
are classified into small size (<10 cells), medium size (10-30 cells), and large size (>30 cells). 
Figure S5. Combinatorial binding specificity displayed by co-expression of two distinct 
Pcdh isoforms. 
(A) Quantification of co-aggregation of two differentially labeled cell populations from Figure 5A. 
The percentages of red and green co-aggregates are quantified and illustrated as bar graph.  
(See also supplemental table 1 for raw data) 
(B) Quantification of co-aggregation of two differentially labeled cell populations. The 
percentages of red and green co-aggregates from C-G are quantified and illustrated as a heat 
map. (See also supplemental table 1 for raw data) 
(C-D) Wider views for cell aggregate images of differentially-tagged two Pcdh isoforms (C) and 
N-cad-Pcdh isoform (D) were shown. Scale bar, 50 µm. 
(E) K562 cells were used to co-express N-cad and Pcdh isoforms or two different Pcdh 
isoforms. The cells were lysed, and mVenus-tagged Pcdh proteins were immunoprecipitated 
using anti-GFP beads. Western blotting was carried out using anti-mCherry and anti-GFP 
antibodies.  Pcdhβ17 was co-immunoprecipitated by PcdhγB1. But N-cad was not co-





(F) Cells expressing differentially tagged N-cad and Pcdh isoforms were mixed with cells 
expressing N-cad with same or different Pcdh isoform (i-iii). In all cases, red and green cells 
intermixed. However, cells expressing the two Pcdh isoforms used in (i-iii) did not interact with 
each other (iv). 
(G) Schematic diagram represents the outcome of co-aggregation of the two cell populations 
expressing mCherry-tagged proteins and mVenus-tagged proteins.  Three types of cell 
aggregate behaviors are presented and the results of interaction between red and green cells 
were summarized below.   
Figure S6. Combinatorial binding specificity displayed by co-expression of up to five 
distinct Pcdh isoforms.  
(A-C) Quantification of co-aggregation of two differentially labeled cell populations. The 
percentages of red and green co-aggregates from (Figures 6A-6C) are quantified. (See also 
supplemental table 1 for raw data) 
(D) Cis-interaction between Pcdh α, β and γ isoforms. Pcdhα4-TAP, Pcdhβ17-mCherry and 
PcdhγB1 mVenus were co-expressed in K562 cells. The cells were lysed, and Pcdhα4 was 
immunoprecipitated using anti-FLAG beads and PcdhγB1 was immunoprecipitated using anti-
GFP beads. Western blotting with anti-mCherry, anti-FLAG and anti-GFP antibodies shows the 
interaction between all three isoforms. Western blotting with anti-FLAG antibodies shows that 
Pcdhα4 is present in all co-IP experiments.  TAP tag contains one HA epitope tag, followed by 
two TEV protease cleavage sites and two FLAG epitope tags. IP,immunoprecipitation; IB, 
immunoblotting. 
(E) Cells co-expressing mVenus-tagged N-cad and two different Pcdh isoforms were mixed with 





of two Pcdhs. Three different behaviors of cell aggregates were observed between two cell 
populations. Transfected with 1µg plasmid input of N-cad and 3µg plasmid input of Pcdhs 
(Upper panels). Transfected with 1µg plasmid input of N-cad, 3µg plasmid input of Pcdhs 
(Lower panels).  
(F) Higher magnification images from experiment transfected with 0.25µg plasmid input of N-cad 
and 3µg plasmid input of Pcdhs. Three different behaviors of cell aggregates were observed 
between red and green cells.  
(G) Schematic diagram represents the outcome of co-aggregation of the two cell populations 
expressing mCherry-tagged proteins and mVenus-tagged proteins.  Three types of cell 
aggregate behaviors are presented and the results of interaction between red and green cells 
were summarized below. N-cad (H)-Pcdhβ-Pcdhγ where “H” represent the high input of plasmid 
encoding N-cad (S6E Upper panels). N-cad (L)-Pcdhβ-Pcdhγ represent the less input of plasmid 
encoding N-cad (S6E Lower panels).  
Figure S7. Experimental procedure for testing combinatorial specificity  
(A) Schematic diagram of testing combinatorial specificity of cells co-expressing multiple 
isoforms. To ensure the equal functional contribution of each Pcdh isoforms in co-transfection 
experiments, three steps of binding assay experiments were performed. First, the expression 
level of an individual isoform in one population of cells was tested by mixing with cells 
expressing individual common isoform. Only mCherry positive cells do not mix with cells 
expressing a single isoform but mix substantially with the identical sets of isoforms. These 
mCherry positive cells are then used for second step of binding assay. These mCherry positive 
cells were mixed with cells expressing distinct sets of Pcdh isoforms including one, two or three 
non-matching mVenus tagged isoforms. These same population of mVenus positive cells were 





(B) Illustration of the control cell aggregation experiments for Figure 6B. mVenus positive cells 
expressing non-matching Pcdh isoforms used in Figure 6B were assayed for their interaction 










Extended Experimental Procedures 
Plasmids. DNA fragments encoding full length Pcdh isoforms or variable exons were amplified 
by PCR using genomic DNA or brain cDNA isolated from C57BL/6J mice (The Jackson 
Laboratory). PCR products were inserted into the entry pDONR™/Zeo vector by using BP 
clonase enzyme as described (Invitrogen). To construct pmax-mCherry gateway expression 
vector, the Ubc promoter from pUbc-RfC1-mCherry (a gift from Dr. Joshua Sane lab, Harvard 
University) was replaced with immediate early promoter of cytomegalovirus with intron element 
(PCMV-IE) promoter from pmaxCloning™ vector (Lonza) by using Xba1 and Sac1 restriction 
sites. A 798 base pair long promoter sequence (PCMV-IE) was amplified by PCR using forward 
primer containing an XbaI site (5’- CCCTCTAGATCAATATTGGCCATTAGCCA-3’) and reverse 
primer containing SacI site (5’-TTTGAGCTCCCCTGTGGAGAGAAAGGCAA-3’). To construct 
pmax-mVenus gateway expression vector, a DNA fragment encoding the mCherry gene is 
replaced with the DNA fragment encoding the mVenus gene by using Ale1 restriction sites in 
the pmax-mCherry gateway expression vector. A DNA FigurThe template of DNA encoding 
mVenus gene was amplified by PCR using pEYFP-C1 (Addgene Plasmid 27794) (Koushik, 
Chen et al. 2006). To generate extracellular c-Myc-tagged Pcdhs, the DNA sequence encoding 
peptide of c-Myc (EQKLISEEDL) was inserted after EC6 domains of Pcdhs by using 
overlapping PCR.  The domain deletion and substitution between different Pcdh isoforms were 
also made by using overlapping PCR. The PCR products were then sub-cloned into gateway 
entry vectors and expression vectors. EC domains were predicted by conserved protein 
sequence encoding DXNDN/XPXF motif (Posy, Shapiro et al. 2008) and cadherin database 
created by Barry Honig lab (Examples are shown in Figure S1A) 
(http://cadherindb.c2b2.columbia.edu/). Transmembrane domaisn (TM) were predicted by using 





by Signal P prediction tools from Signal IP 4.1 server (http://www.cbs.dtu.dk/services/SignalP/). 
Primer sequences used for PCR amplifications will be provided upon request.  
Antibodies. The following commercial antibodies were used: anti-FLAG (Sigma), anti-mCherry 
(Clontech), anti-GFP (MBL) and anti-c-Myc-FITC (Miltenyi Biotec).  
Immunostaining. K562 cells were transfected as described above. After 24 hours, FITC-
conjugated anti-c-Myc antibodies were added to the cells and then incubated with shaking for 
one hour. Cells were then fixed with 4% PFA and washed in PBS. Fixed single cells or 
aggregates were collected on glass coverslips by using a cell concentrator (StatSpin) at 1000 
rpm for 10 minutes. Images were collected with an Olympus Fluoview FV1000 confocal 
microscope. 
Binding specificity assay for cells expressing single Pcdh isoform. Differentially tagged 
Pcdh isoforms were transfected into K562 cells as described above. Transfected cell 
populations expressing mCherry- or mVenus-tagged Pcdh(s) were mixed after 24 hours by 
shaking for one to three hours. Images of cell aggregates were imported into ImageJ 
(http://rsbweb.nih.gov/ij), and the number of aggregates containing red cells only (R), green 
cells only (G), and both red and green cells (RG) were counted for analysis of binding 
specificity.  
Binding assay to test combinatorial specificity of multiple isoforms. The binding assay 
was performed as described above. We noted that surface expression of different subtype of 
Pcdh isoforms varies when they are overexpressed in K562 cells. To overcome the variability in 
the level of cell surface expression of individual Pcdh isoforms among individual cells, we 
selected Pcdh isoforms that display similar sized cell aggregates for testing the combinatorial 
specificity (Refer to Figures 1D and S1B). Among four subtypes of Pcdh isoforms, surface 





observed that Pcdhα’s surface expression is less compared to those of Pcdhβ or Pcdhγ 
isoforms in the co-expression experiments (Data not shown. FACS experiment was used to 
quantify the surface expression of different Pcdh isoforms by using the fluorescent labeling of 
extracellular epitope of the proteins.) Thus, in the co-expression experiments, plasmids 
encoding Pcdhα:Pcdhβ:Pcdhγ isoforms were used in 2:1:1 ratio to normalize the equal surface 
delivery of Pcdhα isoforms to other Pcdh subtypes. In these multiple isoforms transfected cells, 
equal contribution of individual Pcdh isoform in combinatorial homophilic interaction is ensured 
by performing the stepwise cell co-aggregation assays as illustrated in Figure S7A.  
 Cells expressing N-cad induce a very robust cell aggregations and a dominant binding 
effect of N-cad was observed in binding assay shown Figure S6D and S6E. Surface expression 
of N-cad is also higher compared to those of Pcdh isoforms when over-express in K562 cells 
(Data not shown). To achieve a similar surface expression level of N-cad and Pcdhs, amount of 
plasmids encoding N-cad was titrated in the co-transfection experiments. For double 
transfections as shown in Figure 5B, plasmids encoding N-cad and Pcdh were used in 1:2 or 
1:3 ratio. For triple isoforms transection, plasmids encoding N-cad and two Pcdhs were used in 
1:3 or 0.25:3:3 ratio.  
Immunoprecipitation and western blotting. HEK293T cells were transfected by using 
Lipofectamine 2000 Reagent as described (Invitrogen). Transfected cells were homogenized in 
IP lysis buffer (Pierce) composed of 25 mM Tris-HCl (pH7.4), 150 mM NaCl, 1 mM EDTA, 1% 
NP-40, and 5% glycerol, supplemented with the Complete Protease Inhibitor Cocktail and the 
PhosSTOP Phosphatase Inhibitor Cocktail (Roche). The cells were incubated in lysis buffer for 
30 minutes by mixing at 4˚C. The supernatant was collected by centrifugation at 10,000 rpm for 
20 minutes. The proteins of interest were immunoprecipitated by incubating the supernatant 





end-to-end rotator at 4˚C.  SDS-PAGE and Western blotting with respective antibodies were 
performed according to standard procedures.  
Quantification of the size of cell aggregates using Matlab. The images of cells from two 
independent aggregation experiments were used to quantify the relative size of cell aggregates 
generated by each Pcdh isoform. The images were first converted to black and white formats 
with 1530x2040 pixels.  Objects with 3500 or fewer pixels were categorized as small (less than 
10 cells), objects between 3500 pixels and 12000 pixels were categorized as medium (10 to 30 
cells), and objects larger than 12000 pixels were categorized as large (more than 30 cells). The 
number of aggregates of each size category was then counted for analysis. 
Statistical Analysis performed for Figure 7 
The probability that two neurons incorrectly recognize each other as self (Figure 7A). The 
probability that a pair of neurons has more than t isoforms in common (ie. the number of shared 
isoforms that can be tolerated), given different number of isoforms (m) stochastically expressed 
from total isoform pool available (i) is calculated using the following formula:  




𝑘=0  (1).  
For Figure 7A we used 58 as the size of the isoform pool (i), and the tolerance (t) was assumed 
to be 67% based on data presented in Figure 6A. Then for a given number of isoforms 
expressed per cell (m), t is calculated as the integer part of 0.67 × m. Using these values in 
formula (1) the probability of two neurons incorrectly recognizing each other is calculated as 




𝑘=0  (2). 
Using a similar statistical framework designed to estimate DSCAM1 diversity, we show 





for Pcdhs. A similar statement was made previously (Yagi 2012), however the probabilities they 
were referring to are different than the probabilities we refer to here. In the previous study, the 
author did not calculate the probabilities of incorrect recognition as self between two contacting 
cells, but rather calculated the fractions of common tetramers between two such cells for 
specific cases of common isoforms. For example in the case of two cells each expressing 15 
isoforms 5 of which are in common 1.3% common tetramer will be generated. However, since 
the probability of these two cells to have 5 common isoforms was not taken into account, 1.3% 
is not the probability of incorrect recognition between two cells and cannot be compared to 
probabilities estimated for DSCAM1, or the probabilities calculated here for Pcdhs. 
 
The relationships between common-isoforms and common-recognition units for different 
multimeric states (Figure 7C). If a cell has i isoforms, j of which are in common with a contacting 
cell, then the percentage of common recognition units between the contacting cells can be 
calculated as (𝑗
𝑖
)𝑛 where n is 1, 2, 3, or 4 for monomer, dimer, trimer, or tetramer, respectively.  
 
Calculation of the average number of copies of each type of multimer expressed in a single cell 
(Figure 7D). Monte-Carlo simulations were used to estimate the average number of copies of 
each multimeric recognition unit generated by the random selection and assembly of Pcdh 
isoforms into multimers (dimers, trimers, and tetramers) per cell. For each case, it was assumed 
that there are an equal number of copies of each of 15 Pcdhs expressed per cell. A striking 
result was observed for the tetramer recognition unit. If we assume that there are 5,000 copies 
each of 15 distinct Pcdh isoforms expressed in an individual cell (75,000 Pcdhs total), there will 
be fewer than two copies of each unique recognition tetramer per neuron (Figure 7D). Although, 





can, in principle, generate 12,720 distinct tetramers (Yagi 2012). In the example described 
above, the total number of tetramers will be 18,750 (75,000 total Pcdh copies/4 Pcdhs per 
tetramer). If we approximate that these 18,750 tetramers are randomly distributed among the 
12,720 possible distinct tetramers, this will result in an average of only 1.5 (18,750/12,720) 









Chapter 3. Protocadherin construct design, protein production and purification 
Introduction 
 Previous studies have shown that the intermolecular binding region responsible for cell-
cell adhesion by classical cadherins is the N-terminal EC1 domain (Shapiro, Fannon et al. 1995, 
Shan, Tanaka et al. 2000, Patel, Ciatto et al. 2006). For vertebrate cadherins, identification of 
the minimal region required for trans binding was important in facilitating the crystallization and 
biophysical characterization of adhesive constructs (Chen, Posy et al. 2005, Katsamba, Carroll 
et al. 2009, Ciatto, Bahna et al. 2010, Harrison, Bahna et al. 2010, Brasch, Harrison et al. 2011). 
Crystallization of EC1-EC2 domain constructs also revealed a cis interface important to 
adherens junction formation (Harrison, Jin et al. 2011). In addition, biophysical characterization 
of these constructs by surface plasmon resonance provided useful insights regarding specificity 
between classical cadherins from different subfamilies (Katsamba, Carroll et al. 2009). 
Mutational, analytical ultracentrifugation experiments and FRET of soluble ectodomain 
fragments have also provided insight into the binding kinetics of classical cadherins and the role 
of the “X-dimer” intermediate (Sivasankar, Zhang et al. 2009, Harrison, Bahna et al. 2010). 
 Structural studies of the N-terminal EC1 domain of Pcdhα4 revealed a Cys-X5-Cys loop 
that is conserved in clustered Pcdhs (Morishita, Umitsu et al. 2006). However, contrary to 
classical cadherins, the EC1 domain is insufficient to mediate trans binding. Domain shuffling 
experiments of Pcdhγ isoforms suggest that EC1 is necessary but not sufficient for binding and 
that the EC2 and EC3 domains determine trans binding specificity (Schreiner and Weiner 2010). 
This study also showed that trans binding does not require the presence of the intracellular 
domain. Despite these advances, the minimal region necessary for trans binding remains 
unclear. The findings of Schreiner and Weiner (2010) have not been generalized to Pcdhs from 
other subfamilies and it remains unclear whether the C-type isoforms behave in a similar 





Production of soluble Pcdh ectodomains and ectodomain fragments has presented a 
challenge. In part, this is likely due to the Cys-X5-Cys loop in the EC1 domain, which may not 
fold properly when produced in Escherichia coli. Previous efforts in our lab focused on 
production of the N-terminal EC1-EC2 domains using a pET expression system in E. coli. Given 
past difficulties with this approach, we chose to focus our efforts on the development of a 
mammalian expression system for Pcdh production. Since the Pcdhγ domain shuffling 
experiments suggest that the three N-terminal domains, EC1-EC3, play a role in trans binding 
(Schreiner and Weiner 2010), we produced constructs containing at least EC1-EC3 from each 
Pcdh subtype.  
Many of the recombinant proteins produced in our current mammalian expression 
system make use of non-native signal peptides to increase protein production. However, the 
native N-terminus of Pcdhs remains unclear. For this reason, we tested protein expression 
using native signal peptides and predicted the N-terminus for use with non-native signal 
peptides. We also predict the C-terminal end of EC6 for EC1-EC6 constructs.  
It has been suggested the Pcdhs form cis-multimers and that the cis binding region is 
within the EC4-EC6 domains in Pcdhγ isoforms (Schreiner and Weiner 2010). In an effort to 
identify the minimal region necessary for cis binding, we performed a series of N-terminal 
domain deletion constructs.  
As described in this chapter, we developed an improved mammalian expression system 
for production of Pcdh ectodomains and ectodomain fragments. We successfully produced and 
purified Pcdh constructs containing EC1-EC3, EC1-EC4, EC1-EC5, or EC1-EC6 in sufficient 
quantities for biophysical characterization and crystallization trials. Using this system, we have 
been able to produce diffracting crystals for multiple Pcdh constructs and obtained three high-





Most attempts to produce and purify Pcdhs with their N-terminal domain deletions were 
unsuccessful, with the one exception being PcdhγA8 EC2-EC6. The drastic improvements in the 
mammalian expression system described here facilitated the production of many proteins 
throughout the lab. Julia Brasch, Oliver Harrison, and I optimized the suspension cell protein 
expression system. I designed all Pcdh constructs tested for protein expression and biophysical 
characterization. Chan Aye Thu provided many of the Pcdh cDNAs that we used for PCR 
amplification. Fabiana Bahna and Seetha Mannepalli, staff scientists in our lab, helped with the 
cloning, protein production, and purification of many of the constructs described in this chapter 
and subsequent chapters. I also performed the deglycosylation experiments.  
Methods 
Vectors and constructs 
Pcdh DNA constructs were obtained from the Maniatis lab at Columbia University. We 
attempted expression in multiple mammalian expression vectors, including the following: pMax 
(Lonza), παSHP-H (obtained from John Hopkins), VRC-8400 (obtained from the Kwong lab at 
NIH), and pCEP4 (Invitrogen). Details of each vector can be found in table 1.  
Vector Type of expression Promoter Other Key Features 




Contains a chimeric 
intron for enhanced 
gene expression  
παSHP-H constitutive, transient chick β-actin  CMV enhancer 
VRC-8400 constitutive, transient CMV-IE CMV enhancer, 
includes HTLV-1 R 
region to enhance 
expression (Barouch, 
Yang et al. 2005) 





resistance for stable cell 
line selection 
Table 1. Vectors used for Pcdh expression 
 We chose to focus on the expression of soluble extracellular regions to enable 
purification of properly folded and glycosylated proteins. We cloned EC1-EC6 containing 
constructs into the pmaxCloning™ vector for a subset of Pcdhs including: Pcdhα4, PcdhαC1, 
PcdhαC2, Pcdhβ17, PcdhγA1, PcdhγB6, PcdhγC3, PcdhγC4, and PcdhγC5. A series of C-
terminal domain deletion constructs containing EC1-EC3, EC1-EC4, or EC1-EC5 of PcdhγC5 
and PcdhγB6 were also cloned into pmaxCloning™. These constructs were screened for protein 
expression in our adherent cell expression system described below. PcdhγC5 EC1-EC3 had the 
highest expression level but levels were still prohibitively low. Protein expression optimization 
was required to obtain sufficient quantities of protein for crystallization trials and biophysical 
characterization. Expression optimization required the use of a codon-optimized PcdhγC5 EC1-
EC3 and a non-native signal peptide. The program Signal-P was used to predict the most likely 
signal peptide cleavage site (Bendtsen, Nielsen et al. 2004) and the non-native signal peptide 
PTPα, hemagglutinin or BiP (Rapoport, Matlack et al. 1999) was used: PTPα is the signal 
peptide from tyrosine phosphatase alpha; Hemagglutinin is an envelope protein of influenza A 
and B viruses; and BiP is the signal peptide from the ER-resident Hsp70 protein, whose 
transmembrane transport is up-regulated by ER stress (Rapoport, Matlack et al. 1999). 
 Expression optimization for other Pcdh constructs required screening of additional 
expression vectors (Table 1) and use of an alternative mammalian expression system 
described in detail below. The pCEP4 vector was used to generate stable cell lines of PcdhγC3 
EC1-EC6 or Pcdhβ17 EC1-EC6 expressing cells. A subset of constructs containing EC1-EC3, 
EC1-EC4, and EC1-EC5 were also cloned into παSHP-H with the BiP signal peptide and 





Protein Domains expression vector Signal Peptide N-terminus 
C-terminal 
tags 
Pcdha4 EC1-EC6 pmaxCloning native native Flag 
Pcdha4 EC1-EC6 παSHP-H BiP 
predicted by 
SignalP 6xHis-Strep 
Pcdha4 EC1-EC3 pmaxCloning native native 8xHis-Strep 
Pcdha6 EC1-EC6 pmaxCloning native native 8xHis-Strep 
Pcdha7 EC1-EC6 παSHP-H BiP 
predicted by 
SignalP 6xHis-Strep 
Pcdha7 EC1-EC3 παSHP-H BiP 
predicted by 
SignalP 6xHis-Strep 
Pcdha7 EC1-EC5 παSHP-H BiP 
predicted by 
SignalP 6xHis 
Pcdha8 EC1-EC6 παSHP-H BiP 
predicted by 
SignalP 6xHis-Strep 
PcdhaC1 EC1-EC6 pmaxCloning native native Flag 
PcdhaC1 EC1-EC6 pmaxCloning native native 6xHis-Strep 
PcdhaC1 EC1-EC3 παSHP-H native native 8xHis-Strep 
PcdhaC2 EC1-EC6 pmaxCloning native native 6xHis 
PcdhaC2 EC1-EC6 VRC native native 6xHis-Strep 
PcdhaC2 EC1-EC3 pmaxCloning native native 8xHis-Strep 
PcdhaC2 EC1-EC5 παSHP-H BiP 
predicted by 
SignalP 6xHis 
PcdhaC2 EC2-EC6 παSHP-H PTPα  XNDN   
Pcdhb1 EC1-EC6 pmaxCloning native native 6xHis 
Pcdhb1 EC1-EC6 παSHP-H BiP 
predicted by 
SignalP 6xHis-Strep 
Pcdhb1 EC1-EC6 παSHP-H BiP predicted by SignalP 6xHis 
Pcdhb17 EC1-EC6 pmaxCloning native native Flag 
Pcdhb17 EC1-EC6 pCEP4 native native 6xHis 
Pcdhb17 EC1-EC3 pmaxCloning native native 8xHis-Strep 
PcdhgA8 EC1-EC6 pmaxCloning native native Flag 
PcdhgA8 EC1-EC6 pmaxCloning native native 6xHis 
PcdhgA8 EC1-EC3 pmaxCloning native native 8xHis-Strep 
PcdhgA8 EC1-EC4 παSHP-H BiP 
predicted by 
SignalP 6xHis 
PcdhgA8 EC2-EC6 παSHP-H PTPα XPXF   
PcdhgB6 EC1-EC6 pmaxCloning native native Flag 





PcdhgB6 EC1-EC6 pmaxCloning BiP predicted by SignalP 6xHis 
PcdhgB6 EC1-EC6 παSHP-H BiP 
predicted by 
SignalP 6xHis 
PcdhgB6 EC1-EC6 VRC native native 6xHis 
PcdhgB6 EC1-EC3 pmaxCloning native native 8xHis-Strep 
PcdhgB6 EC1-EC4 pmaxCloning native native 6xHis 
PcdhgB6 EC1-EC5 παSHP-H BiP 
predicted by 
SignalP 6xHis 
PcdhgB6 EC4-EC6 παSHP-H PTPα  XPXF? 6xHis 
PcdhgC3 EC1-EC6 pmaxCloning native native Flag 
PcdhgC3 EC1-EC6 pCEP4 native native 6xHis 
PcdhgC3 EC1-EC6 pmaxCloning native native 6xHis 
PcdhgC3 EC1-EC6 pmaxCloning native native 6xHis-Strep 
PcdhgC3 EC1-EC6 παSHP-H BiP predicted by SignalP 6xHis-Strep 
PcdhgC3 EC1-EC3 pmaxCloning native native 8xHis-Strep 
PcdhgC4 EC1-EC6 pmaxCloning native native 6xHis 
PcdhgC4 EC1-EC3 pmaxCloning native native 8xHis-Strep 
PcdhgC5 EC1-EC6 pmaxCloning native native Flag 
PcdhgC5 EC1-EC6 παSHP-H BiP predicted by SignalP Strep-6xHis 
PcdhgC5 EC1-EC6 παSHP-H BiP 
predicted by 
SignalP 6xHis 
PcdhgC5 EC1-EC3 pmaxCloning BiP predicted by SignalP Strep-6xHis 
PcdhgC5 EC1-EC3 παSHP-H BiP 
predicted by 
SignalP Strep-6xHis 
PcdhgC5 EC1-EC3 παSHP-H BiP 
predicted by 
SignalP 6xHis 
PcdhgC5 EC1-EC3 pmaxCloning native native Flag 
PcdhgC5 EC1-EC4 pmaxCloning native native 6xHis 
PcdhgC5 EC1-EC5 παSHP-H BiP 
predicted by 
SignalP 6xHis 
Table 2. Pcdh Expression Constructs 
Protein production – adherent system 
 Polyethylenimine (PEI) transfection by standard protocols was used to transfect Pcdh 
DNA constructs into HEK293F cells. Briefly, HEK293F cells were grown to 70-90% confluence 
in a 75cm2 flask. 40ug of the Pcdh construct was mixed with PEI at a DNA:PEI ratio of 1:2 and 





added to the solution and incubated with HEK293F cells for five hours. Media was aspirated and 
replaced with standard culture medium. Conditioned media was collected four days post-
transfection and the expressed and secreted protein purified as described below. Stable cell 
lines of HEK293F cells expressing PcdhγC3 EC1-EC6 or Pcdhβ17 EC1-EC6 in pCEP4 were 
generated by selection with hygromycin by standard protocols (Life Technologies). Conditioned 
media was collected when cells reached greater than 90% confluence, approximately once per 
week. 
Protein production – suspension system 
 An adapted protocol for the FreeStyle™ 293 expression system (Life Technologies) was 
developed for the production of Pcdhs and other calcium-containing proteins. The FreeStyle™ 
293 expression system specifies the use of the transfection reagent 293fectin™ which would be 
cost prohibitive. For this reason, our first goal was to identify an alternative transfection method. 
Previous studies had shown that polyethylenimine (PEI) transfection could be used to transfect 
suspension-adapted HEK293 cells (Sun, Hia et al. 2008) and in serum-free conditions 
(Schlaeger and Christensen 1999, Durocher, Perret et al. 2002, Backliwal, Hildinger et al. 
2008). FreeStyle™ 293 cells were cultured in serum-free media using standard protocols. Cells 
were cultured to a cell density of ~1.2 × 106 cells/ml with at least 90% viable cells. 37.5µg of 
pmax-GFP DNA per 30ml of cells was transfected using DNA:PEI ratios of 1:1.5 – 1:4.5. GFP 
expression. 
Pcdh constructs were transfected as described above using 1ug DNA per mL of cells 
and a 1:4.5 DNA:PEI ratio. Conditioned media was collected two, three, four, five, and six days 
post-transfection and purified as described below. Initial tests did not show any Pcdh 
expression. Since Pcdhs are predicted to bind calcium, and the calcium content of the serum-
free media is unknown, expression was attempted with 5-10mM supplemental calcium chloride 





Further optimization of transfection conditions and protein expression showed that 0.5ug of DNA 
per mL of cells, a DNA:PEI ratio of 1:2, and 10mM supplemental CaCl2 were sufficient for 
protocadherin expression and these conditions were used in all subsequent expression tests. 
Protein purification 
 Conditioned media was supplemented with 20mM Tris, pH 8.0, 3mM CaCl2, 20mM 
imidazole, and 500mM NaCl. Conditioned media was incubated with 5ml of nickel sepharose 
beads with gentle stirring for 45 minutes. The beads we allowed to settle over 10 minutes 
without stirring. Conditioned media was poured over a gravity flow column until only a small 
amount of conditioned media and nickel beads remained in the bottom of the flask. Beads and 
media were mixed by gently swirling and the slurry was poured over the gravity flow column. 
Remaining beads were rinsed from the flask with wash buffer (20mM Tris, pH 8.0, 3mM CaCl2, 
20mM imidazole, and 500mM NaCl) and the beads were washed by gravity flow with 40CV of 
wash buffer. Protein was eluted in 20mM Tris, pH 8.0, 3mM CaCl2, 75-125mM imidazole, and 
500mM NaCl. The eluate was collected and analyzed by SDS-PAGE for purity. In cases where 
the nickel elution fractions were not sufficiently pure, the eluate was collected and dialyzed into 
10mM Tris, pH 8.0, 3mM CaCl2, and 150mM NaCl at 4C overnight and bound to 2mL Strep-
tacin resin for 30 minutes. The beads were washed with 10CV of dialysis buffer and the protein 
was eluted in 10CV of dialysis buffer supplemented with 2.5mM desthiobiotin. Once greater 
than 90% purity was achieved, the protein was and dialyzed into 10mM Tris, pH 8.0, 3mM 
CaCl2, and 150mM NaCl (and 100-125mM imidazole when necessary to prevent precipitation) 
at 4C overnight. The protein was then concentrated and run over an S200 sizing column (GE 
Life Sciences) and fractions of interest were analyzed by SDS-PAGE, collected, pooled, and 





Protein characterization by deglycosylases 
 Purified PcdhγC5 EC1-EC3 was digested with EndoH (NEB P0702S), which removes 
only high mannose and some hybrid types of N-linked carbohydrates, or PNGase F (NEB 
P0704S), which removes almost all types of N-linked glycosylation. Briefly, 10-20 μg of protein 
and 1 μl of 10X Glycoprotein Denaturing Buffer (NEB) were mixed to make a 10 μl total reaction 
volume. The protein was denatured by heating reaction at 100°C for 10 minutes. For PNGase F 
digestion, the reaction was brought to 20 μl by the addition of 2 μl of 10X G7 Reaction Buffer, 2 
µl of 10% NP-40, distilled water, and 2 μl PNGase F. For EndoH digestion, the reaction was 
brought to 20 μl by adding 2 μl of 10X G5 Reaction Buffer, distilled water, and 5 μl Endo H. The 
reactions were then incubated at 37°C for one hour and analyzed by SDS-PAGE. 
Results 
Prediction of N-terminus 
In constructs using a non-native signal peptide, the web-server SignalP4.1 was used to 
predict the N-terminus (Petersen, Brunak et al. 2011). For PcdhγC5, the signal peptide cleavage 
site was predicted to occur between residues 28 and 29, leaving the mature N-terminus 
QLRYSVVE (Fig. 7). Similar start sites were predicted for many Pcdhγ isoforms. This led to the 
decision to begin the PcdhγC5 expression constructs with an N-terminus beginning at Gln29. 






Figure 7. Prediction of N-terminus with SignalP. 
SignalP signal peptide cleavage prediction output showing the cleavage 
to occur between Gly28 and Gln29. 
 
Design of the C-terminus for Pcdh expression constructs 
EC6 is the membrane-proximal EC (MPEC) domain of clustered Pcdhs. The C-terminal 
end of most EC domains can be easily located using a calcium binding motif which is conserved 
in sequential EC domains, DXNDN / XPXF (Posy, Shapiro et al. 2008). However, the C-
terminus most suitable for use in Pcdh expression constructs intended for crystallography is 
unclear since the calcium binding motif is not present. The C-terminal end of our expression 
constructs were designed by preparing a multiple sequence alignment of Pcdh and classical 
cadherin MPEC domains using the Clustal Omega web server (Sievers, Wilm et al. 2011). We 
then analyzed the conservation of C-terminal residues most likely to be important for 
preservation of secondary structure elements with Espript 3.0 (Fig. 8) (Gouet, Robert et al. 
2003). We note that the cysteine residues which form a disulfide bond located near the C-





The C-terminal end used in our EC6 containing expression constructs is shown in Fig. 8 with an 
arrow. 
 
Figure 8. Membrane-Proximal EC domains 
An alignment of the membrane-proximal EC domains of a subset of Pcdhs and 
classical cadherins. The secondary structure elements from E-cadherin are 
shown above the alignment. A green arrow marks the C-terminal end of EC6-
containing constructs. 
 
Pcdh expression optimization and purification in adherent cells 
We produced four different constructs for production of PcdhγC5: EC1-EC3, EC1-EC4, 
EC1-EC5, and EC1-EC6 in HEK-293 cells using transient expression. Initial expression 
constructs included the native signal peptide and a 6xHis tag at the C-terminus for purification. 
Expression tests showed that PcdhγC5 was one of the highest expressed of the Pcdhs tested, 
but further optimization was required to achieve quantities sufficient for structural studies. After 





modification of all rare codons to produce a human tRNA-optimized coding sequence; and (2) 
replacement of the predicted native signal peptide with the signal peptide from the ER-resident 
Hsp70 protein BiP, whose transmembrane transport is up-regulated by ER stress (Rapoport, 
Matlack et al. 1999). These changes significantly increased protein expression, but we were still 
unable to purify the protein to homogeneity (Fig. 9A). To overcome this problem, we added an 
additional affinity purification tag—the Strep tag II—to implement a tandem affinity purification 
(TAP) with His- and Strep tag-binding steps.  This modification of the purification protocol 
enabled production of sufficient quantities of pure protein for structural and biophysical analyses 
(Fig. 9B). While these modifications enabled improved Pcdh expression and purification, it was 
later discovered that the Strep tag caused protein aggregation (see Chapter 3). We were also 
able to produce sufficiently pure PcdhαC2 EC1-EC6 for biophysical characterization using the 
adherent cell expression system (Fig. 10). However, these modifications were insufficient to 
enable sufficient protein production for biophysical characterization and crystallization trials for 
any other Pcdh constructs tested. 
In parallel to the transient expression trials described 
above, stable cell lines expressing PcdhγC3 EC1-EC6 or 
Pcdhβ17 EC1-EC6 with their native signal peptides and a 
6xHis tag at the C-terminus were also generated. Though 
these cell lines were successfully produced, protein 
production yields were low (only 40ug/L of conditioned media) 
and proteins were insufficiently pure for biophysical 
characterization or crystallization trials. 
Pcdh expression optimization and purification in suspension cells 
 We adapted the FreeStyle 293 expression system for our needs by optimizing 
transfection with a cost-efficient transfection reagent, PEI, and by optimizing expression 
 
Figure 9. Purification of His-
tagged PcdhγC5 EC1-EC3 
compared to TAP-tagged 
A) purification of wild type gC5 EC1-3 
with a 6xHis tag B) tandem affinity 
purification of codon optimized gC5 
EC1-3 with a BiP signal peptide, 






conditions to include supplemental CaCl2. We first transfected pmax-GFP using DNA:PEI ratios 
of 1:1.5 – 1:4.5 or with 293fectin™. GFP expression was observed after 48 hours in all 
conditions (Fig. 11). After we confirmed that DNA could be transfected into FreeStyle 293 
suspension cells, we attempted expression of PcdhγC5 EC1-EC3, which we previously 
expressed in our adherent system (Fig. 9). Sidekick1 (Sdk1) Ig1-4, which expresses well in the 
adherent cell system, was used as a positive control. Aliquots of conditioned media were 
collected two, three, four, five, and six days post-transfection and purified as described below.  
 
Figure 10. PcdhαC2 EC1-EC6 purification and SEC 
A) Size exclusion chromatogram from TAP PcdhaC2 EC1-EC6 (inset) 
run on Superdex 200 HR (26/60) B) Size exclusion chromatogram from 
VE-cadherin EC1-EC5 run on Superdex 200 HR (26/60). VE-cadherin is 






Initial tests did not show any Pcdh expression 
(Fig. 12A). Since Pcdhs are predicted to bind calcium, 
and the calcium content of the serum-free media is 
unknown, expression was attempted with supplemental 
calcium. Supplementing the media with calcium 
chloride enabled the expression of Pcdhs. An example 
for PcdhαC2 EC1-EC6 is shown in figure 12B. 
 We then carried out a trial one liter protein 
preparation of PcdhαC2 EC1-EC6-Strep-6xHis in the 
suspension cell expression system. The protein yield was 0.6mg/L of conditioned media, which 
was more than ten times the yield using the adherent cell expression system. To further 
optimize protein expression, we screened additional protein expression vectors including VRC-
8400 (from the Kwong lab) and παSHP-H (Fig. 12C). All expression tests so far have indicated 
similar improvements by using either VRC-8400 or παSHP-H. Using the BiP signal peptide 
greatly increased Pcdh expression levels and has been used in most of the successfully 
expressed and purified proteins. A summary of successfully purified proteins can be found in 
table 3. Each of the purified proteins was characterized biophysically and will be discussed in 
more detail in Chapter 4. 
 
Figure 11. GFP expression in FreeStyle™ 
293 cells transfected with the PEI 
transfection method 
From left to right: Untransfected cells, cells 
transfected with pmax-GFP using 
293fectin™, cells transfect pmax-GFP using 






Figure 12. Pcdh expression in suspension 293 cells. 
A) Aliquots of conditioned media collected at different time points post-transfection. Cells 
were transfected with PcdhgC5 EC1-3 (left) or Sdk1 Ig1-4 (right). An aliquot of conditioned 
media from untransfected cells is shown (-) on the far right. B) Fractions from Pcdh 
purification over Ni-NTA beads from conditioned media supplemented with 5 or 10 mM 
calcium chloride four hours post-transfection is shown. C) Proteins expressed and purified 









Protein Domains expression vector Signal Peptide C-terminal tags 
Pcdha7 EC1-EC5 παSHP-H BiP 6xHis 
PcdhaC2 EC1-EC6 pmaxCloning native 6xHis 
PcdhgA8 EC1-EC4 παSHP-H BiP 6xHis 
PcdhgB6 EC1-EC6 παSHP-H BiP 6xHis 
PcdhgB6 EC1-EC5 παSHP-H BiP 6xHis 
PcdhgC5 EC1-EC6 παSHP-H BiP 6xHis 
PcdhgC5 EC1-EC3 παSHP-H BiP 6xHis 
PcdhgC5 EC1-EC4 παSHP-H Sii BiP 6xHis 
PcdhgC5 EC1-EC5 παSHP-H BiP 6xHis 
Pcdha7 EC1-EC6 παSHP-H BiP 6xHis-Strep 
Pcdha7 EC1-EC3 παSHP-H BiP 6xHis-Strep 
Pcdhb1 EC1-EC4 παSHP-H BIP 8xHis 
Pcdhb1 EC1-EC5 παSHP-H BIP 8xHis 
Pcdhb17 EC1-EC5 παSHP-H BIP 8xHis 
PcdhgA8 EC1-EC5 παSHP-H BIP 8xHis 
Pcdhb1 EC1-EC3 παSHP-H Sii BIP 8xHis-Strep 
Pcdha8 EC1-EC5 παSHP-H Sii BIP 8xHis-Strep 
PcdhgC5 EC1-EC6 παSHP-H BiP Strep-6xHis 
PcdhgC5 EC1-EC3 pmaxCloning BiP Strep-6xHis 
PcdhgC5 EC1-EC3 παSHP-H BiP Strep-6xHis 
PcdhgA8 EC2-EC6 παSHP-H 
PTPα (tyrosine 
phosphatase alpha) 6xHis 
Table 3. Summary of successfully purified Pcdhs 
PcdhγC5 characterization by deglycosylases and native gel electrophoresis 
 PcdhγC5 EC1-EC3-Strep-6xHis was expressed using the παSHP-H vector in both 
Freestyle 293F and in suspension GNTi(-) cells and purified as described above (Fig. 13A). 
Each protein was then purified as described above, digested with PNGase F and EndoH 
deglycosylases, and analyzed by SDS-PAGE. No significant shift in size was observed in either 
case (Fig. 13B). Both proteins were also run on a native gel to check for aggregation. The 
protein was flash frozen in liquid nitrogen, thawed, and run on a native gel to test the stability of 






Figure 13. PcdhγC5 EC1-EC3 digestion by EndoH and PNGase F. 
A) Purified and concentrated PcdhγC5 EC1-EC3 produced in either GNTi(-) (left) or FreeStyle 
293 suspension cells (right) B) Digestion of PcdhγC5 EC1-EC3 by EndoH or PNGase F. 
EndoH has a molecular weight of approximately 29kDa and PNGase has an approximate 
molecular weight of 36kDa. C) Native gel of PcdhγC5 EC1-EC3, unfrozen and freeze-thawed. 
Lanes 1, 3, and 5 are unfrozen PcdhγC5 EC1-EC3 produced in F cells (1 and 3) or GNTi (5). 
Lanes 2, 4, and 6 show protein that has been through one freeze-thaw cycle. 
Discussion 
Previous studies produced recombinant Pcdh EC1 domains in E. coli (Morishita, Umitsu 
et al. 2006), which behaved as monomers. Subsequent studies showed that at least the first 
three N-terminal EC domains were necessary for trans binding (Weiner). Based on these 
studies, we postulated that EC1-EC3 would contain the minimal region necessary for trans 
binding. If our predictions were correct, Pcdh EC1-EC3 constructs would be expected to bind 
homophilically in solution and in crystal lattices. As discussed in ensuing chapters, this is not the 
case, and larger ectodomain regions are required for binding in all cases tested so far. 
Nevertheless, the structural, mutational, and domain shuffling studies described in this thesis 
represent a significant advance in understanding the binding mechanism of clustered Pcdhs. 
Additional studies suggested that Pcdhs form cis multimers in addition to trans binding, 
but the intermolecular binding region responsible for this is unknown (Han, Lin et al. 2010, 
Schalm, Ballif et al. 2010, Schreiner and Weiner 2010). We therefore designed expression 
constructs of varying lengths from one to six EC domains whose N-terminal regions were either 
native or predicted by SignalP, and whose C-terminal region was designed by bioinformatics. In 
most cases, use of the native signal peptide produced insufficient quantities of protein for 
purification and further characterization. However, we were able to produce PcdhαC2 EC1-EC6 





Edman degradation, most likely due to an N-terminal glutamine residue which interferes with the 
chemical reactions used in Edman degradation. The N-terminus will be discussed in more detail 
in Chapter 5. Constructs where the EC1 domain was deleted did not express, which the 
exception of PcdhγA8 EC2-EC6. 
The goal of the work described in this chapter was the production of natively folded Pcdh 
extracellular regions for biophysical characterization and crystallization. We were able to 
achieve both of these goals. We produced EC1-EC3, EC1-EC4, EC1-EC5, and EC1-EC6 
containing constructs in sufficient quantities for biophysical characterization and crystallization 
trials. Characterization of PcdhγC5 EC1-EC3 by size exclusion chromatography during 
purification and native gels suggests that the protein is properly folded. Digestion of PcdhγC5 
EC1-EC3 with enzymes that remove N-linked glycosylation had little effect on the protein as 
evidenced by SDS-PAGE. This suggests that of PcdhγC5 EC1-EC3 may contain O-linked 
glycosylation. In fact, a previous study suggests that Pcdhs contain conserved O-linked 
glycosylation sites (Vester-Christensen, Halim et al. 2013). The drastic improvements in the 
mammalian expression system presented in this chapter facilitated the production of natively 






Chapter 4. Biophysical characterization of purified Pcdhs 
Introduction 
 Biophysical techniques have been extremely useful in elucidating the homophilic and 
heterophilic binding properties of many proteins studied in our lab including classical cadherins, 
nectins, neurexins and neuroligins (Koehnke, Jin et al. 2008, Miloushev, Bahna et al. 2008, 
Katsamba, Carroll et al. 2009, Ciatto, Bahna et al. 2010, Harrison, Bahna et al. 2010, Koehnke, 
Katsamba et al. 2010, Brasch, Harrison et al. 2011, Brasch, Harrison et al. 2011, Harrison, Jin 
et al. 2011, Harrison, Vendome et al. 2012, Jin, Walker et al. 2012). The goal of this chapter is 
to characterize the binding affinities of soluble Pcdh ectodomains and ectodomain fragments, to 
identify the minimal region necessary for trans binding, and to determine the multimeric state of 
Pcdh complexes formed by individual Pcdh isoforms.  
One method to estimate the molecular weight of proteins is by size exclusion 
chromatography. However, for elongated molecules such as cadherins and protocadherins, 
molecular weight estimates from size exclusion chromatography are inaccurate. To enable more 
accurate characterization of soluble Pcdh ectodomains and ectodomain fragments, we used a 
multiangle light scattering (MALS) detector attached downstream of a size exclusion column. 
The size exclusion column used upstream of our MALS system is a higher resolution sizing 
column than the one that we use for large-scale protein purification and thus is better equipped 
to separate various species present in our samples. MALS allows us to measure the mass of 
each peak from the size exclusion column. In particular, MALS is an excellent method to use to 
detect protein aggregation, and we use this method to assure that we have stable protein for 
crystallography.  
 The second biophysical method that we will use in this chapter is analytical 





homophilic molecules and has been used to characterize many proteins produced in our lab. In 
addition, this technique has allowed thorough characterization of mutants designed to disrupt 
binding or alter affinities. So far, all Pcdhs tested in cell aggregation assays bind with strict 
homophilic specificities (Schreiner and Weiner 2010). However, the binding affinities of Pcdhs 
remain unknown. In addition, Schreiner and Weiner (2010) suggested that Pcdhγs form cis 
tetramers. Their model was based on size exclusion chromatography of over-expressed, 
detergent solubilized proteins. As mentioned above, size exclusion chromatography is not a 
reliable method by which to determine the molecular weight of complexes formed by elongated 
molecules. In this chapter, we characterize Pcdh ectodomains and ectodomain fragments in an 
attempt to determine the size and homophilic binding properties of Pcdh complexes. Further 
work will be required to characterize Pcdh complexes made up on multiple isoforms. 
 I designed all Pcdh constructs tested for protein expression and biophysical 
characterization. Fabiana Bahna and Seetha Mannepalli, staff scientists in our lab, and I, ran 
purified Pcdh proteins on the Multi-angle light scattering system (MALS) and analyzed the data. 
Purified proteins were given to Goran Ahlsen, a staff scientist in the Honig-Shapiro lab, who ran 
all of the sedimentation equilibrium experiments in the analytical ultracentrifuge. Goran also 
taught me how to use MALS system and analyze the data. 
Methods 
Size Exclusion Chromatography - Multi-angle light scattering (SEC-MALS) 
 Proteins were purified and concentrated to at least 1mg/mL. 100µL of protein was spun 
down at max speed in a tabletop centrifuge for 10 minutes prior to injection into the SEC-MALS 
system. Purified, concentrated proteins were then run on a Superdex 200 10/300 GL column 
(GE Life Sciences) that was equilibrated with the same buffer used in the protein sample. 





and the Optilab T-rEX (Wyatt). The Dawn Heleos II is the MALS detector, and the Optilab T-rEX 
is the dRI (differential refractive index) detector.  
Data were analyzed using Astra 6.0. Briefly, baselines for the data were established for 
LS-11 (one of the light scattering angles), UV, and dRI. The peaks were selected and fitted. In 
results fitting, the molecular weight at each point across the peak is calculated. If the molecular 
weight (MW) stays fairly consistent throughout the peak, you can be fairly confident of the fit. In 
the results summary, the average MW and polydispersity can be found. Polydispersity is a 
measure of how well your data fit the equations used to calculate the MW. A polydispersity of 
close to 1.000 is representative of a good fit. 
Analytical Ultracentrifugation (AUC)- Sedimentation Equilibrium Experiments 
 Experiments were performed in a Beckman XL-A/I analytical ultracentrifuge (Beckman-
Coulter, Palo Alto CA, USA), utilizing six-cell centerpieces with straight walls, 12-mm path 
length and sapphire windows. Samples were dialyzed over-night and then diluted in either 10 
mM Tris, pH 8.0, 150 mM NaCl, 3 mM CaCl2, (PcdhγC5 EC1-EC3), or 10 mM Tris, pH 8.0, 
150mM NaCl, 3mM CaCl2, 125mM imidazole, pH 8.0 (PcdhγB6 EC1-EC6, Pcdhα7EC1-EC5, 
and PcdhγA8 EC1-EC4). Proteins were diluted to an absorbance at 10 mm and 280 nm of 0.65, 
0.43 and 0.23 in channels A, B and C, respectively. Each protein was measured in duplicate. 
Dilution buffer was used as the blank. All samples were run at four speeds: the lowest speed 
was held for 20 h then four scans collected with 1 h interval; the second lowest was held for 10 
h then four scans collected with 1h interval; the third lowest and the highest speed were run like 
the second lowest. The speeds were 9000, 11000, 13000 and 15000 rpm (PcdhγB6 EC1-EC6 
and Pcdhα7 EC1-EC5) or 12000, 16000, 20000 and 24000 rpm (PcdhγA8 EC1-EC4 and 
PcdhγC5 EC1-EC3), respectively. Measurements were done at 25oC, and detection was by UV 





SednTerp (Alliance Protein Laboratories, Corte Cancion, Thousand Oaks, CA, USA). For 
calculation of Kd and apparent molecular weight, all useful data were used in a global fit, using 
the program HeteroAnalysis, obtained from University of Connecticut. 
(www.biotech.uconn.edu/auf) 
Results 
Sedimentation equilibrium experiments with PcdhγC5 EC1-EC3 and PcdhαC2 EC1-EC6 
produced in adherent cells 
 Both PcdhγC5 EC1-EC3 and PcdhαC2 EC1-EC6 were produced and purified from our 
adherent cell system using tandem affinity purification with a strep-his tag at the C-terminus 
(see Chapter 3). In the initial characterization PcdhγC5 EC1-EC3 behaved as a 5µM dimer and 
PcdhαC2 EC1-EC6 behaved as a tight tetramer with a Kd below 1µM. (Affinitiess were 
calculated from AUC data.) Both proteins were unstable in that they could not be frozen and 
thawed without precipitation and significant loss of sample. These data were collected prior to 
our acquisition of the SEC-MALS system. Subsequent purification and characterization of these 
proteins by SEC-MALS showed that each formed soluble aggregates that eluted in or near the 
void volume of the analytical sizing column connected to the MALS detector. 
SEC-MALS and sedimentation equilibrium experiments of PcdhγC5 EC1-EC3 Strep-his 
produced in suspension cells 
 PcdhγC5 EC1-EC3 had an apparent MW of about 37 kilodaltons (kDa) by SEC-MALS 
and the polydispersity was close to 1. Data are shown in Figure 14. The predicted MW of this 
protein is 35.7 kDa and it ran at about 38kDa on SDS-PAGE gels. Therefore by SEC-MALS, this 
protein appears to behave as a monomer. These results were confirmed by sedimentation 





non-specific aggregates, with the exception of PcdhγA8 EC1-EC4 which will be discussed in the 
next section. 
 
Figure 14. PcdhγC5 EC1-EC3 SEC-MALS 
The results fitting by Astra 6.0 of the PcdhγC5 EC1-EC3 data is shown. The fitting across the entire peak 
is fairly consistent, suggesting a good fit for the data. The MW corresponds to approximately 37 kDa. 
 
Biophysical data summary for other Pcdh constructs 
 All Pcdh constructs were purified from the suspension cell system with a C-terminal 
6xHis tag, with the exception of PcdhgA8 EC1-EC4 which was either purified with a C-terminal 
6xHis tag only or a C-terminal Strep-6xHis tag. Purified proteins were analyzed by SEC-MALS. 
All Pcdh constructs tested by SEC-MALS behaved as monomers except for Pcdhα7 EC1-EC5, 
which behaved as a dimer. A summary of all SEC-MALS data can be found in table 4. AUC was 
used to measure the homophilic dissociation constants for a subset of four constructs: PcdhγC5 
EC1-EC3, PcdhγA8 EC1-EC4, Pcdhα7 EC1-EC5, and PcdhγB6 EC1-EC6 at equilibrium at 25ºC 
(see table 5 for summary). Three domain Pcdh constructs (containing EC1-EC3) behaved as 
monomers by SEC-MALS and by AUC in all cases tested, suggesting that additional EC 
domains may be required for trans binding. We also tested EC1-EC4 constructs for PcdhγC5 
and PcdhγA8. Both behaved as monomers in SEC-MALS, but PcdhγA8 EC1-EC4 formed a 





sedimentation equilibrium experiments by AUC. PcdhγC5 EC1-EC4 has not yet been tested by 
AUC. We also tested EC1-EC5 containing constructs by SEC-MALS including: PcdhγC5, 
PcdhαC2, and Pcdhα7. PcdhγC5 EC1-EC5 and PcdhαC2 EC1-EC5 behaved as monomers in 
SEC-MALS. By contrast, Pcdhα7 EC1-EC5 had an apparent MW of 110kDa, which is 
approximately the size we would expect for a dimer. When tested in sedimentation equilibrium 
experiments, Pcdhα7 EC1-EC5 was found to have a Kd in the low micromolar range, 
corresponding to a strong dimer (see Table 5 for details). As mentioned above, PcdhγC5 EC1-
EC3 behaved as a monomer. PcdhγB6 EC1-EC6 had an apparent MW of  85.5kDa by SEC-
MALS and 250kDa by AUC. The MW of a monomer was estimated to be 75kDa by SDS-PAGE. 
A summary of AUC results for proteins that were also characterized by SEC-MALS can be 
found in table 5. As indicated by the disparity between the AUC and SEC-MALS results for 
PcdhγA8 EC1-EC4, the oligomeric state of the protein determined by SEC-MALS is contingent 
upon the concentration of the protein on the column and may not fully reflect the homophilic 
binding properties or multimeric state of the protein.   
Protein Construct Apparent MW  (kDa) polydispersity 
Apparent 
oligomeric state 
Pcdhα7 EC1-EC5 110 1.004 Dimer 
PcdhαC2 EC1-EC5 70.5 1.005 Monomer 
Pcdhβ1 EC1-EC6 79.4 1.000 Monomer 
PcdhγA8 EC1-EC4 55.46 1.006 Monomer 
PcdhγB6 EC1-EC3 36.4 1.001 Monomer 
PcdhγB6 EC1-EC6 75.7 1.001 Monomer 
PcdhγB6 EC1-EC6 85.5 1.003 Monomer 
PcdhγC3 EC1-EC3 37.1 1.000 Monomer 
PcdhγC3 EC1-EC6 84.6 1.001 Monomer 
PcdhγC5 EC1-EC3 37 1.002 Monomer 
PcdhγC5 EC1-EC4 48.5 1.001 Monomer 
PcdhγC5 EC1-EC5 64.7 1.002 Monomer 
Table 4. Pcdh SEC-MALS data summary 





PcdhγC5 EC1-EC3 Monomer, apparent MW of 
24.7kDa 
N/A 
PcdhγA8 EC1-EC4 Dimer 39µM (from Strep-6xHis 
protein) 
30 ± 1.5µM, n = 2 
PcdhγA8 EC2-EC6 Dimer 31.7 ± 4.1µM in one run 
15.4 ± 2.2µM in a second 
Pcdhα7 EC1-EC5 Dimer 1.2µM in one run 
6.3µM in a second run 
PcdhγB6 EC1-EC6 Apparent MW ~250kDa, 
monomer ~75kDa by SDS-
PAGE 
N/A 
Table 5. Pcdh AUC data summary 
Discussion 
 Little is known about direct interactions between Pcdhs. Previous reports demonstrated 
that EC1 alone was insufficient (Morishita, Umitsu et al. 2006), but necessary (Schreiner and 
Weiner 2010), for binding and that EC2 and EC3 play an important role in Pcdhγ specificity 
(Schreiner and Weiner 2010). Previous reports have also suggested a role for cis interactions 
between Pcdhs (Schalm, Ballif et al. 2010, Schreiner and Weiner 2010) and that this interaction 
occurs in the membrane-proximal EC4-EC6 domains in Pcdhγ complexes (Schreiner and 
Weiner 2010). Since the minimal regions necessary to encompass trans and/or cis binding 
remained unclear, Pcdh constructs of varying lengths were produced to characterize 
biophysically.  
In this chapter, we learned that purification of Pcdhs with the Strep tag usually causes 
aggregation and destabilizes the protein. Two exceptions to this rule are PcdhγA8 EC1-EC4 and 
PcdhγC5 EC1-EC3. For clarity, the remainder of this discussion will focus on the proteins that 
did not aggregate. Dimers were only observed in constructs containing at least four amino-





clear that the sample contains species larger than a dimer at equilibrium, but we cannot 
conclude a particular multimeric state. We cannot distinguish between trans or cis interactions in 
AUC experiments. However, since EC1 is necessary for trans binding in cell aggregation 
assays, we expect that the PcdhγA8 EC2-EC6 construct is a cis dimer: Whereas the dimers 
involving the amino-terminal EC domains required for cell adhesion could correspond to a trans 
dimer. One possibility for future experiments is to produce the PcdhγA8 EC2-EC4 and compare 
AUC results from this construct with the PcdhγA8 EC1-EC4 and the PcdhγA8 EC2-EC6 since 
this may clarify whether the dimers observed for these two constructs result from interaction via 
the same interface, i.e. within domains EC2-EC4, or two distinct interfaces. This comparison 
could help to localize the trans and cis interactions. If possible, a full set of domain deletion 
constructs for a single Pcdh isoform from each Pcdh subfamily (α, β, and γ) including: EC1-EC3, 
EC1-EC4, EC1-EC5, EC1-EC6, EC2-EC6 could be very informative. 
 The data presented in this chapter represent initial biophysical characterization of 
natively folded Pcdh ectodomains and ectodomain fragments. Our initial data on Strep-tagged 
Pcdhs, PcdhγC5 EC1-EC3 and PcdhαC2 EC1-EC6 produced in the adherent cell system, 
showed that each formed a multimer with a low Kd. Later, characterization by SEC-MALS 
showed that both proteins form soluble aggregates. In addition, PcdhγA8 EC1-EC4 appeared to 
behave as a monomer by SEC-MALS but was found to form a 30-40µM dimer in AUC. 
Combined, these results showed that it is critical to characterize purified Pcdhs by SEC-MALS 
prior to running sedimentation equilibrium experiments by AUC. This is now part of our stand 
protocol for Pcdhs and other proteins throughout the lab. 
Many of the constructs characterized by SEC-MALS have yet to be measured by AUC 
sedimentation equilibrium experiments. Since SEC-MALS is an analytical system and not an 
equilibrium measurement, it is only after these Pcdh constructs are measured by AUC that we 





further investigation is required to determine whether the multimers that we observe correspond 







Chapter 5. Crystallization, data collection, phasing, and structure determination of 
PcdhγC5 EC1-EC3 
Introduction 
 In an effort to determine the structure of a Pcdh ectodomain fragment, the three amino-
terminal domains of PcdhγC5 were expressed in suspension FreeStyle 293 cells or glycosylase 
deficient GNTi suspension cells, and purified by affinity and size exclusion chromatography (see 
Chapter 3 for details). The three amino-terminal domains were chosen because Schreiner and 
Weiner (2010) suggested that at least the three N-terminal EC domains were involved in trans 
binding. Our biophysical data suggested that this protein behaved as a monomer (see Chapter 
4). While we were aware that this meant the protein may not crystallize as a functional complex, 
other molecules with binding affinities too weak to measure by AUC will sometimes reveal 
native binding conformations when crystallized. In addition, comparison of the PcdhγC5 EC1-
EC3 structure to previously determined structures of related molecules such as vertebrate 
cadherins, non-clustered Pcdhs, and other non-classical cadherins was expected to yield useful 
information that could potentially translate into functional hypotheses.  
After purification, PcdhγC5 EC1-EC3 was used for crystallization trials and yielded 
protein crystals in a many conditions. Optimization of crystals in two different conditions yielded 
crystals large enough to screen for diffraction at a synchrotron light source. Of the crystals 
tested, most diffracted to lower than 4 angstroms. However, I was able to collect two data 
sets with ~3Å resolution. In crystallography, we continually rotate the protein crystal as it is 
exposed to the x-ray beam and collect images at set time intervals, usually corresponding to 
the amount of time that it takes to rotate the crystal by one degree. The exposure time is 
adjusted according to the strength of the signal from the diffracting crystal. Each spot in the 





data contain the amplitude information from the peak intensity but the phases must be 
determined using additional information. One of the most common methods used to obtain 
phases is molecular replacement, which uses the phases of a known protein structure as 
initial estimates for phases. In order for this method to be successful, one usually needs to 
start with a known protein of similar structure and conformation. Few protein structures exist 
for proteins with high sequence identity to PcdhγC5 EC1-EC3, and none of the available 
protein structures we tested could be used to successfully phase our data using molecular 
replacement. This meant that I would need to obtain phases by an alternative method. 
 Other methods that can be used to obtain phases include isomorphous replacement 
and anomalous scattering. Isomorphous replacement involves the addition of marker 
atom(s) to a protein crystal. In order for two crystals to be isomorphous, they must both 
have the same space group and unit cell and the marker atom(s) must be located in 
identical or nearly identical positions within each unit cell. This will result in slight 
perturbations in the diffraction pattern which can be used to estimate phases. In order for 
these perturbations to be large enough to measure, the atom(s) added must diffract 
strongly. Here, I use heavy atoms for this purpose. Another property of heavy atoms is that 
they absorb X-rays of specified wavelength and reemit them with an altered phase. This 
absorption results in an inequality of symmetry related reflections. This phenomenon is 
called anomalous scattering.  
Crystallization trials in the presence of the heavy atom ytterbium (III), in the form of 
ytterbium chloride, yielded a new crystal form. In parallel, I screened for binding of heavy 
atoms including platinum, gold, mercury and uranium using an electromobility gel shift 
assay. Through a combination of heavy atom soaks and optimization of the new crystal 





that contained heavy atoms. Using these data, we were able to combine isomorphous 
replacement and anomalous scattering to successfully phase one of the data sets for 
PcdhγC5 EC1-EC3 and solve the others by molecular replacement. This chapter will 
discuss the details of PcdhγC5 EC1-EC3 crystallization, phasing, and data processing to 
solve the structure in three different crystal forms. Julia Brasch and Oliver Harrison, post-
docs in our lab, taught me how to use DENZO and SCALEPACK to analyze my data. Larry 
Shapiro helped with analysis of the phasing data to make initial phase estimates. Kerry 
Goodman, another post-doc in our lab, taught me how to use COOT and Phenix, and 
helped with the refinement of all three PcdhγC5 EC1-EC3 structures. Functional studies 
guided in part by the PcdhγC5 EC1-EC3 structure will be discussed in detail in Chapter 7. 
Methods 
Crystallization Screens (96-well) and optimization 
 PcdhγC5 EC1-EC3 was purified from FreeStyle 293 suspension cells and concentrated 
to 9.3mg/mL. A separate purification of PcdhγC5 EC1-EC3 produced in GNTi suspension cells 
was concentrated to 10.7mg/mL. Initial crystallization screens were conducted using a Mosquito 
robotic crystallization system (TTP lab tech). 0.2μl drop volumes were used (0.1μL of protein, 
0.1μL crystallization buffer). This system enables extensive screening with relatively small 
protein quantities. Many crystallization hits were obtained. Conditions were then optimized with 
respect to pH, ionic strength, and precipitant concentration. This optimization included additive 
screening with cryoprotectants including glycerol, ethylene glycol, and polyethylene glycol 
(PEG) 400. Crystal optimization trials were carried out using the hanging drop method. Hanging 
drops were set up with a 1:1 or 1:2 ratio of crystallization liquor and recombinant protein in gel 
filtration buffer (150mM NaCl, 10mM Tris HCl, pH 8.0, 3mM CaCl2). The crystallization 





PcdhγC5 EC1-EC3 produced in FreeStyle 293 cells: 16% (w/v) PEG 6000, 100mM imidazole, 
pH 8.0, 200mM calcium acetate (30% (v/v) PEG 400); PcdhγC5 EC1-EC3 produced in 
suspension-adapted GNTi cells: 25.5% [w/v] PEG 4000, 15% [v/v] glycerol, 85mM Tris, pH 8.5, 
3mM calcium chloride (20% [v/v] ethylene glycol).  
Heavy atom screen by native gel shift 
 Gel shift experiments exploit differences often observed in protein migration on native 
polyacrylamide gel electrophoresis that can result from covalent binding of heavy atoms 
(Boggon and Shapiro 2000). The heavy atoms tested included: K2PtCl4, KAu(CN)2, mersalyl 
acid, ethyl meruric phosphate (EMP), HgCl2, ethylmerurithiosalicylic acid (EMS), K2HgI4, p-
Chloromercuribenzoic acid (PCMB), YbCl3, UO2 acetate, and K2UO2F5. All heavy atoms were 
dissolved to a final concentration of 10mM in gel filtration buffer (10mM Tris, pH 8.0, 150mM 
NaCl, 3mM CaCl2). 1µL of heavy atom, 1µL of 9.3mg/mL protein, and 8µL of gel filtration buffer 
were added to each of eleven tubes. As a control, 1µL of 9.3mg/mL protein and 9µL of sizing 
buffer was added to a separate tube. Each was incubated at 20ºC for 2-3 hours. After 
incubation, 1µL of each sample was loaded onto a 4-18% native gel and run on our PhastGel 
System. A YbCl3 dilution series was also tested to determine optimal concentration for re-
screening. Samples were prepared as described above but instead of using 10mM YbCl3, a 
dilution series using 1, 1/2, 1/5, 1/10, or 1/20 the concentration was used. YbCl3 was diluted in 
gel filtration buffer. These samples were also analyzed by native gel. 
Heavy atom soaks and re-screening with YbCl3 
 C2 and P21 crystal forms were grown in fresh plates and soaks with three different heavy 
atoms were carried out. The heavy atoms tested were ethyl mercuric phosphate (EMP), HgCl2, 
and K2HgI4. 10mM solutions of each heavy atom were prepared in 10mM Tris, pH 8.0, 150mM 





atom solution was added to each drop containing PcdhγC5 EC1-EC3 crystals. After soaking for 
2-3 hours, or overnight, crystals were frozen in cryoprotectant (crystallization liquor and 30% 
PEG400). In addition, new crystallization screens using PcdhγC5 EC1-EC5 + 0.3mM YbCl3 
were set up using a Mosquito robotic crystallization system (TTP lab tech) as described above. 
A new crystal hit that had not been observed previously was optimized in the hopes of obtaining 
YbCl3 containing crystals for phasing. The crystallization conditions were as follows (added 
cryoprotectants are indicated in parentheses): mouse PcdhγC5 EC1-EC3 produced in FreeStyle 
293 cells + 0.3mM yitterbium (III) chloride: 40% [v/v] MPD, 100mM sodium cacodylate, pH 6.0, 
5% [w/v] PEG 8000. This crystal form was also soaked with the three heavy atoms described 
above. 
Data Collection at APS ID-24E 
 Data collection was carried out remotely at the APS ID-24E beamline. ID-24E is fixed at 
12.68 keV and 0.98Å, the absorption edge of selenium, which is frequently used to phase 
selenomethionine containing proteins. Crystals were mounted by the robot using the remote 
data collection software. The beam was centered and then two images were recorded, one at 
the current angle and one at +90º. Data was recorded with an exposure time of one second, at 
a distance of about 470nm, and transmission at 20%. If the diffraction pattern appeared 
promising and could be successfully auto-indexed by APS’s program, RAPD, then data was 
collected from 0-180 degrees, usually beginning with the angle recommended by RAPD and 
adjusting the transmission if necessary. 
Data processing, phasing and solving the structures of each crystal form 
All data sets collected were indexed using DENZO and scaled and integrated with 
SCALEPACK (Otwinowski and Minor 1997, Otwinowski and Minor 2001). Heavy atom searches 
for the PcdhγC5 EC1-EC3 crystal form (P43212 space group) were conducted using SOLVE 





Bricogne 1997). Manual model building of EC domains into appropriate electron density was 
done using COOT (Emsley, Lohkamp et al. 2010). We began with a homology model built by 
Rotem Rubinstein in the Honig-Shapiro lab. Simulated annealing of the initial model was carried 
out using Phenix (Adams, Afonine et al. 2010). The structure of PcdhγC5 EC1-EC3 in C2 and 
P21 space groups were determined by molecular replacement using Phaser MR (McCoy, 
Grosse-Kunstleve et al. 2007) with the refined PcdhγC5 EC1-EC3 P43212 structure as the 
search model. For all three structures, iterative model rebuilding was done using COOT 
(Emsley, Lohkamp et al. 2010) and refinement using Phenix (Adams, Afonine et al. 2010). 
K562 cell aggregation assay 
 All K562 cell aggregation assays described here were completed by Chan Aye Thu, a 
post-doc in the Maniatis lab. Briefly, expression constructs were transfected into K562 cells 
(human leukemia cell line, ATCC CCL243) by electroporation using Amaxa 4DNucleofactor 
(Lonza). After 24 hours in culture, the transfected cells were allowed to aggregate for one to 
three hours on a rocker kept inside the incubator. The cells were then fixed in 4% PFA for 10 
minutes, washed in PBS, and cleared with 50% glycerol for imaging.  
Results 
Crystallization screens, optimization, data collection, and analysis (native data sets) 
 Screening of PcdhγC5 EC1-EC3 produced in FreeStyle 293 or GNTi suspension cells in 
the JCSG screens yielded about ten crystal hits for each protein (Fig. 15 and 16 respectively). 
Conditions marked by red boxes were optimized. Optimized conditions for PcdhgC5 produced in 
FreeStyle 293 cells included 16% polyethylene glycol (PEG) 1000, 100mM imidazole, pH 8.0, 
and 200mM calcium acetate. Optimized conditions for GNTi suspension cells included 25.5% 
PEG 4000, 15% glycerol, 85mM Tris, pH 8.5, and 3mM CaCl2. Crystals were frozen in six 





xylitol, or 15% 1,4-butane-diol. Crystals were screened for diffraction at the APS ID-24E line and 
data collected for all crystals that diffracted to higher than 3.5Å. Data was indexed using 
DENZO and scaled and integrated with SCALEPACK (Otwinowski and Minor 1997, Otwinowski 
and Minor 2001). A summary of the unit cell dimensions, space group, and notes from all 
processed data can be found in Table 6. 
 















Table 6. Summary of Diffraction Data for C2 and P21 crystal forms 
 
We collected multiple data sets for two different crystal forms with diffraction ranging from 3-
3.5Å (see Fig. 17 for examples). Data processing with DENZO and SCALEPACK (Otwinowski 
and Minor 1997) showed that the space groups for these crystal forms were C2 and P21. 
Attempts to phase this data by molecular replacement were not successful. 
 
Figure 17. Diffraction images from native PcdhγC5 crystals 





Crystallization screens, optimization, data collection, and phasing 
 Two approaches were used to obtain crystals containing heavy atoms for phasing. The 
first was to attempt to replace at least one of the calcium ions bound by our protein with 
ytterbium chloride (YbCl3). Native gel shifts with YbCl3 suggested the use of 0.3mM to minimize 
protein precipitation (Fig. 18A). New crystal screens of PcdhγC5 EC1-EC3 produced in 
FreeStyle 293 cells with the addition of 0.3mM YbCl3 yielded new hits in crystal conditions that 
were not observed previously. Since YbCl3 was most likely to bind to our protein at low pH, the 
condition containing 100mM sodium cacodylate at pH 6.5 was chosen to optimize. This 
condition also appeared to be a new crystal form as compared with what we produced in the 
absence of ytterbium chloride.  
The second approach was to screen for heavy atoms that could bind to our protein, 
without causing precipitation, by native gel shift. This experiment yielded three candidate heavy 
atoms: EMP, HgCl2, and K2HgI4 (Fig. 18B). These were used in heavy atom soaks with the C2, 
P21, and YbCl3 crystal forms. The C2 and P21 crystals were frozen in 30% PEG400 or 20% 
ethylene glycol respectively, the best cryoprotectants for each crystal from the previous 
synchrotron trip. The YbCl3 crystal form did not require cryoprotectant since the crystal 






Figure 18. Heavy atom native gels 
A) YbCl3 native gel shifts. Lane 1-7: PcdhγC5 (no YbCl3), PcdhγC5 + 1mM YbCl3, PcdhγC5 + 0.5mM 
YbCl3, PcdhγC5 + 0.2mM YbCl3, PcdhγC5 + 0.1mM YbCl3, PcdhγC5 + 0.05mM YbCl3, and PcdhγC5 (no 
YbCl3). B) Heavy atom native gel shifts. Lanes 1, 5, 8, 9, 16: PcdhγC5 (no heavy atom), lane 2: K2PtCl4, 
lane 3: KAu(CN)2, lane 4: mersalyl acid, lane 6: ethyl mercuric phosphate, lane 7: HgCl2, lane 10: 
ethylmerurithiosalicylic acid, lane 11: K2HgI4, lane 12: p-Chloromercuribenzoic acid, lane 13: YbCl3, lane 
14: UO2 acetate, and lane 15: K2UO2F5 
 Diffraction data was obtained for the YbCl3 crystal form. Data processing with DENZO 
and SCALEPACK (Otwinowski and Minor 1997) showed that the space group for this crystal 
form was P41212 or P43212. It was only later in data analysis that we could distinguish between 
these two and found that the space group was P43212. We obtained one native data set and two 
heavy atom data sets with anomalous signal using the P43212 crystal form (see Table 7 for data 
summary and Table 8 for anomalous ). These data sets were isomorphous (the unit cells were 
approximately the same size) and could therefore be used for phasing. Analysis of these data 
sets by SOLVE and RESOLVE (Terwilliger and Berendzen 1999) allowed us to generate a 
heavy atom pdb file containing possible coordinates for heavy atoms within the unit cell and an 
initial electron density map. These coordinates and the initial electron density map were 
improved using SHARP (de La Fortelle and Bricogne 1997) and an electron density map with 
sufficient information to begin model building was obtained (Fig. 20). 
heavy 





native 108.637 108.637 96.614 90 90 90 
K2HgI4 108.817 108.817 96.949 90 90 90 
EMP 108.718 108.718 95.924 90 90 90 
Table 7. Unit cell size for native and heavy atom data sets 
 
Table 8. Anomolous signal in EMP data set 
It should be noted that these data were collected at 12.68keV, which is not optimal for Hg atoms. 
 
 








Figure 20. Initial electron density map used for model building. 
 
Model building, and refinement for P43212 crystal form 
 Manual model building of EC domains into appropriate electron density was carried out 
using COOT (Emsley, Lohkamp et al. 2010). We began with the electron density map generated 
in the previous section and a homology model built by Rotem Rubinstein, a post-doc in the 
Honig-Shapiro lab. Simulated annealing of the initial model was carried out using Phenix 
(Adams, Afonine et al. 2010). Iterative model building was carried out with COOT and 
refinement by Phenix. The final refinement statistics can be found in Table 9. Further details on 





Molecular replacement and refinement of C2 and P21 crystal forms 
The structure of PcdhγC5 EC1-EC3 in C2 and P21 space groups were determined by 
molecular replacement using Phaser MR (McCoy, Grosse-Kunstleve et al. 2007) with the 
refined PcdhγC5 EC1-EC3 P43212 structure as the search model. For each structure, iterative 
model rebuilding was carried out using COOT (Emsley, Lohkamp et al. 2010) and refinement 
using Phenix (Adams, Afonine et al. 2010). The details of each resolution shell from 
SCALEPACK for C2 and P21 crystal forms can be found in Fig. 21A and 21B can be found in 






Figure 21. Refinement statistics 
A) C2 refinement statistics B) P21 refinement statistics 
 
  P43212 P21 C2 
Resolution range 
(Å) 
30.06  - 2.9 (2.847  - 
2.749) 40  - 3.0 (3.11  - 3.0) 40  - 3.1 (3.21  - 3.1) 
Space group P 43 21 2 P 1 21 1 C 1 2 1 
Unit cell 
108.637 108.637 96.614 
90 90 90 
67.188 84.563 109.144 90 
106.43 90 
190.806 104.916 80.066 
90 97.03 90 
Total reflections  194493 85896 94869 
Unique reflections 14827 23389 26871 
Multiplicity  12.7 (8.9) 3.7 (2.8) 3.5 (2.9) 
Completeness (%) 95.25 (73.82) 99.16 (93.05) 94.02 (72.86) 





Wilson B-factor 55.56 74.18 56.8 
R-merge 0.118 (0.516)  0.068 (0.392) 0.11 (0.391) 
R-work 0.2119 (0.4226) 0.2248 (0.2947) 0.2911 (0.3619) 
R-free 0.2477 (0.5346) 0.2610 (0.3456) 0.3305 (0.4011) 
Number of atoms 2438 4600 7201 
macromolecules 2348 4436 6994 
ligands 71 112 184 
water 19 52 23 
Protein residues 322 642 970 
RMS(bonds) 0.006 0.004 0.015 
RMS(angles) 0.96 0.77 1.17 
Ramachandran 
favored (%) 94 95 94 
Ramachandran 
outliers (%) 0 0 0.32 
Clashscore 3.8 2.79 26.45 
Average B-factor 77.7 84.8 74.6 
macromolecules 76.1 84.6 73.9 
ligands 133.6 106.9 106.2 
solvent 62.6 51.2 30 
  EMP K2HgI4 
Resolution range (Å) 30  - 3.5 (3.62  - 3.5) 30  - 2.9 (3  - 2.9) 
Space group P 43 21 2 P 43 21 2 
Unit cell 
108.637 108.637 96.614 90 90 
90 
108.637 108.637 96.614 90 90 
90 
Total reflections 92356 154516 
Unique reflections 14827 14827 
Multiplicity 12.2 (9.6) 11.7 (8.3) 
Completeness (%) 95.25 (73.82) 95.25 (73.82) 
Wilson B-factor 55.56 55.56 
R-merge 0.174 (0.48) 0.15 (0.426) 
R-work 0.2119 (0.4226) 0.2119 (0.4226) 
R-free 0.2477 (0.5346) 0.2477 (0.5346) 
Table 9. Final Refinement Statistics 
Comparison of all three crystal forms 
 All crystal forms had one interface in common. However, the buried surface area of this 
structure was only 1400Å2 (Fig. 22A), unusually low for a biologically relevant interface. In 
addition, the interface contains almost entirely hydrophilic residues as opposed to burying 





between R193 and E9 (Fig. 22B). To test the biological relevance of this interface, we asked 
that Chan Aye Thu, a post-doc from the Maniatis lab, help us to make the following mutants: 
S101M, S101Y, and R193E. None of these mutations disrupted binding and therefore this 







Figure 22. Crystal Interface and Mutations 
A) Alignment of solved structures of all three crystal forms. B) Crystallographic interface from the P43212 
crystal form. A salt bridge can be seen between R193 and E9. S101 is near the center of the interface. C) 





Analysis of the N-terminus 
 Examination of the N-terminus in the crystal structure shows the N-terminal A-strand 
appears short relative to the neighboring beta strand and leaves hydrophobic residues exposed 
(Fig. 23A). Since the interface observed in all three crystal forms does not appear to be the 
biologically relevant interface involved in trans binding and PcdhγC5 EC1-EC3 behaves as a 
monomer in solution (see Chapter 4), we wanted to test whether the N-terminus used in our 
crystallization construct was functional in trans binding. To do this we cloned a construct to test 
in cell aggregation assays with the same signal peptide and N-terminus used in our 
crystallization construct. In addition, to test whether an extended N-terminus may be necessary, 
we designed a new construct beginning with GWVSG (a five amino acid extension).  
 The PcdhγC5 EC1-EC3 with an extended N-terminus (PcdhγC5 EC1-EC3 extN) 
behaved as a monomer in SEC-MALS and AUC. On-going efforts to crystallize this protein will 
be described in Chapter 6. However, it may not be necessary to solve this structure as cell 
aggregation assays showed that the N-terminus used in our crystallization construct was 
functional for trans binding (Fig. 23B). 
 





A) Close-up of the N-terminus of PcdhγC5 EC1-EC3 with residues shown in stick representation. B) Full-
length PcdhγC5 with the same signal peptide and N-terminus used in the crystallography construct used 
in a cell aggregation assay. 
Discussion 
 We used Multiple Isomorphous Replacement with Anomalous Scattering (MIRAS) to 
obtain initial phases for the PcdhγC5 EC1-EC3 structure. My analysis of the heavy atom 
derivatives of the P43212 crystal form showed that each contained only Hg atoms despite being 
grown in the presence of Ytterbium. Since this crystal form only grew in the presence of YbCl3 
this suggests that the YbCl3 may have aided in initial nucleation of the crystals. We were able to 
successfully obtain a native data set and two data sets containing Hg atoms from this crystal 
form. Using these data sets we calculated an initial estimate of phases and generated an 
electron density map with sufficient information to begin model building. Refinement of our 
model resulted in a 2.9Å structure. The refined model was used for molecular replacement to 
phase the C2 and P21 crystal forms, which were then refined to 3.1Å and 3.0Å respectively.  
This chapter described the structure determination for PcdhγC5 EC1-EC3, produced in 
mammalian cells, in three different crystal forms. This Pcdh region was expected to encompass 
the minimal region required for trans binding and a common interface was observed in all three 
crystal forms. However, mutational studies of the common interface indicated that it is not 
necessary for trans binding. We also confirmed that production of PcdhγC5 with the non-native 
signal peptide used in the crystallography construct could produce a function protein in cell 
aggregation assays. It is possible that we will only be able to determine the binding interface(s) 
of clustered Pcdhs when structures of larger molecules that crystalize as multimers are 
determined. These efforts are on-going and will be described in Chapter 6. 
To the best of our knowledge, PcdhγC5 EC1-EC3 is the first multi-domain structure of a 
clustered Pcdh. We observe three Ca2+ ions coordinated between each consecutive EC domain, 





of calcium for Pcdh binding will be described in Chapter 7. In addition, to investigate the trans 
binding interface and extract useful information from the PcdhγC5 EC1-EC3 structure, 
bioinformatic analysis, homology modeling, and mutational studies were required and these 








Chapter 6. Crystallization trials of additional Pcdhs: PcdhγB6 EC1-EC6, PcdhγB6 EC1-
EC5, Pcdhα7 EC1-EC5, PcdhγA8 EC1-EC4, and Pcdhβ1 EC1-EC3 
Introduction 
 The work presented in previous chapters showed that all Pcdhs bind with homophilic 
specificities, that domain shuffling of EC1-EC3 is sufficient to swap trans binding specificity, that 
EC1-EC4 are necessary for trans binding in all cases tested, and that cis interactions are likely 
to occur in the membrane-proximal EC4-EC6 domains. Despite these advances, the molecular 
details of complex formation remain a mystery. In this chapter, we attempt to crystallize 
additional Pcdh constructs to characterize the binding interface(s) of Pcdh complexes. 
 We have been able to produce a number of Pcdh ectodomain fragments of varying 
lengths at a sufficient purity and yield for crystallization experiments as described in Chapter 3 
and a number of these constructs crystallized. The work in this chapter focuses on optimization 
crystals obtained for each of the following constructs: PcdhγB6 EC1-EC6, PcdhγB6 EC1-EC5, 
Pcdhα7 EC1-EC5, PcdhγA8 EC1-EC4, and Pcdhβ1 EC1-EC3. We showed that Pcdhα7 EC1-
EC5 and PcdhγA8 EC1-EC4 behave as dimers (Chapter 4) and we therefore expect that a 
crystal structure of these constructs will reveal at least one binding interface, though at this time, 
we do not know if the dimers that we observe form in cis or in trans. Similarly, PcdhγB6 EC1-
EC6 also forms a multimer, but we could not distinguish the nature of the multimer from our 
sedimentation equilibrium analytical ultracentrifugation experiments (Chapter 4). Here I 
describe a summary of the status of the optimization of the crystals for each of the constructs 
listed above. 
 Much of the work described in this chapter was completed by other members of the 
Honig-Shapiro lab. PcdhγA8 constructs were produced, purified and screened for crystallization 





purified and screened for crystallization by Fabiana Bahna, another staff scientist in our lab. 
Guidance in crystal optimization was provided by Kerry Goodman, a post-doc in our lab. Kerry 
also froze the crystals and carried out the freezing optimization trials. I provided guidance on 
which protein constructs to pursue and optimization of their purification to stabilize the proteins 
for crystallization trials. I also provided input on optimization techniques that helped with the 
PcdhγC5 crystals and helped to collect data at the Advanced Photon Source (APS) and 
Brookhaven National Labs (BNL) national synchrotron light source (NSLS). 
Methods 
Crystallization Screens (96-well) 
 PcdhγB6 EC1-EC6, PcdhγB6 EC1-EC5, Pcdhα7 EC1-EC5, PcdhγA8 EC1-EC4, and 
Pcdhβ1 EC1-EC3 were purified from FreeStyle 293 suspension cells as described in Chapter 3 
and concentrated to 5-10mg/mL. Initial crystallization screens were conducted using a Mosquito 
robotic crystallization system (TTP lab tech). 0.2μL drop volumes were used (0.1μL of protein, 
0.1μL crystallization buffer). This system enables extensive screening with relatively small 
protein quantities. Initial hits were obtained for each protein, but PcdhγB6 EC1-EC5 and Pcdhβ1 
EC1-EC3 have not yet been optimized. All crystallization experiments described in this chapter 
were conducted at 20ºC unless otherwise noted. 
PcdhγB6 EC1-EC6 crystal optimization and freezing 
An initial hit for PcdhγB6 EC1-EC6 was obtained in 100mM HEPES, pH 7.0, and 10% 
polyethylene glycol (PEG) 6000. Crystal optimization trials were carried out using the hanging 
drop method. Hanging drops were set up with a 1:1 or 1:2 ratio of crystallization liquor and 
recombinant protein in gel filtration buffer (150mM NaCl, 10mM Tris HCl, pH 8.0, 3mM CaCl2, 
125mM imidazole). Crystal conditions were optimized with respect to pH, ionic strength, and 





10mM CaCl2, 350mM NaCl, 80mM HEPES, pH 7.0, and 5% polyethylene glycol (PEG) 6000. An 
additive screen (Hampton Research) using the optimized condition appeared to generate 
improvements including a crystal form with individual rods (optimized condition + 5% PEG 400) 
and one with plates (optimized + 0.7% v/v 1-Butanol). Crystals were frozen in the crystal 
condition + 35% glycerol. Crystals were screened for diffraction at the APS ID-24E beamline. 
Pcdhα7 EC1-EC5 crystal optimization and freezing 
An initial hit for Pcdhα7 EC1-EC5 was obtained in 10% PEG 6000, and 100mM HEPES, 
pH 7.0. Crystal optimization trials were carried out using the hanging drop method. Hanging 
drops were set up with a 1:1 or 1:2 ratio of crystallization liquor and recombinant protein in gel 
filtration buffer (150mM NaCl, 10mM Tris HCl, pH 8.0, 3mM CaCl2, 125mM imidazole). Crystal 
conditions were optimized with respect to pH, ionic strength, and precipitant. Optimized 
conditions included 15% PEG 3350, and 100mM HEPES, pH 7.5. Many cryoprotectants were 
screened including 30% sucrose, 30% ethylene glycol, 30% PEG400, 30% glycerol, and 33% 
xylitol with 30% ethylene glycol being the best. The Pcdhα7 EC1-EC5 crystals are fairly large 
(>250μm) and often crack during cryoprotection prior to freezing. Efforts to optimize freezing of 
these conditions are on-going. To date, we have tried dehydrating crystals by transferring the 
coverslip with hanging drops containing crystals to a new well containing 30-35% PEG 3350, 
and 100mM HEPES, pH 7.5 and incubated overnight at 20ºC. We have also tried improve 
crystal stability by cross-linking. To do this 2μL of 25% glutaraldehyde, a cross-linking reagent, 
was placed on to a bridge used for sitting drops. The coverslip with the dehydrated crystals in 
the hanging drop was then removed, the bridge containing glutaraldhyde was added to the well, 
and the coverslip was placed back over the well. Crystals were incubated with cross-linker for 
30-60 minutes at 20ºC. Crystals were then frozen in the crystallization condition + 30% ethylene 





PcdhγA8 EC1-EC4 crystal optimization and freezing 
 An initial hit for PcdhγA8 EC1-EC4 was obtained in 10% PEG 6000 and 100mM HEPES 
pH 7.0. Crystal optimization trials were carried out using the hanging drop method. Hanging 
drops were set up with a 1:1 or 1:2 ratio of crystallization liquor and recombinant protein in gel 
filtration buffer (150mM NaCl, 125mM imidazole,10mM Tris HCl, pH 8.0, 3mM CaCl2). Crystal 
conditions were optimized with respect to pH, ionic strength, and precipitant concentration. 
Optimized conditions included 5% PEG 6000 and 100mM MES, pH 5.3. Crystals were frozen in 
the crystal condition + 30% PEG400 and screened for diffraction at the APS ID-24E beamline. 
We also screen the following cryoprotectants: 30% sucrose, 30% ethylene glycol, and 30% 
glycerol, but 30% PEG400 worked best. None of these efforts resulted in PcdhγA8 EC1-EC4 
crystal X-ray diffraction sufficient to solve the crystal structure. Alternative conditions are now 
being optimized. One condition undergoing optimization is 200mM NaCl, 10% isopropanol, 
100mM HEPES, pH 7.5. 
PcdhγC5 EC1-EC3 ExtN crystal optimization and freezing 
 An initial hit for PcdhγC5 EC1-EC3 with an extended N-terminus (N-GWVSG) was 
obtained in 18% PEG 3350 and 200mM potassium nitrate. Crystal optimization trials were 
carried out using the hanging drop method. Hanging drops were set up with a 1:1 or 1:2 ratio of 
crystallization liquor and recombinant protein in gel filtration buffer (150mM NaCl, 125mM 
imidazole, 10mM Tris HCl, pH 8.0, 3mM CaCl2). Crystal conditions were optimized with respect 
to pH, ionic strength, and precipitant concentration. Crystals appeared to improve in the 
presence of the additive 3% trehalose. Crystals were frozen in the crystallization condition + 





Data Collection at APS ID-24E 
 Data collection was carried out remotely at the APS ID-24E beamline. ID-24E is fixed at 
12.68 keV and 0.98Å. Crystals were mounted by the robot using the remote data collection 
software. The beam was centered and then two images were recorded, one at the initial angle 
and one at +90º. Data was recorded with an exposure time of one second, at a distance of 
about 470nm, and transmission at 20%. If the diffraction pattern appeared promising and could 
be successfully auto-indexed by APS’s program, RAPD, then data was collected from 0-180 
degrees, usually beginning with the angle recommended by RAPD and adjusting the 
transmission if necessary. 
Results 
 A summary of the status of all on-going Pcdh crystals are shown in Table 8. Datasets for 
the PcdhγB6 EC1-EC6 and Pcdhα7 EC1-EC5 were collected and auto-indexed by the RAPD 
program at APS. The predicted space group and unit cell for each dataset can be found in 
Table 9. Using the parameters estimated by RAPD, we calculated the Matthews probabilities 
(Matthews 1968, Matthews 1976, Kantardjieff and Rupp 2003) using a Matthews Probability 
Calculator (http://www.ruppweb.org/mattprob/default.html). The Matthews coefficient calculated 
provides an estimate for the number of molecules per asymmetric unit. In the case of both 
PcdhgB6 EC1-EC6 and Pcdha7 EC1-EC5, the Matthews coefficient suggests four molecules 
per asymmetric unit. The graphical results from the Matthews probability calculator can be seen 
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Table 10. Summary of Pcdh crystals currently undergoing optimization 
 PcdhγB6 EC1-EC6 Pcdhα7 EC1-EC5 
Space 
group C 2 I 2 2 2 
Unit cell 306.80 72.60 139.00 90.00 103.00 
90.00 
64.17 103.40 557.40 90.00 90.00 
90.00 






Figure 24. Matthews Coefficient for PcdhgB6 EC1-EC6 and Pcdha7 EC1-EC5 crystals 
A) PcdhgB6 EC1-EC6 B) Pcdha7 EC1-EC5 
 
Discussion 
 The crystallography described in this chapter is an on-going effort and the trans and cis 
binding interfaces of clustered Pcdhs remain unknown. However, from the AUC experiments 
described in Chapter 4, we know that at least three of constructs that have crystallized behave 
as multimers. We expect that a crystal structure of PcdhγB6 EC1-EC6, the full Pcdh 
ectodomain, will include both trans and cis interfaces. We expect that PcdhγA8 EC1-EC4 and 
Pcdhα7 EC1-EC5 structures will encompass the trans interface because they include the N-
terminal four EC domains required for binding in cell aggregation studies (see Chapter 2). While 
we are less hopeful that the Pcdh EC1-EC3 constructs will include a biologically relevant 
interface, solving these structures may still yield useful insights and will facilitate the phasing of 
additional Pcdh structures by molecular replacement. In the case of PcdhγC5 EC1-EC3 ExtN, 
we made the extension of the N-terminal A-strand to bury the exposed hydrophobic pocket 
exposed in the PcdhγC5 EC1-EC3 structure that we determined previously(see Chapter 5 for 
details). If this strand is flexible, perhaps clustered Pcdhs could bind via a strand-swapping 





Solution of the Pcdhβ1 EC1-EC3 crystal structure would allow the comparison of Pcdhs from 
different clusters. 
 The improvements in protein production described in Chapter 3 have enabled us to 
produce and screen many constructs for crystallization. In addition, characterization of these 
constructs by SEC-MALS has enabled us to test whether these proteins behave well in solution. 
These advances have allowed us to advance to the point where we now have multiple Pcdh 
crystals containing proteins that behave as multimers. It seems likely that a Pcdh crystal 








Chapter 7. Identification of Pcdh trans binding specificity determining regions 
(Manuscript in preparation) 
Introduction 
 Prior to the work described in this chapter, a monomeric NMR structure of the EC1 
domain of Pcdhα4 was determined (Morishita, Umitsu et al. 2006). Classical cadherins bind 
through their amino-terminal EC1 domains. Domain shuffling experiments where EC1 of N-
cadherin was replaced by Pcdhα4 EC1 showed that Pcdhα4 EC1 is insufficient to mediate 
homophilic interactions (Morishita, Umitsu et al. 2006). Another previous study that focused on 
Pcdhγs suggested that the EC1 domain was necessary for homophilic binding and that EC2 and 
EC3 are the specificity determining domains (Schreiner and Weiner 2010). These results 
suggest that at least the N-terminal EC1-EC3 domains of Pcdhs are necessary to mediate 
homophilic interactions. 
 This chapter focuses on the x-ray structure determination of the N-terminal EC1-EC3 
domains of PcdhγC5 and the identification of the specificity determining regions in EC1-EC3 for 
Pcdhs from each of the three Pcdh gene clusters. Fabiana Bahna optimized the expression of 
Pcdhγ5 EC1-EC3 and I purified the protein and determined the structure. Kerry Goodman 
helped with refinement of the PcdhγC5 structure. Rotem Rubenstein performed an extensive 
sequence analysis of Pcdhs, built homology models based on the PcdhγC5 structure, and 
designed domain shuffling and mutagenesis experiments for closely-related pairs of Pcdhs. 
Chan Aye Thu and Maxime Cheeve prepared constructs and performed K562 cell aggregation 
assays for the closely-related pairs of Pcdhs. Rotem and I used his analysis and the PcdhγC5 
structure to design charge scanning mutants with the potential to disrupt the binding interface. I 
cloned these mutants and gave them to Ayethu and Maxime for analysis in the cell aggregation 
assay. Please note that the experiments required to finish this paper are not yet complete but 





term future which could change the tone of this paper, depending on what the new structure(s) 
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Identification of Pcdh trans binding specificity determining regions 
 
Summary 
 Clustered protocadherins (Pcdhs) are a subgroup of the cadherin superfamily that 
mediates self-avoidance in vertebrate neural circuit assembly. Recent studies showed that the 
clustered protocadherins interact in a strictly homophilic manner and suggested that the 
specificity of these interactions is determined by the extracellular cadherin (EC) domains, EC2 
and EC3, that EC1 is necessary for binding, and that all clustered Pcdhs bind homophilically. 
Here we present the X-ray structure of the specificity determining region (EC1-EC3) of mouse 
PcdhγC5. The EC1-EC3 domains of PcdhγC5 form a rod-shaped monomer that coordinates 
three Ca2+ ions between each successive EC domain, as is observed in classical cadherins. We 
show that Pcdh binding is calcium dependent. Guided by the PcdhγC5 structure, we conducted 
an extensive sequence analysis, structural modeling, and mutagenesis studies among pairs of 
Pcdhs from each gene cluster with nearly identical sequences and distinct binding specificities.  
Our findings illustrate that the EC1 domain contributes to specificity in all three pairs and that 
Pcdh specificity determining regions can be localized to specific areas in each domain. 
Furthermore we show that mutating these regions in PcdhγC5 disrupts trans binding.  
Introduction 
The specific interactions of proteins expressed on the cell surface are responsible for a 
wide array of biological processes including cell and tissue patterning (Takeichi 1995) and 
neural circuit assembly (Zipursky and Sanes 2010). Neural circuit assembly is perhaps one of 
the most striking examples where expression of distinct repertoires of proteins with diverse 
extracellular regions provides distinct cell surface identities. Dscam1 isoforms in invertebrates 





(Zipursky and Sanes 2010, Chen and Maniatis 2013, Zipursky and Grueber 2013). Vertebrate 
clustered Pcdh encode 58 isoforms in mouse that bind with strictly homophilic specificities 
(Chapter 4).  
An essential feature of neural circuit assembly is that the axons and dendrites of the 
same neuron do not overlap each other while interacting freely with those from different 
neurons. This characteristic of neural circuits requires that dendritic arborations from the same 
neuron recognize and repel each other (Montague and Friedlander 1989, Hughes, Bortnick et 
al. 2007, Matthews, Kim et al. 2007, Grueber and Sagasti 2010, Zipursky and Sanes 2010, 
Lefebvre, Kostadinov et al. 2012, Gibson, Tymanskyj et al. 2014), a process known as self-
avoidance. Self-avoidance requires the each neuron have a unique cell surface identity to that 
of neighboring neurons. Self-avoidance is best understood in Drosophila, where a large family 
of immunoglobulin (Ig)-containing proteins, encoded by the down syndrome cell adhesion 
molecule (Dscam1) gene locus, mediate this process (Wang, Su et al. 2002, Zhan, Clemens et 
al. 2004, Hughes, Bortnick et al. 2007, Matthews, Kim et al. 2007, Soba, Zhu et al. 2007). In the 
case of vertebrates however, Dscam genes do not generate significant cell surface diversity 
(Schmucker and Chen 2009), suggesting that other genes may serve this function in the 
vertebrates. The most promising candidate is the clustered protocadherins (Pcdhs) (Zipursky 
and Sanes 2010, Hoang and Grueber 2013, Zipursky and Grueber 2013), which were recently 
shown to be involved in neuronal self-avoidance in starbust amacrine neurons and Purkinje 
neurons (Lefebvre, Kostadinov et al. 2012). 
Previous studies have demonstrated that Pcdh isoforms engage in specific homophilic 
trans interactions (Chapter 4) (Schreiner and Weiner 2010). Multiple sequence and structure 
analysis suggested that because Pcdhs are missing canonical features of classical cadherin 
interface, the Pcdhs homophilic recognition interface is likely different from the adhesion 





strand swapping (Posy, Shapiro et al. 2008). Initial structural characterization by NMR of a 
monomeric N-terminal EC1 domain from Pcdhα4 suggested that there is not a hydrophobic 
pocket large enough to bury a tryptophan residue as occurs in the strand-swapped classical 
cadherin dimer (eg. N-cadherin). In addition, domain shuffling experiments in which N-cadherin 
EC1 is replaced by Pcdhα4 EC1 showed the Pcdhα4 EC1 was insufficient for trans binding 
(Morishita, Umitsu et al. 2006). Schreiner and Weiner (2010) suggested that EC1 is necessary 
for binding and EC2 and EC3 determine Pcdhγ specificity. The observations that the EC2 and 
EC3 domains are the most diverse among the EC domains (Chapter 4) (Schreiner and Weiner 
2010) are consistent with this notion.   
Sequence comparisons with related “classical” cadherins show that Pcdh molecular 
architecture and binding mechanism differs from that of classical cadherins (Posy, Shapiro et al. 
2008). While the structure of the trans interaction for “classical” cadherins is well established 
(Tamura, Shan et al. 1998, Boggon, Murray et al. 2002, Chen, Posy et al. 2005, Patel, Ciatto et 
al. 2006, Shapiro 2007, Katsamba, Carroll et al. 2009, Ciatto, Bahna et al. 2010, Harrison, 
Bahna et al. 2010, Brasch, Harrison et al. 2011), little is known of the structure of Pcdhs, or of 
their homophilic complexes. The classical cadherins contain five extracellular (EC) domains 
while the Pcdhs contain six. In addition, classical cadherins bind in trans through their EC1 
domains (for review see (Brasch, Harrison et al. 2012)) whereas for Pcdhs. In addition, it was 
also suggested the Pcdh binding is much less calcium dependent than that of classical 
cadherins (Schreiner and Weiner 2010). 
Cadherins are named for their adhesive function, which is dependent on the presence of 
extracellular Ca2+ ions. Calcium ions bind to cadherins through conserved sites located in 
linkers between successive EC domains, each site binding to three Ca2+ ions. In classical 
cadherins (which bind 12 Ca2+) the adhesive role of the calcium ions is in rigidifying the 





binding. Although clustered Pcdhs contain the conserved Ca2+ ion binding ligands in the linkers 
between all EC domains, the role of Ca2+ ions in Pcdh-mediated cell recognition remains 
unclear. Frank et al (2005) used cell aggregation assays to test the calcium dependence of 
PcdhγA3 and PcdhγC3 binding using HEK293 cells and concluded the Pcdh binding was 
calcium dependent. However, it was later indicated that this Ca2+ dependence could arise from 
the HEK293 endogenous expression of N-cadherin (Schreiner and Weiner 2010). 
Here we present a monomeric, rod-like x-ray crystal structure of the specificity 
determining region of PcdhγC5. We show that PcdhγC5 coordinates three calcium ions between 
each consecutive EC domain, as is observed with classical cadherins, and that Pcdh binding is 
calcium dependent. To investigate Pcdh binding specificity, we performed an extensive 
sequence analysis of clustered Pcdhs and identified one pair from each cluster with nearly 
identical sequences in their EC2 and EC3 domains, the putative specificity determining region. 
Based on the PcdhγC5 structure, we built models of the closely-related Pcdh pairs from each 
cluster and mapped the variable regions to the molecule. The specificity determining regions 
were further narrowed by domain shuffling and mutagenesis experiments. Combined with the 
analysis of the close pairs, variable regions that contained solvent exposed residues were 
mutated to arginine or glutamic acid in an attempt to disrupt the binding interface. Combined, 
these two methods suggest a region likely to be involved in the trans Pcdh binding interface. 
Results 
Rod-like structure of PcdhγC5 
 In an effort to visualize the trans binding region of a clustered Pcdh, we first determined 
whether we could produce functional PcdhγC5 using a non-native signal peptide that increasing 
protein expression and would be necessary to obtain sufficient quantities of protein for 





transmembrane transport is up-regulated by ER stress (Rapoport, Matlack et al. 1999). We 
used SignalP 4.0 (Petersen, Brunak et al. 2011) to predicted the PcdhγC5 signal peptide (SP) 
cleavage site and replaced the native SP with BiP. We show that BiP-PcdhgC5 produces robust 
cell aggregates (Fig. 1A). Since shorter molecules are more likely to crystalize, we wanted to 
identify the minimal specificity determining region. To test the specificity determining region of 
PcdhgC5, we produced a chimeric fusion protein containing PcdhγC5 (EC1-EC3) followed by 
PcdhγC3 (EC4-C-terminus) and tested the binding specificity of the chimeric protein against 
wild-type PcdhγC5. Intermixing of differentially labeled cells expressing the chimera or the wild-
type PcdhγC5 indicate that EC1-EC3 is the specificity determining region for PcdhγC5 (Fig. 1A).  
We then produced soluble BiP-PcdhγC5 EC1-EC3 in mammalian cells (see Methods for 
details). Characterization of this protein by sedimentation equilibrium analytical 
ultracentrifugation experiments indicated that this protein behaved as a monomer in solution. 
Nevertheless, crystallization of proteins with low binding affinities can sometimes reveal weak 
binding interfaces. However, the crystal structures of PcdhγC5 EC1-EC3 also suggest that this 
protein behaves as a monomer. As was observed in a previous NMR structure of Pcdhα4 EC1, 
we see a di-sulfide bond between the Cys-X5-Cys motif in EC1 (Morishita, Umitsu et al. 2006). 
In addition, we see single O-mannosylation on two residues in EC2 (S194 and T196) (Fig. 1B). 
A previous study found that members of the cadherin family contain conserved O-
mannosylation sites but the functional role of this glycosylation remains to be determined 
(Vester-Christensen, Halim et al. 2013). We detected continuous hydrophobic surface patches 
with Quilt (Lijnzaad, Berendsen et al. 1996). We found that the largest hydrophobic patch 
(~560ºÅ2) occurs in EC2 (Fig. 1B). These structural features could have an impact on how Pcdh 





Pcdh binding is calcium dependent 
 Previous studies reported conflicting results regarding the calcium dependence of Pcdh 
binding. Frank et al (Frank, Ebert et al. 2005) reported that Pcdh binding is calcium dependent, 
whereas Schreiner and Weiner (2010) suggested that Pcdh binding is much less calcium 
dependent than classical cadherins. We observed three calcium ions coordinated between each 
consecutive EC domain in our PcdhγC5 structure, as is observed in classical cadherins (Fig. 
2A). Given this observation and the conservation of calcium binding ligands in all clustered 
Pcdhs, we expected calcium binding to be calcium dependent. We noted that Schreiner and 
Weiner (2010) used EDTA as a calcium chelator. EGTA chelates divalent ions better than 
EDTA. For this reason, we tested the effect of both chelators, EDTA and EGTA, on Pcdh 
binding in the K562 cell aggregation assay. In both cases, we observed an abrogation of Pcdh 
binding upon the addition of chelating agent. We also tested whether Pcdh binding could be 
rescued by the addition of fresh medium (without chelator) and found the Pcdh binding could be 
restored by this addition (see Supp. Fig.  2). These observations and the conservation of 
calcium binding ligands in all clustered Pcdh sequences strongly suggested that Pcdh binding is 
calcium dependent. 
Identification of candidate specificity determining regions in EC1, EC2, and EC3 
An understanding of the molecular mechanism underlying homophilic interactions of 
Pcdhs requires an accurate definition of the binding interface. In the absence of a high-
resolution structure of a Pcdh complex, we undertook an extensive sequence analysis of Pcdh 
isoforms in order to identify candidate specificity determining regions. Previous studies suggest 
that Pcdh EC2 and EC3 domains determine specificity and that the EC1 domain is required for 
trans binding (Schreiner and Weiner 2010). We reasoned that if pairs of Pcdh isoforms with 
nearly identical sequences in their EC2 and EC3 domains bind strictly homophilically, then the 





subset of the variable residues in this pair should be specificity-determining residues, which are 
expected to be located at or approximate to the interface.  
In all three clusters, we recently identified pairs of Pcdh isoforms that share over 90% 
pairwise sequence identity in their EC2-EC3 domains, the putative specificity-determining 
region. The pairs are Pcdh-α7 and -α8, -β6 and - β8, and -γA8 and -γA9 with 97%, 95%, and 
92% pairwise sequence identities, respectively. Remarkably, each of these proteins binds 
strictly homophilically (Chapter 4). Since previous studies (Chapter 4)(Schreiner and Weiner 
2010) showed that the EC1 domain is required for Pcdh trans binding, we have included this 
domain in our analysis of the closely-related Pcdh pairs from each cluster. Residues differing 
between the closely-related Pcdh pairs are highlighted in Figure 3A. Using the PcdhγC5 
structure as a template, we created homology models for each of the three pairs, and mapped 
the variable residues in each pair onto the structural models (Fig. 3B).  
Variable residues were mainly located in the BC loop region of the EC2 domain and in 
the FG loop of the EC3 domain. In all three models variable residues do not distribute equally 
on the surface of the molecules. For example, the EC2 domain has residues that are different 
among Pcdh-β6 and -β8 only on Face A whereas in the EC3 domain only Face B contains 
residues that are differ between Pcdh-β6 and -β8 (Fig. 3, center panels). Such a conservation 
pattern suggests that not all domains contribute to the specificities of the closest pairs. 
Therefore, knowledge of the contribution of each domain to the specificity within these pairs can 
elucidate the face the molecule involved in the binding interaction and also reduce the number 
of candidate specificity-determining residues.  
EC Domain shuffling between closely-related Pcdh isoform pairs 
 We shuffled the first three N-terminal EC1-EC3 domains among each of the closely-





resulting from domain shuffling using a K562 cell aggregation assay (Chapter 4)(Schreiner and 
Weiner 2010). In this assay, chimeric Pcdh constructs were fused to mCherry at their C-termini. 
Cells expressing wild-type Pcdh isoforms fused to mVenus at their C-termini were then mixed 
with the differentially labeled cells expressing chimeric Pcdh constructs. We tested the 
specificity of chimeric constructs where one, two, and/or all three amino-terminal EC domains 
were shuffled between closely-related pairs. Our goal was to determine which EC domains were 
necessary to convert the binding specificity of between one Pcdh isoform in the closely-related 
pairs (the original isoform) to that of the other Pcdh isoform (the target isoform). We attempted 
to convert Pcdh-α7 to –α8, Pcdh-β6 to -β8, Pcdh-γA8 to –γA9, and vice versa for Pcdh-γA9 to –
γA8 (see Supp. Fig. 3).  
All the chimeric Pcdh isoforms bound to themselves, demonstrating that these 
constructs are functional in mediating trans binding interactions. For each chimeric Pcdh isoform 
tested, we found one of the following three outcomes: binding to the original isoform, binding to 
the target isoform, or binding only to itself. We first tested whether the EC1-EC3 domains 
comprise the specificity-determining region in all three pairs. In all three pairs, shuffling of 
domains EC1-EC3 between the closely-related Pcdh isoforms converted specificity from the 
original isoform to that of the target isoform (Fig. 4). We then explored the minimum domain 
combinations that comprise the specificity-determining region. We found that in order to 
interchange specificity from Pcdh-α7 to -α8 it was necessary to exchange all three N-terminal 
EC domains (EC1-EC3) (Fig. 4A). In contrast, in order to interchange the specificities of Pcdh-
β6 to -β8 or from Pcdh-γA8 to -γA9, exchange of only two EC domains was sufficient to 
interchange specificity. In the case Pcdh-β6 to -β8, shuffling of the first two N-terminal EC 
domains (EC1-EC2) interchanged the specificity, whereas converting Pcdh-γA8 to -γA9 required 
the exchange of domains EC1 and EC3. Importantly, we found that in all three cases tested 





specificity-determining region comprises the EC1 domain. These results are in contrast to a 
previous report that suggested that only EC2 and EC3 domains contribute to trans specificity 
(Schreiner and Weiner 2010). 
Identification of specificity-determining residues in EC1, EC2, and EC3 
The results above show that the EC2 domain affects binding specificity for both the 
Pcdhα and Pcdhβ closely-related pairs. There is only a one residue difference between Pcdh-
α7 and -α8 isoforms at position 114 and seven residue differences between Pcdh-β6 and -β8 
isoforms (Fig. 3). Four of these seven residues (116, 117, 120, and 124) are structurally in close 
proximity to position 114 and are also located in or close to the hydrophobic patch identified in 
the PcdhγC5 structure (Fig. 1). To test whether these residues are important to specificity, we 
mutated these residues in chimeric constructs as shown in Figure 5A and tested the binding 
specificity of these new constructs.   
We also found that the EC3 domains affect binding specificities for both Pcdh-α7/-α8 
and Pcdh-γA8/-γA9 pairs. We noted that both of these pairs have three variable residues in the 
FG loop of the EC3 domain. These positions are also varied among the Pcdh-γA8 and -γA9 
pairs within orthologs, thereby suggesting that these three residues are important for specific 
homophilic recognition of this pair. Interestingly, the FG loop is in close structural proximity to 
residue 114 of the EC2 domain found to be important for specificity above. To test whether 
these residues are important to specificity, we mutated these residues in chimeric constructs as 
shown in Figure 5B and tested the binding specificity of these new constructs. We found that 
exchanging residues in the FG loop of chimeric Pcdhs converted specificity between Pcdh-α7/-
α8 pair and between the Pcdh-γA8/-γA9 pair. Thus, these residues are important to Pcdh 





Charge scanning mutations of PcdhγC5 can abrogate binding 
 Previous studies have used arginine scanning as a method to probe the site of 
interaction between antibodies and their antigens (Pancera, Shahzad-Ul-Hussan et al. 2013). 
Here, we use a similar approach to probe the binding interface of PcdhγC5. Candidate residues 
for mutagenesis were designed based on the alignment of closely related Pcdhs in Figure 3 
and on the PcdhγC5 structure. Only solvent exposed residues were mutated. Since some of the 
candidate residues of interest were arginines in the native PcdhγC5 protein, we mutated these 
residues to glutamic acid and have called this method charge scanning mutagenesis. A 
summary of all mutations can be found in Supplemental Table 1. The results of the cell 
aggregation assays were mapped to the PcdhγC5 structure and colored according to their effect 
on cell aggregation (Fig. 6A).  
An alternative method to identify candidate regions for a biological binding interface 
involves the identification of contiguous hydrophobic surfaces which result in regions that would 
be energetically favorable to bury in a biological interface. We mapped contiguous hydrophobic 
surfaces on the PcdhγC5 structure using Quilt (Lijnzaad, Feenstra et al. 2008). The results of 
this mapping showed a hydrophobic region of ~580Å2 in EC2, suggesting that this region may 
be involved in the Pcdh binding interface. Mapping of the mutations that disrupted binding or 
decreased aggregate size also highlight this region (Fig. 6B). Most of the mutations had no 
effect on Pcdh binding. Only two of the twenty mutants produced both expressed and negatively 
affected Pcdh binding. In the case of the PcdhγC5 S116R mutant, we see no cell aggregates. In 
PcdhγC5 D126R we see a reduction in aggregate size (Fig. 6C). These results suggestion that 
the region of EC2 highlighted in Figure 6 is likely to be involved in the Pcdh trans binding 
interface. Further mutagenesis in this region on PcdhγC5 and on other clustered Pcdhs is 






 Combinatorial expression of Pcdh isoforms generates unique cell recognition 
specificities. Critically, even Pcdh isoforms with high sequence identity in the specificity 
determining region (EC1-EC3) bind strictly homophilically. The studies described here localize 
the specificity determining regions of the EC2 and EC3 domains in closely related Pcdh pairs. 
Further, we show that mutagenesis of this region in the EC2 domain of PcdhγC5 disrupts 
binding. Combined, these results support the hypothesis that this region is involved in the Pcdh 
trans binding interface for Pcdhs from each gene cluster. Given that the x-ray structure of 
PcdhγC5 EC1-EC3 contained the specificity determining region of the molecule, we consider 
why it is that the soluble PcdhγC5 EC1-EC3 behaves as a monomer in sedimentation 
equilibrium experiments by AUC and in the crystal structures. Previous studies suggest that 
Pcdhs form cis complexes (Schalm, Ballif et al. 2010) and that the membrane proximal EC4-
EC6 are involved in this process (Chapter 4) (Schreiner and Weiner 2010). Since the PcdhγC5 
crystallography construct did not include any of these domains, one possibility is that cis 
interactions are required for trans recognition to occur. This could happen in the formation of a 
cis complex formed a composite interface involved in trans interactions.  
 Overall, there is striking similarity in the molecular logic by which Dscam1 isoforms and 
clustered Pcdhs achieve highly specific self-recognition. Invertebrate Dscam1 diversity is 
realized by the combinations of three alternatively spliced exons to generate thousands of 
Dscam1 isoforms that bind homophilically, where the binding specificity comprising region of is 
composed of the modular interactions of three domains (Ig2, Ig3, and Ig7). Here we show that 
the Pcdh binding specificity region is also modular and composed of three domains (EC1, EC2, 
and EC3). To achieve neuronal self recognition and non-self discrimination both Dscam1 and 
Pcdhs require distinct binding specificities. For Dscam1, it was shown that cells expressing 





show that Pcdhs have this property as well (Fig. 5). It is remarkable that both invertebrate 
Dscam1 and vertebrate clustered Pcdh proteins mediate highly specific homophilic interactions, 
function in self-avoidance, and generate single cell diversity in the nervous system involving 
different molecular mechanisms with a common logic. 
 The work described here is not yet complete. Currently, we are expanding the set of 
PcdhγC5 mutants to include: S114R, A118R, Q298Y, Q302R, A300R, and Q296R. Here we 
showed evidence that the PcdhγC5 S116R mutation abrogates binding. We are producing the 
analogous mutation in one of the Pcdhs from each of the closely related pairs: Pcdhα7/γC3 
(EC6) S116R, PcdhγA8 I116R, and Pcdhβ6 S117R. In addition, we are producing soluble, 
recombinant PcdhγC5 EC1-EC3 (S116R) for biophysical characterization and/or crystallization 
to show that the S116R mutation does not disrupt the protein’s structure. Though none of the 
EC1 charge scanning mutants seemed to have an effect on binding, we continue to search for 
evidence localizing the binding interactions in the EC1 domain by exchanging the CD loop 
region in EC1 between the Pcdhα7 and Pcdhα8 pairs.  
 While this work identifies regions on each EC domain likely to be involved in the Pcdh 
trans binding interface, the question of why the PcdhγC5 EC1-EC3 structure behaves 
monomerically remains. In addition, the molecular determinants of Pcdh binding specificity will 
likely require additional structural studies of Pcdh molecules that behave as multimers such as 
PcdhγA8 EC1-EC4, Pcdhα7 EC1-EC5, and PcdhγB6 EC1-EC6 (Chapter 3). If we find that the 
analogous S116R mutations disrupt binding in the closely-related pairs in cell aggregation 
assays, we will produce soluble Pcdh extracellular regions containing these mutations for the 
constructs that behave as multimers listed above and test whether the mutations have an effect 





address whether the binding affinities that we measured in Chapter 4 correspond to cis or trans 
interactions.  
Methods 
Cell aggregation assays. Expression constructs were transfected into K562 cells (human 
leukemia cell line, ATCC CCL243) by electroporation using Amaxa 4DNucleofactor (Lonza). 
After 24 hours in culture, the transfected cells were allowed to aggregate for one to three hours 
on a rocker kept inside the incubator. The cells were then fixed in 4% PFA for 10 minutes, 
washed in PBS, and cleared with 50% glycerol for imaging.  
Production of PcdhγC5 EC1-EC3 in FreeStyle 293 cells. Mouse PcdhγC5 EC1-EC3 was 
cloned into the pi-alpha H vector with a C-terminal Strep-6xHis  tag (WSHPQFEK-HHHHHH). 
DNA was transfected into FreeStyle 293 or suspension-adapted GNTi cells (obtained from the 
Kwong lab) using standard PEI transfection methods. Transfected cells were supplemented with 
200mL of fresh media per 800mL cells and 10mM CaCl2 approximately 12 hours after 
transfection. Conditioned media was collected after six days and purified over Ni-Sepharose 
beads. Eluate was concentrated and purified over a preparatory S200 (16/60 GE LifeSciences) 
size-exclusion column and then concentrated to approximately 10mg/mL.  
Crystalization and phasing of PcdhγC5 EC1-EC3. We grew crystals with the vapor diffusion 
method by mixing equal volumes of protein solution and crystallization buffer at 20°C. The 
crystallization conditions were as follows (added cryoprotectants are indicated in parentheses): 
mouse PcdhγC5 EC1-EC3 produced in FreeStyle 293 cells: 16% (w/v) PEG 6000, 100mM 
imidazole, pH 8.0, 200mM calcium acetate (30% (v/v) PEG 400); mouse PcdhγC5 EC1-EC3 
produced in FreeStyle 293 cells + 0.3mM yitterbium (III) chloride: 40% [v/v] MPD, 100mM 
sodium cacodylate, pH 6.0, 5% [w/v] PEG 8000; PcdhγC5 EC1-EC3 produced in suspension-





calcium chloride (20% [v/v] ethylene glycol). We obtained two phasing derivatives of the 
PcdhγC5 EC1-EC3 by soaking either in mother liquor containing 1mM ethylmercury phosphate 
or 1mM potassium mercuric iodide for 2-3 hours or overnight. Complete datasets from crystals 
frozen at 100K were collected at the NE-CAT beamline facilities (ID-24E) at the Advanced 
Photon Source. We processed and scaled the data with the HKL2000 suite (Otwinowski and 
Minor 1997, Otwinowski and Minor 2001). We collected all data sets at 0.9791Å wavelength. 
We obtained initial low-resolution phases for the mouse PcdhγC5 EC1-EC3 crystal 
structure by SIR/AS analysis of the ethylmercury phosphate derivative using site positions 
determined with the program SOLVE (Terwilliger and Berendzen 1999). These phases were 
then utilized to locate the positions of ordered mercury atoms in anomalous-difference Fourier 
maps. We performed phase calculations utilizing the mercury sites, using SOLVE to generate 
experimental electron density maps. After solvent flattening using SHARP (de La Fortelle and 
Bricogne 1997), models of the individual PcdhγC5 EC1, EC2, and EC3 domains were fit into the 
experimental maps and fitted manually using the program COOT (Emsley, Lohkamp et al. 
2010). We performed structure refinement with Phenix (Adams, Afonine et al. 2010). We solved 
all other crystal structures by molecular replacement with the program Phaser MR (McCoy, 
Grosse-Kunstleve et al. 2007) using the refined mouse PcdhγC5 EC1-EC3 structure as 
independent search models. Rounds of manual model fitting in COOT were alternated with 
refinement using Phenix (all structures). Crystallographic statistics are summarized in Table 1. 
Sequence alignments. The sequence alignment was calculated with Muscle (Edgar 2004) and 
presented using ESPript (Gouet, Robert et al. 2003). 
Homology Modeling. The structural models of PcdhγA8, Pcdhα7 and Pcdβ6 were constructed 






Identification of Hydrophobic Patch on PcdhγC5. We used the following parameters for Quilt 
(Lijnzaad, Berendsen et al. 1996): probe and polar expansion radius of 1.4Å was used, 252 
sampling/grid points per atom, and 50 randomized structures to test patches significance. 
Mutagenesis. PcdhγC5 mutants were prepared using the full length PcdhgC5 gene in the 
pDONR-zeo vector (Invitrogen) obtained from the Maniatis lab. Mutatgenesis primers were 
designed using the QuickChange Primer Design program (Agilent Technologies). PCR 
reactions were carried out using standard protocols for the Expand High Fidelity PCR system 
(Roche 11 732 641 001). PCR reactions were digested by DpnI (NEB R0176S) for one hour at 
37C, purified, and then 5uL of the reaction was transformed in TOP10 cells (Invitrogen). 
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  P43212 P21 C2 
Resolution range 
(Å) 
30.06  - 2.9 (2.847  - 
2.749) 40  - 3.0 (3.11  - 3.0) 40  - 3.1 (3.21  - 3.1) 
Space group P 43 21 2 P 1 21 1 C 1 2 1 
Unit cell 
108.637 108.637 96.614 
90 90 90 
67.188 84.563 109.144 90 
106.43 90 
190.806 104.916 80.066 
90 97.03 90 
Total reflections  194493 85896 94869 
Unique reflections 14827 23389 26871 
Multiplicity  12.7 (8.9) 3.7 (2.8) 3.5 (2.9) 
Completeness (%) 95.25 (73.82) 99.16 (93.05) 94.02 (72.86) 
Mean I/sigma(I)   12.04 (2.30) 8.30 (2.47) 
Wilson B-factor 55.56 74.18 56.8 
R-merge 0.118 (0.516)  0.068 (0.392) 0.11 (0.391) 





R-free 0.2477 (0.5346) 0.2610 (0.3456) 0.3305 (0.4011) 
Number of atoms 2438 4600 7201 
macromolecules 2348 4436 6994 
ligands 71 112 184 
water 19 52 23 
Protein residues 322 642 970 
RMS(bonds) 0.006 0.004 0.015 
RMS(angles) 0.96 0.77 1.17 
Ramachandran 
favored (%) 94 95 94 
Ramachandran 
outliers (%) 0 0 0.32 
Clashscore 3.8 2.79 26.45 
Average B-factor 77.7 84.8 74.6 
macromolecules 76.1 84.6 73.9 
ligands 133.6 106.9 106.2 
solvent 62.6 51.2 30 
  EMP K2HgI4 
Resolution range (Å) 30  - 3.5 (3.62  - 3.5) 30  - 2.9 (3  - 2.9) 
Space group P 43 21 2 P 43 21 2 
Unit cell 
108.637 108.637 96.614 90 90 
90 
108.637 108.637 96.614 90 90 
90 
Total reflections 92356 154516 
Unique reflections 14827 14827 
Multiplicity 12.2 (9.6) 11.7 (8.3) 
Completeness (%) 95.25 (73.82) 95.25 (73.82) 
Wilson B-factor 55.56 55.56 
R-merge 0.174 (0.48) 0.15 (0.426) 
R-work 0.2119 (0.4226) 0.2119 (0.4226) 
R-free 0.2477 (0.5346) 0.2477 (0.5346) 
Table 1. Refinement statistics 
Figure Legends 
Figure 1. Structure determination of the specificity determining region for PcdhγC5 and 
comparison to other related molecules 
A) Left panel: K562 aggregation assay using full-length PcdhγC5 produced with the artificial 





C-terminus. B) Cartoon representation of PcdhγC5 EC1-EC3 with the glycosylated residues 
labeled. A continuous hydrophobic patch found in EC2 is shown. 
Figure 2. Pcdh binding is calcium dependent 
A) Cartoon representation of PcdhγC5 with the side chains of calcium binding residues shown 
as sticks for the EC1-EC2 junction (left panel) and the EC2-EC3 junction (right panel). B) K562 
cell aggregation assay in the absence (top panels) and presence of chelator (middle and lower 
panels). N-cadherin binding is calcium dependent, and this protein was used as a control (left 
panels). The middle panels show PcdhγA3 and the right panels show the results for PcdhγC3. 
Figure 3. Multiple sequence alignment of the EC1-EC3 domains of PcdhγC5 and the three 
most similar Pcdh pairs.  
A) An alignment of the EC-EC3 domains of PcdhgC5 and each of the mostly closely-related 
Pcdh pairs from each cluster is shown. Secondary structure elements derived from the PcdhγC5 
structure are indicated above the alignment. Highlighted in red are sequence positions that are 
invariant in all seven sequences. Variable sequence positions among the close isoform pairs 
are colored according to the pair color: purple, green and blue for Pcdh-α, -β, and -γ isoforms 
respectively.  B) Structural models for each of the three pairs are shown. Two faces of the 
molecule are presented, Face A (top) and Face B (bottom). Highlighted in red are residues that 
are different between each pair. 
Figure 4. Domain shuffling experiments reveal that EC1, EC2 and EC3 contribute to Pcdh 
binding specificity 
A-C) Schematic representations of chimeric proteins and the results of cell aggregation assays 
used to test binding specificity are presented. Each of the chimera Pcdh construct contained a 
C-terminal mCherry fusion and was intermixed with cells expressing a wild-type Pcdh isoform 





homophilic binding. In all cases tested, domain shuffling of the EC1-EC3 domains interchanged 
specificity between closely-related pairs. EC domains are depicted as ellipses, TM – 
Transmembrane region, and ICD – intracellular domain. Domains from the original isoforms are 
colored in yellow and domains from the target isoform are colored in blue.  The results for the 
Pcdh-α, -β, and -γ pairs are shown in panels A, B, and C respectively. 
Figure 5. Identification of specificity determining residues in EC2 and EC3. 
A) Schematic representation of the chimeric construct and the shuffled residues are presented 
together with a space filling structural model of the domain (light blue) and residues shuffled 
among different isoforms (red). Binding capabilities of the new isoforms with the shuffled 
residue(s) to the wild-type Pcdh isoforms are presented. All chimeric Pcdh isoforms recognized 
themselves (see Supplemental Materials) and are only able to recognize one of the wild-type 
Pcdh isoforms.  
Figure 6. Charge scanning mutations on PcdhγC5 
A) The PcdhγC5 structure is shown in cartoon representation. Residues that were mutated to 
either arginine or glutamic acid are shown as spheres. Mutations that abrogated binding are 
shown in red. Mutations that resulted in smaller aggregates are shown in orange. Mutations that 
had no visible affect are shown in blue. B) A close-up of EC2 with the same representations 
descried above and also all side chains that were not mutated shown as sticks (left and right 
panels). A continuous hydrophobic patch identified by Quilt (Lijnzaad, Berendsen et al. 1996) is 
shown in surface representation (right panel). C) Representative results of K562 cell 
aggregation assays of PcdhγC5 point mutants are shown. Each protein contained a C-terminal 







Supplemental Figure 1. Comparison of PcdhγC5 EC domains with the EC domains of 
other cadherins of known structure 
 
 
Supplemental Figure 2. Pcdh binding is calcium dependent. 
Left panels show Pcdh and N-cadherin aggregates prior to the addition of EGTA. Center panels 
show that the addition of EGTA disrupts Pcdh and N-cadherin binding to form aggregates. Right 







Supplemental Figure 3. Pcdh domain shuffling in reverse direction. 
 
Supplemental Figure 4. CD-loop region in EC1 to be mutated. 
Supplemental Tables 
PcdhγC5 
Mutants Aggregates? Notes 
R3E Y   
E11R Y   
N18R Y   
K26E Y   
T28R Y   
R36E Y   





S47R Y   
V51R Y   
S72R Y   
H83R Y   
E86R Y   
R89E Y   
S101R Y   
D108R No expression   
E110R Y   
S116R N   
R122E No expression   
D126R Y small aggregates 
F162R Y   
V186R No expression   
T190R Y   
Q298R No expression   
 
Supplemental Table 1. Charge scanning mutants 
 
Future Directions 
Characterization and crystallization of additional Pcdh constructs 
 While we have made tremendous progress in our ability to produce soluble Pcdh 
ectodomains and ectodomain fragements (Chapter 3) and in our understanding of Pcdh 
interactions (Chapters 2, 4, 5, and 6), the nature of Pcdh complexes and the molecular 
determinants of binding specificity remain unclear. Biophysical characterization of additional 
Pcdh constructs that form multimers in AUC experiments are necessary to determine the 
minimal region required for trans binding and whether this region is consistent between 
subfamilies. Structure determination of Pcdh proteins known to form multimers in AUC 
experiments will provide atomic-level detail of the Pcdh binding interface(s). Determination of 
the structure of representative Pcdhs from each subfamily (Pcdhα, -β, and -γ) will demonstrate 





multiple Pcdh structures is likely to enable the identification of the molecular determinants of 
binding specificity.  
We have established the alternate Pcdhα isoforms must interact with other “carrier” 
Pcdhs in cis to reach the cell surface (Chapter 2), but whether or not there are rules governing 
cis interactions on the cell surface requires further investigation. Biophysical characterization 
and crystal structure determination of Pcdh ectodomains and ectodomain fragments could 
address each of these questions. Production of additional ∆EC1-Pcdhs, which are incapable of 
trans binding, will allow further investigation of Pcdh cis interactions and characterization of the 
relative affinities of homophilic or heterophilic cis interactions between Pcdhs. Alternatively, our 
work in Chapter 7 may have identified a single point mutation that abrogates trans binding in 
Pcdhs. Once this finding is confirmed, this single point mutation can be used to disrupt trans 
binding and study cis interactions in soluble Pcdh ectodomains and ectodomain fragments. 
Determination of cis binding affinities may provide critical insights into potential rules for Pcdh 
cis complex formation. 
Additional possibilities for uses of purified Pcdh proteins 
A significant contribution of this work was the development of methods to purify soluble, 
well-behaved Pcdh ectodomains and ectodomains fragments in quantities sufficient for 
biophysical characterization and structural studies (Chapter 3 and 4). The ability to produce 
large quantities of Pcdh proteins paves the way for many other possible experiments. One 
challenge in studying Pcdhs in vivo is the current Pcdh antibodies are of poor quality and 
frequently bind to non-specific targets. Purified Pcdh proteins from our mammalian expression 
system could be used to produce superior Pcdh antibodies and may pave the way for a wide 
range of in vivo studies. In addition, purified Pcdh ectodomains or ectodomain fragments may 
allow the production of Pcdh antibodies that target specific subtypes of Pcdhs such as Pcdhαs. 





require further investigation and collaboration with a lab or facility that produces high quality 
antibodies.  
Another possible use for purified Pcdh extracellular regions is the surface staining of 
neurons in culture. The Maniatis lab is interested in developing a neuronal culture system where 
particular Pcdhs can be over-expressed. In this system, cell-surface staining using purified Pcdh 
extracellular regions containing a C-terminal tag such as alkaline phosphatase could allow the 
direct visualization of Pcdh binding on neuronal surfaces. Another possibility is that purified 
Pcdh extracellular regions could be used in neuronal cell culture experiments to induce the 
signaling events that result in self-repulsion. 
In addition to the possibility to study Pcdh interactions in vivo, purified Pcdh extracellular 
regions open up many possibilities for structural studies to characterize Pcdh complexes.  
Characterization of cell adhesion molecules on liposomes, which mimic the lipid bilayer found at 
the cell surface, by electron microscopy has provided insights into the structure of cadherin 
junctions (Harrison, Jin et al. 2011). Many questions remain about Pcdh complexes. 
Characterization of Pcdh complexes formed between to liposomes could provide valuable 
informs about whether Pcdhs form discrete complexes or larger junction-like regions between 
cells. 
Overall, the work presented in this thesis provided valuable insights into Pcdh binding 
properties. Understanding the interactions between Pcdh molecules is likely to aide in our 
understanding of Pcdh signaling and neuronal self-avoidance. In addition, the protein production 
tools developed here will aide in our ability to produce properly folded proteins in sufficient 
quantity and purity for biophysical and structural characterization for years to come. Our work 
with computational researchers in the Honig-Shapiro lab and wet-lab biologists in the Maniatis 





details of Pcdh interactions, structure, and function in vitro, and later investigate the effect of 
these interactions in vivo using tools and mouse strains being developed in the Maniatis lab. 
 
Supplemental Figure 3. Pcdh domain shuffling in reverse direction. 
 
Supplemental Figure 4. CD-loop region in EC1 to be mutated. 
Supplemental Tables 
PcdhγC5 
Mutants Aggregates? Notes 
R3E Y   
E11R Y   





K26E Y   
T28R Y   
R36E Y   
G38R Y   
S47R Y   
V51R Y   
S72R Y   
H83R Y   
E86R Y   
R89E Y   
S101R Y   
D108R No expression   
E110R Y   
S116R N   
R122E No expression   
D126R Y small aggregates 
F162R Y   
V186R No expression   
T190R Y   
Q298R No expression   
 
Supplemental Table 1. Charge scanning mutants 
 
Future Directions 
Characterization and crystallization of additional Pcdh constructs 
 While we have made tremendous progress in our ability to produce soluble Pcdh 
ectodomains and ectodomain fragements (Chapter 3) and in our understanding of Pcdh 
interactions (Chapters 2, 4, 5, and 6), the nature of Pcdh complexes and the molecular 
determinants of binding specificity remain unclear. Biophysical characterization of additional 
Pcdh constructs that form multimers in AUC experiments are necessary to determine the 
minimal region required for trans binding and whether this region is consistent between 
subfamilies. Structure determination of Pcdh proteins known to form multimers in AUC 





the structure of representative Pcdhs from each subfamily (Pcdh-α, -β, and -γ) will demonstrate 
whether all clustered Pcdhs binding through a common interface. In addition, comparison of 
multiple Pcdh structures is likely to enable the identification of the molecular determinants of 
binding specificity.  
We have established the alternate Pcdhα isoforms must interact with other “carrier” 
Pcdhs in cis to reach the cell surface (Chapter 2), but whether or not there are rules governing 
cis interactions on the cell surface requires further investigation. Biophysical characterization 
and crystal structure determination of Pcdh ectodomains and ectodomain fragments could 
address each of these questions. Production of additional ∆EC1-Pcdhs, which are incapable of 
trans binding, will allow further investigation of Pcdh cis interactions and characterization of the 
relative affinities of homophilic or heterophilic cis interactions between Pcdhs. Alternatively, our 
work in Chapter 7 may have identified a single point mutation that abrogates trans binding in 
Pcdhs. Once this finding is confirmed, this single point mutation can be used to disrupt trans 
binding and study cis interactions in soluble Pcdh ectodomains and ectodomain fragments. 
Determination of cis binding affinities may provide critical insights into potential rules for Pcdh 
cis complex formation. 
Additional possibilities for uses of purified Pcdh proteins 
A significant contribution of this work was the development of methods to purify soluble, 
well-behaved Pcdh ectodomains and ectodomains fragments in quantities sufficient for 
biophysical characterization and structural studies (Chapter 3 and 4). The ability to produce 
large quantities of Pcdh proteins paves the way for many other possible experiments. One 
challenge in studying Pcdhs in vivo is the current Pcdh antibodies are of poor quality and 
frequently bind to non-specific targets. Purified Pcdh proteins from our mammalian expression 
system could be used to produce superior Pcdh antibodies and may pave the way for a wide 





allow the production of Pcdh antibodies that target specific subtypes of Pcdhs such as Pcdhαs. 
Whether or not production of antibodies that target specific clusters of Pcdhs is possible will 
require further investigation and collaboration with a lab or facility that produces high quality 
antibodies.  
Another possible use for purified Pcdh extracellular regions is the surface staining of 
neurons in culture. The Maniatis lab is interested in developing a neuronal culture system where 
particular Pcdhs can be over-expressed. In this system, cell-surface staining using purified Pcdh 
extracellular regions containing a C-terminal tag such as alkaline phosphatase could allow the 
direct visualization of Pcdh binding on neuronal surfaces. Another possibility is that purified 
Pcdh extracellular regions could be used in neuronal cell culture experiments to induce the 
signaling events that result in self-repulsion. 
In addition to the possibility to study Pcdh interactions in vivo, purified Pcdh extracellular 
regions open up many possibilities for structural studies to characterize Pcdh complexes.  
Characterization of cell adhesion molecules on liposomes, which mimic the lipid bilayer found at 
the cell surface, by electron microscopy has provided insights into the structure of cadherin 
junctions (Harrison, Jin et al. 2011). Many questions remain about Pcdh complexes. 
Characterization of Pcdh complexes formed between to liposomes could provide valuable 
informs about whether Pcdhs form discrete complexes or larger junction-like regions between 
cells. 
Overall, the work presented in this thesis provided valuable insights into Pcdh binding 
properties. Understanding the interactions between Pcdh molecules is likely to aide in our 
understanding of Pcdh signaling and neuronal self-avoidance. In addition, the protein production 
tools developed here will aide in our ability to produce properly folded proteins in sufficient 





with computational researchers in the Honig-Shapiro lab and wet-lab biologists in the Maniatis 
lab has provided the foundation for a fruitful collaboration in which we can study the molecular 
details of Pcdh interactions, structure, and function in vitro, and later investigate the effect of 
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